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Abstract……. 
 
Kinetochores connect centromeres with spindle microtubules during mitosis and 
meiosis to ensure correct chromosome segregation. The initial step of kinetochore 
establishment in point centromere species, like budding yeast, is the sequence-
specific recognition of the centromere by the essential CBF3 complex. CBF3 
consists of four proteins, Ndc10, Cep3, Ctf13 and Skp1, and its binding to the 
centromere is required for the assembly of all other kinetochore proteins. Beside this, 
the complex is involved in the recruitment of the centromere-specific histone Cse4 
through its interaction with the histone chaperone Scm3 and it also impacts the 
overall conformation of the centromere through DNA looping and bending. Besides 
its crucial role in kinetochore establishment, little structural data is available for the 
CBF3 complex, mainly due to difficulties with recombinantly expressing and purifying 
the full complex. This thesis describes a working co-expression and purification 
protocol for CBF3, which allowed structural as well as functional studies of the 
complex and led to the cryoEM structure of the core CBF3 complex, comprising the 
centromere-binding Cep3 and the regulatory subunits Ctf13 and Skp1. Besides the 
overall core architecture, this structure provides the first insights into the inherently 
unstable subunit Ctf13, as well as a potential new conformation of the Skp1/F-box 
interaction. Furthermore, it provides interesting insights into the unusual DNA-
binding properties of the dimeric Cep3 to a single consensus site in the centromere, 
a matter of some debate in the field. Biochemical studies revealed a potential and 
previously undescribed regulatory mechanism of DNA-binding activity through 
phosphorylation of the Skp1 subunit. Additional work was undertaken to better 
understand how Ndc10 binds to the core complex and therefore how the full CBF3 
assembles, as well as interaction studies with the centromere-specific nucleosome. 
As a side project, interaction studies between Ndc10 and Scm3 were undertaken, to 
elucidate the proposed Cse4-loading function of CBF3. 
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Impact Statement 
 
Faithful chromosome segregation is a critical step in a cell’s life and mistakes in this 
complicated process can lead to cell death or chromosomal instability, the latter 
being a hallmark of cancer. Understanding of this crucial process is therefore 
important, and whilst intensive previous research has shed light on the regulatory 
mechanism, proteins involved and their functions, lots still remains unknown. 
Budding yeast has served as a faithful and widely used model organism for 
kinetochore studies, as it comprises a much simpler but highly conserved 
environment. Although CBF3, the subject of this thesis, has no homologue in higher 
eukaryotes, its function may well be conserved. Already it is known, that it impacts 
the loading of the yeast homologue of CENP-A through its interaction with the 
conserved centromere-specific histone chaperone Scm3. However, its centromere-
binding function might also be conserved, given its ability to change the overall 
conformation of the centromere by bending, which has also been proposed for the 
human centromere protein CENP-B. The role of CENP-B, despite being among the 
first centromere proteins to be discovered, is still unclear. Besides these functional 
similarities, CBF3 plays an essential role in budding yeast kinetochore establishment 
and therefore is crucial to ongoing attempts to reconstitute the whole budding yeast 
kinetochore. The latter will provide an invaluable tool to study kinetochore function 
and regulation and cannot easily be done with the more complex human kinetochore. 
CBF3 has so far been difficult to recombinantly express and purify, and was therefore 
lacking in the reconstituted kinetochores. The protocol described in this thesis should 
prove to be beneficial for future efforts in reconstitution of the whole budding yeast 
kinetochore, as well as for structural studies of larger parts of the inner kinetochore 
and centromere. 
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Chapter 1. Introduction 
1.1 Mitosis and chromosome segregation 
One of the characteristics of a living organism is its ability to propagate. To be able 
to do so cells need to divide, which is a complicated process and needs to be heavily 
regulated to avoid abnormal growth, as happens in cancer (Hanahan and Weinberg, 
2000). Before a cell divides, it needs to replicate its entire genome, which happens 
during S-phase of the cell cycle. The two identical copies must then be organised 
and separated into the two emerging daughter cells. This process, also called 
mitosis, was first described in the 18th century by a number of scientists, one of them 
being Walther Flemming, who coined the term. Mitosis is only a short period of the 
cell cycle and is preceded by interphase, in which the cell grows in size, replicates 
its genome and generally prepares for mitosis (Figure 1). 
 
Figure 1: The cell 
cycle of budding 
yeast 
Mitosis and cyto-
kinesis is followed by 
the much longer 
interphase, which can 
be divided into G1, S-
phase and G2. The 
progression through 
interphase is heavily 
regulated by cyclins 
and cyclin-dependent 
kinases and cells must 
fulfil checkpoints (high-
lighted in red) to progress into the next stages. In G1 the cell grows in size by normal 
metabolism. Replication of the genome happens in S-phase, followed by G2 in which the cell 
has time for DNA repair of damage happened during replication. If the G2 checkpoint is 
fulfilled it enters mitosis in which the sister chromatids are separated. Cytokinesis describes 
the process of the physical separation of the two emerging daughter cells and therefore the 
end of one cell cycle and beginning of the following one. 
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The process in which the mitotic spindle physically separates the two sister 
chromatids is called chromosome segregation (Figure 2). The enormous 
macromolecular complex, which facilitates this separation, is the kinetochore 
(McAinsh et al., 2003, Santaguida and Musacchio, 2009, Perpelescu and Fukagawa, 
2011, Biggins, 2013, Westhorpe and Straight, 2013, Cheerambathur and Desai, 
2014). The function of the kinetochore is to connect the centromeres of the sister 
chromatids to spindle microtubules of the opposite pole. Once this connection is 
correct, sensed by the kinetochore, the sister chromatids can be pulled apart into the 
two emerging daughter cells.  
 
 
Figure 2: Chromosome segregation of budding yeast 
Schematic representation of chromosome segregation: the newly replicated sister 
chromatids (chromosomes), held together by cohesin, are pulled apart into the two emerging 
daughter cells. Budding yeast undergoes a so-called ‘closed’ mitosis in which the nuclear 
membrane stays intact during the whole process. Microtubules are organised from the two 
spindle pole bodies, which are embedded in the nuclear envelope at the opposite poles. One 
can differentiate between microtubules attaching to the kinetochores and therefore to the 
centromeres (kinetochore microtubules), those extending towards the opposite spindle pole 
body (interpolar microtubules) and those extending towards the cell membrane (astral 
microtubules). Whilst the latter are important throughout the whole cell cycle to position the 
nucleus, interpolar microtubules are essential for spindle stability during mitosis. The 
kinetochores are responsible for sensing if all sister chromatids are correctly attached, a 
process involving establishment of tension.  
Chapter 1 Introduction 
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The overall architecture and mode of function is conserved between budding yeast 
and man, as are the majority of proteins involved (Meraldi et al., 2006). The budding 
yeast kinetochore, however, represents a much more simplified version and 
therefore has been used by many research groups as a model to study kinetochore 
function. Yet even this ‘simple’ budding yeast kinetochore consist of more than 60 
different proteins (Santaguida and Musacchio, 2009, McAinsh et al., 2003), which 
are orchestrated by a variety of regulative factors to facilitate faithful segregation. 
Defects in the kinetochore or its regulation result in chromosome mis-segregation, 
which can lead to cell cycle arrest and apoptosis or to chromosomal instability 
(Schuyler et al., 2012). The latter is observed in many types of cancer (Tanaka and 
Hirota, 2009, Jallepalli and Lengauer, 2001), which underlines the importance of 
understanding chromosome segregation and its regulation, thus enabling a better 
understanding of how it malfunctions in cancer. 
As this thesis is describing work on the essential budding yeast kinetochore complex 
CBF3, the following chapters are focussing on the architecture, function and 
regulation of the budding yeast kinetochore and centromere, whilst trying to 
emphasise similarities, but also discrepancies towards higher eukaryotes.  
1.2 The Centromere 
Whilst the overall structure of the kinetochore and the majority of its proteins are 
conserved (Meraldi et al., 2006), the centromeric sequence is highly divergent 
(Steiner and Henikoff, 2015). Indeed, centromeres can be separated into two groups, 
the point centromeres of budding yeasts and the regional centromeres of higher 
eukaryotes (Figure 3). The former are about 125bp long and consist of three 
elements, CDEI, II and III. Whilst CDEII is exceptionally A-T rich but vary in sequence 
and length, CDEI and III are conserved (Jehn, 1991, Clarke and Carbon, 1980) and 
are recognised and bound in a sequence-specific matter by Cbf1 and CBF3 
respectively (Cai and Davis, 1989, Lechner, 1991, Ng and Carbon, 1987). In 
contrast, the regional centromeres of higher eukaryotes are much longer, varying in 
size from a few thousand to mega base-pairs and their sequence is not conserved 
but consists of repetitive elements (Malik and Henikoff, 2002).  
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Figure 3: Point vs. regional centromeres 
A The short (~125bp) point centromere of budding yeast consists of three elements, CDEI, 
II and III. CDEII is non-conserved, but AT-rich and varies in length, whereas the other two 
elements are conserved sites for specific protein interaction. The essential CCG triplet in the 
CDEIII is highlighted in red. One centromeric nucleosome binds the entire centromeric 
sequence. B The long regional centromere of S.pombe consists of a central core (cnt), 
flanked by inner repeats (imr) and outer repeats (otr). The latter is made out of three 
elements: the dg, cen253 and dh repeats. Dg repeats are most conserved between the three 
chromosomes of S.pombe and are essential for centromere function alongside the cnt 
region. Centromeric nucleosomes, as well as H3 nucleosomes, featuring lysine-24 double 
methylation, as well as lysine-9 methylation in neighbouring heterochromatin. Human 
centromeres are up to Mbp long and consist mainly of alpha satellite DNA, of various 
sequence conservation and other elements inserted, such as the CENP-B box bound by 
CENP-B. 
 
Beside these differences all centromeres are epigenetically defined by the 
occurrence of a centromere-specific nucleosome, in which the canonical histone H3 
is replaced by the centromere-specific variant CENP-A (Cse4 in S.cerevisiae;  
Palmer et al., 1987, Stoler et al., 1995, Allshire and Karpen, 2008). In point 
centromere species, it is believed that a single CENP-A nucleosome binds the entire 
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centromere and is connected through the kinetochore to a single microtubule (Meluh 
et al., 1998, Furuyama and Biggins, 2007, Camahort et al., 2009, Cole et al., 2011). 
On the other hand, in regional centromere species many copies of CENP-A 
nucleosomes are bound to the long centromeric sequence, which in turn are 
connected to many spindle microtubules (Zinkowski et al., 1991, Bodor et al., 2014). 
The consequently larger kinetochore is believed to be assembled from a repetition 
of the basic ‘budding yeast kinetochore unit’; a widely accepted view, which is also 
known as the ‘repeat subunit’ model (Zinkowski et al., 1991, Joglekar et al., 2008, 
Santaguida and Musacchio, 2009, Burrack and Berman, 2012). These findings 
underline the importance of the simpler budding yeast kinetochore as the choice 
model organism, despite its different centromere structure.  
1.2.1 Centromere-specific nucleosome 
As mentioned above, a unique feature of both point and regional centromeres is the 
occurrence of the centromere-specific nucleosome. Whilst it is generally accepted 
that the centromeric nucleosome is defined by the replacement of H3 with CENP-A, 
its composition and structure is still a matter of debate. Whilst in vitro reconstituted 
centromeric nucleosomes tend to form conventional octamers, as determined by 
biochemistry (Yoda et al., 2000, Camahort et al., 2009, Kingston et al., 2011) and 
the crystal structure of the human CENP-A nucleosome (Tachiwana et al., 2011), 
there are several in vivo evidences of alternative structures. One of these is the so-
called ‘hemisome’, consisting of only one copy of CENP-A, H4, H2A and H2B. It was 
first purified from interphase Drosophila melanogaster cells after crosslinking and 
immunoprecipitation of CENP-ACID (Dalal, 2007) and could be stably reconstituted 
on 78bp AT-rich DNA with budding yeast proteins (Furuyama et al., 2013). Beside 
this hemisome structure, there is evidence in S.cerevisiae that the non-histone 
protein Scm3 can replace histones H2A and H2B from pre-assembled octameric 
nucleosomes (Mizuguchi et al., 2007). That and results from CHIP assays, which 
showed that H2A and H2B is absent at centromeric chromatin, led to the suggestion 
of a hexameric Cse4/H4/Scm3 structure (Mizuguchi et al., 2007). Furthermore, in 
vivo DNA topology studies showed that functional budding yeast centromeres 
introduce positive supercoiling (Diaz-Ingelmo et al., 2015, Furuyama and Henikoff, 
2009). A canonical nucleosome, as well as the CENP-A nucleosome crystal 
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structure, however, wraps DNA in a right-handed way, which subsequently leads to 
negative supercoiling (Figure 4).  
 
Figure 4: H3 vs. CENP-A nucleosome 
Side-to-side comparison of the H3 (left; 1AOI) and CENP-A (right; 3AN2) nucleosome crystal 
structures in two orientations. Whereas the histones themselves pack in a very similar 
fashion, the main difference between the two structures are the DNA ends: whereas all 146bp 
of DNA are tightly wrapped around the H3-containing histone octamer, 13 base pairs from 
both ends of the DNA in the CENP-A crystal structure are not resolved, indicating a loose 
interaction (the corresponding base pairs in the H3 nucleosome structure are highlighted in 
pink). One should note that both H3 as well as CENP-A nucleosomes were reconstituted 
with 146bp DNA. The boxed close-up view shows the difference in the Nα helix between H3 
(green) and CENP-A (red). The latter is shorter and its preceding tail completely disordered, 
explaining the looser DNA contacts in this region. All other differences are reviewed in detail 
in Tachiwana et al., 2011. Histones are coloured as following: H2A… light grey; H2B… dark 
grey; H4… yellow; H3… green; CENP-A… red.  
 
On the other hand, many features of the CENP-A nucleosome crystal structure align 
with biochemical data (Tachiwana et al., 2011, Moreno-Moreno et al., 2017). One of 
these features is, that the CENP-A nucleosome binds DNA ends less stably, resulting 
Nα 
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in a more open conformation as is seen for the H3 nucleosomes (Figure 4). This 
explains biochemical data from human, as well as budding yeast and drosophila, 
showing that their centromeric nucleosomes protect less DNA from nuclease 
treatment than a conventional nucleosome (Yoda et al., 2000, Cole et al., 2011, 
Kingston et al., 2011). Two arguments speak for a conserved structure of the 
centromeric nucleosome between budding yeast and human. First, the high 
sequence conservation of the proteins in their histone-fold-domain (HFD; Sullivan et 
al., 1994, Stoler et al., 1995), and second the fact that overexpression of Cse4 can 
rescue a RNAi induced CENP-A deletion in human cells (Wieland et al., 2004). To 
clarify the composition of the budding yeast centromeric nucleosome, it will be 
necessary to investigate the structure of the yeast centromere bound by the 
nucleosome and other centromere-associated proteins, like the essential, four-
subunit centromere-binding factor 3 (CBF3). A limiting factor for the reconstitution of 
such a bigger assembly so far, was the inability to recombinantly express and purify 
the budding yeast CBF3 complex in useful quantities. 
Besides the composition of the centromeric nucleosome, another interesting 
question in the field is how is CENP-A specifically recruited to the centromere. 
Besides the differences in centromere sequence, a conserved histone chaperone, 
HJURP in human and Scm3 in yeasts, is involved in this process (Camahort et al., 
2007, Shuaib et al., 2010). It forms a stable and soluble complex with CENP-A and 
H4 and is involved in their assembly into centromeric chromatin (Shuaib et al., 2010, 
Dechassa et al., 2014). A variety of proteins act to prime centromeric sequence for 
CENP-A incorporation through their interaction with HJURPScm3 in regional 
centromere species (Hayashi et al., 2004, Fujita et al., 2007, Nardi et al., 2016, An 
et al., 2018; reviewed in Musacchio and Desai, 2017). In budding yeast, however, it 
is suggested, that Scm3 is recruited to the centromere through its interaction with the 
centromere binding complex CBF3 (Camahort et al., 2007, Cho and Harrison, 2012). 
The latter is discussed in more detail in 1.4.3. 
1.3 The Kinetochore 
The main function of the kinetochore is to connect the centromeres of sister 
chromatids to spindle microtubules of the opposite pole. This is facilitated through 
one of the biggest macromolecular assemblies in the cell. One can divide the overall 
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kinetochore structure in three different layers: The inner layer which recognises and 
binds the centromere; the outer layer which interfaces with spindle microtubules and 
the middle layer which acts as a bridge between the other two and is involved in the 
regulation of function (reviewed in Santaguida and Musacchio, 2009 and Musacchio 
and Desai, 2017). Beside the physical anchoring of centromeres to spindle 
microtubules, the kinetochore is also responsible for the verification of correct 
attachment, the activation of the spindle assembly checkpoint (SAC) and also 
participates in microtubule dependent force generation for movements of 
chromosomes (Joglekar et al., 2010, Suzuki et al., 2016). The budding yeast 
kinetochore consists of more than 60 different proteins, many of which cluster in 
subcomplexes and most are conserved to humans (Figure 5, Table 1; McAinsh et 
al., 2003, De Wulf et al., 2003, Meraldi et al., 2006). Although featuring the simplest 
kinetochore, much of the molecular architecture and function is still unknown.  
 
Figure 5: Kinetochore schematic 
A Illustration of kinetochore sub-complexes from budding yeast (left) and human (right), 
excluding regulator proteins like the chromosomal passenger complex and SAC 
Chapter 1 Introduction 
24 
 
components. Some available structures are shown in Figure 6 and all kinetochore proteins 
are listed in Table 1. B Schematic of the ‘repeat subunit’ model, demonstrating that the 
human kinetochore consists out of many repeats of the basic budding yeast kinetochore unit. 
Therefore, each of the CENP-A nucleosomes is connected to a spindle microtubule, whereas 
in budding yeast the single Cse4 nucleosome connects to only one spindle microtubule.  
 
Figure 6: Selection of structures of kinetochore subunits 
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3XZU: crystal structure of the heterodimer of the K.lactis Mcm21 and Ctf19, part of the four 
subunit COMA complex, featuring four RWD domains. 6COW: cryoEM structure of the 
CENP-A nucleosome bound by CENP-N, which interacts with CENP-A through its L1 loop. 
5LSK: Crystal structure of the budding yeast MIND complex, made out of four subunits and 
participating an elongated structure which connects both to the inner kinetochore through its 
interaction with CENP-CMif2 and to the outer kinetochore complexes like Ndc80 complex. 
5T58: crystal structure of the human homologue, the MIS12 complex, exhibiting a similar 
structure. Here also a small part of CENP-C could be co-crystallised and resolved. 3IZO: 
cryoEM structure of Ndc80/Nuf2 bound to microtubule, shown as only one alpha and beta 
tubulin. 6CFZ: CryoEM analysis of the DASH/Dam1 ring whereas only one heterodecameric 
unit of the ring is shown. 
 
Below, an overview of the current understanding of the budding yeast kinetochore 
architecture is given, starting from the inner layer of centromere associated proteins 
and moving towards the outer layer of microtubule binding subunits. Differences and 
similarities to higher eukaryotes with regional centromeres are discussed. All main 
kinetochore proteins and their conservation between the three largely studied 
organism are listed in Table 1. Finally, the regulative functionalities of the kinetochore 
are described, including the error-correction and the spindle assembly checkpoint 
(SAC). 
 
Table 1: Overview list of main kinetochore proteins  
Kinetochore proteins in budding yeast, fission yeast and humans grouped by subcomplexes. 
It should be noted that this list is not comprehensive and additional kinetochore proteins exist. 
For a more elaborate list see Musacchio and Desai, 2017. 
 
Kinetochore proteins  Subcomplexes 
S.cerevisiae S.pombe H.sapiens S.cerevisiae S.pombe H.sapiens 
Ndc10 - - CBF3 - 
- 
- 
- 
- 
- 
- 
- 
Cep3 - - 
Ctf13 - - 
Skp1 - - 
Cse4 Cnp1 CENP-A - - - 
      
Cbf1 - - - - - 
      
Mif2 Cnp3 CENP-C - Part of CCAN Part of CCAN 
      
- - CENP-B    
      
Cnn1 - CENP-T Ctf19 complex Sim4 complex CCAN 
Wip1 - CENP-W 
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Mcm16 Fta3 CENP-H 
Ctf3 Mis6 CENP-I 
- Sim4 CENP-K 
- - CENP-M 
Mcm21 Mal2 CENP-O 
Ctf19 Fta2 CENP-P 
Okp1 - CENP-Q 
- - CENP-R 
Ame1 Fta4 CENP-U 
Iml3 Fta1 CENP-L 
Chl4 Mis15 CENP-N 
Mhf1 - CENP-S 
Mhf2  CENP-X 
Mcm22 - - 
- Mis17 - 
- Fta5 - 
- Fta6 - 
- Fta7 - 
      
Spc105 Spc7 KNL1 Spc105 
complex 
Spc7 
complex 
KNL-1 
complex Kre28 - Zwint 
      
Mtw1 Mis12 MIS12 MIND 
complex 
Mis12 
complex 
MIS12 
complex Dsn1 Mis13 DSN1 
Nnf1 Nnf1 PMF1 
Nsl1 Mis14 NSL1 
      
Ndc80 Ndc80 NDC80 Ndc80 
complex 
Ndc80 
complex 
Ndc80 
complex Nuf2 Nuf2 NUF2 
Spc24 Spc24 SPC24 
Spc25 Spc25 SPC25 
      
Dam1 Dam1 - Dam1 
complex 
Dam1 
complex 
- 
Duo1 Duo1 - 
Spc34 Spc34 - 
Dad1 Dad1 - 
Spc19 Spc19 - 
Ask1 Ask1 - 
Dad2 Dad2 - 
Dad3 Dad3 - 
Dad4 Dad4 - 
Hsk3 Hsk3 - 
      
- - ROD - - RZZ 
complex - - ZW10 
- - Zwilch 
      
- - SKA1 - - Ska 
complex - - SKA2 
- - SKA3 
      
Mad2 Mad2 MAD2 Mitotic 
checkpoint 
complex 
Mitotic 
checkpoint 
complex 
Mitotic 
checkpoint 
complex 
Bub3 Bub3 BUB3 
Mad3 Mad3 BUBR1 
Cdc20 Slp1 CDC20 
      
Ipl1 Ark1 Aurora B Chromosome 
Passenger 
complex 
Chromosome 
Passenger 
complex 
Chromosome 
Passenger 
complex 
Sli15 Plc1 INCENP 
Bir1 Cut7 Survivin 
Nbl1p - Borealin 
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1.3.1 Inner kinetochore 
One of the first budding yeast kinetochore complexes to be described was the CBF3 
complex, which binds sequence-specifically to the centromere and is required for the 
recruitment of all other kinetochore proteins to the centromeric DNA (Ng and Carbon, 
1987, Lechner, 1991, Goh, 1993, Strunnikov et al., 1995, Connelly and Hieter, 1996). 
CBF3 consists of four subunits, all of which are essential and mutations of these lead 
to a complete loss of kinetochore function in vivo, as well as a loss of 
centromere/spindle microtubule attachment in vitro (Goh, 1993, Sorger, 1994, He et 
al., 2001).  
Other inner kinetochore proteins bound directly to the centromere include the 
homodimeric protein Cbf1 (Bram and Kornberg, 1987), the centromere-specific Cse4 
nucleosome (Meluh et al., 1998) and Mif2 (Meluh and Koshland, 1997). Cbf1 
recognises and specifically binds the centromere element CDEI and although it is 
not essential, its deletion leads to an increased loss of a mitotic CEN plasmid (Cai 
and Davis, 1989, Mellor et al., 1990). On the other hand, the centromeric nucleosome 
and Mif2 are absolutely essential for kinetochore establishment and function (Brown 
et al., 1993). The latter has been shown to specifically bind to the Cse4-nucleosome 
(Falk et al., 2015, Xiao et al., 2017), as well as other inner and middle kinetochore 
complexes (see 1.3.2). How all of these proteins can bind such a short stretch of 
DNA is still debated, as is the conformation of the centromeric nucleosome (see 
1.2.1). Structural studies of the whole inner kinetochore will be crucial to clarify these 
issues. Whilst the centromere-specific nucleosome and Mif2 (CENP-C in human) are 
conserved between budding yeast and regional centromere species, Cbf1 and CBF3 
are not (Cai and Davis, 1989, Mellor et al., 1990, Meluh and Koshland, 1995). 
However, additional proteins are found in higher eukaryotic centromeres, such as 
CENP-B and members of the CCAN (constitutive centromere-associated network; 
reviewed in Musacchio and Desai, 2017).  
CENP-B was one of the earliest centromere binding proteins identified, however, its 
role is still unclear and it is not essential for kinetochore function (Earnshaw and 
Rothfield, 1985). It binds, however, to the 17bp CENP-B boxes of the human 
centromere (K-type repeats in S.pombe) and introduces DNA bending (Tanaka et 
al., 2001). Interestingly both Cbf1 and CBF3 also influence DNA conformation 
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through bending and possibly looping of the DNA (Niedenthal et al., 1993, 
Pietrasanta, 1999). 
The budding yeast homologue to the CCAN network is the Ctf19 complex, with many 
proteins being conserved (Table 1). The CENP-TWXS complex of the CCAN directly 
interacts with the long regional centromere (Hori et al., 2008, Nishino et al., 2012) 
with the homologues yeast proteins likely playing a similar role (Schleiffer et al., 
2012, Pekgoz Altunkaya et al., 2016, Singh et al., 2010). The centromere localisation 
depends on CENP-ACse4, but no direct interaction exists with the CENP-ACse4 
nucleosome (Hori et al., 2008). Besides these DNA-binding subunits, the CCAN 
network consists of eleven other proteins, which themselves are organised into 
individual subcomplexes (reviewed in Musacchio and Desai, 2017). It is involved in 
the recruitment of CENP-A (Carroll et al., 2009, Suma et al., 2018), SAC proteins 
(Liu et al., 2003) and cohesin (Lacefield, 2017), as well as in establishing the 
connection between the centromere and outer microtubule-binding kinetochore 
proteins (Hori et al., 2008, Huis In 't Veld et al., 2016, Schleiffer et al., 2012). The first 
proteins of the Ctf19 complex to be described were members of the COMA complex, 
Ctf19, Okp1 and Mcm21. This sub-complex has been found to associate with the 
budding yeast centromere in vivo through its interaction with CBF3, Cse4 as well as 
Mif2 (Ortiz et al., 1999). Other subunits were found by genetic lethality screens, 
affinity purification and mass spectrometry and a variety of subcomplexes were 
successfully reconstituted (Hyland et al., 1999, Measday et al., 2002, De Wulf et al., 
2003, Hornung et al., 2011, Hornung et al., 2014, Schmitzberger and Harrison, 2012, 
Schmitzberger et al., 2017, Weir et al., 2016). Most of the Ctf19 complex subunits 
are conserved to the CCAN of higher eukaryotes and they also share most of their 
functionality. One known exception is the involvement of the CCAN in CENP-A 
loading in higher eukaryotes, as all known Ctf19 subunits are dependent on prior 
CBF3, Mif2 and Cse4 localisation to the centromere (Ortiz et al., 1999, Hyland et al., 
1999, De Wulf et al., 2003). 
1.3.2 Middle kinetochore 
Two complexes, MIND and Spc105, form the middle part of the budding yeast 
kinetochores. Both complexes are conserved towards higher eukaryotes (see Table 
1) and are involved in the regulation of kinetochore function, as well as forming the 
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bridge between the above described centromere associated subcomplexes and the 
microtubule binding subunits (Euskirchen, 2002). Together with the outer 
microtubule-binding subcomplex Ndc80 (see 1.3.3) they can also be classified as the 
KMN network, named after the human homologues KNL1, MIS12 and Ndc80 
complexes (Cheeseman et al., 2006).  
The MIND complex consists of four proteins, Mtw1, Nnf1, Nsl1 and Dsn1, and 
exhibits an elongated structure with the C- and N-termini of all four subunits 
clustering on both ends (Maskell et al., 2010, Dimitrova et al., 2016, Petrovic et al., 
2016). A region near the C-termini of Dsn1 and Nsl1 binds to the Spc24/25 subunits 
of the Ndc80 complex and therefore establishes connection to the outer microtubule-
binding site of the kinetochore. The opposite end of the structure connects to the 
centromere-associated inner kinetochore through a conserved interaction with Mif2 
(Hornung et al., 2011, Dimitrova et al., 2016, Petrovic et al., 2016). This connection 
is additionally stabilised through the COMA complex, although this has only been 
shown for budding yeast (Hornung et al., 2014). In both human and budding yeast, 
however, phosphorylation of Dsn1 by Ipl1 kinase (Aurora B in human) reliefs an auto-
inhibitory mechanism and therefore increases the binding affinity between the Mif2 
and the MIND complex significantly (Akiyoshi et al., 2013, Yang et al., 2008, Welburn 
et al., 2010, Dimitrova et al., 2016, Petrovic et al., 2016). Besides bridging the inner 
and outer kinetochore, the MIND complex also binds the Spc105 complex, and 
therefore is often described as the platform for KMN assembly (Petrovic et al., 2010, 
Petrovic et al., 2014). Both in human, as well as budding yeast there is an additional 
linking between inner and outer kinetochore proteins through a direct connection 
between the CENP-TCnn1 subunits of the CCANCtf19 and the Ndc80 complex 
(Malvezzi et al., 2013, Nishino et al., 2013, Pekgoz Altunkaya et al., 2016, Huis In 't 
Veld et al., 2016). This additional bridging is supposed to help to recruit additional 
Ndc80 complexes to the kinetochore and increase binding stability of the spindle 
microtubules (reviewed in Musacchio and Desai, 2017). 
The Spc105 complex of the middle kinetochore, on the other hand, does not 
contribute to inner and outer kinetochore cohesion, but builds a platform for the 
assembly of SAC components. It consists out of two conserved subunits, Spc105 
and Kre28 (see Table 1) and it connects to the MIND complex through a C-terminal 
region of Spc105 (Petrovic et al., 2010, Petrovic et al., 2014). The large subunit 
Spc105, or KNL1 in human, recruits a number of proteins including the SAC proteins 
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Bub1 and Bub3 through its large intrinsically disordered N-terminal part (Liu et al., 
2010, Rosenberg et al., 2011, Primorac et al., 2013). 
1.3.3 Outer kinetochore 
The outer kinetochore’s function is to establish an end-on connection to the spindle 
microtubules. This connection ensures the separation of the sister chromatids by 
utilising the force generated by depolymerisation of the microtubules.  
The budding yeast outer kinetochore is mainly formed by two complexes, the Dam1 
and the Ndc80 complex. Only the latter, however, is conserved to human (Zheng et 
al., 1999, Cheeseman et al., 2006). It consists out of four subunits which together 
form a long coiled-coil with globular domains on each end (Wei et al., 2007, Ciferri 
et al., 2008). These globular domains bind to microtubules on one end and to the 
MIND complex on the other (Wei et al., 2005, Ciferri et al., 2008). The Ndc80 complex 
is one of the best structurally and functionally described subcomplexes of the 
kinetochore and binds microtubules through two calponin-homology (CH) domains 
of Ndc80 and Nuf2 subunits, as well as through the structurally disordered N-terminal 
tail of Ndc80 (reviewed in Musacchio and Desai, 2017, Ciferri et al., 2008, Alushin et 
al., 2012). The latter is also involved in the regulation of microtubule binding through 
Aurora BIpl1 kinase (Alushin et al., 2012), which is discussed in more detail in 1.3.4. 
Multiple copies of the Ndc80 complexes exist in parallel and might bind to the same 
microtubule in a cooperative manner (Alushin et al., 2010, Suzuki et al., 2016). 
The second main player in budding yeast is the Dam1 complex (Hofmann et al., 
1998), which is responsible for microtubule/kinetochore coupling and is able to track 
growing and shrinking microtubules (Asbury et al., 2006). Although Dam1 proteins 
are not conserved, a functional homologue, the SKA complex, exists in human 
(Hanisch et al., 2006, Gaitanos et al., 2009). Both interact with the Ndc80 complex 
and enhance the microtubule attachment helping to form load-bearing connection 
(Tien et al., 2010, Lampert et al., 2010, Schmidt et al., 2012). Furthermore, both are 
negatively regulated by Aurora B kinase, as phosphorylation of Dam1 and Ska 
complex subunits decreases their binding affinity for the Ndc80 complex and 
microtubules respectively (Tien et al., 2010, Schmidt et al., 2012). This regulation is 
part of the error correction mechanism of kinetochores, discussed in the following 
section. 
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1.3.4 Error correction 
To ensure proper chromosome segregation the cell not only needs to establish a 
connection between centromere and spindle microtubules, it also needs to sense if 
this attachment is correct (reviewed in Lampson and Grishchuk, 2017). In budding 
yeast two possible connections can be made (Figure 7). The first and correct one is 
called amphitelic and describes an attachment of the two sister chromatids to spindle 
microtubules of the opposite pole. The second possibility is an attachment of the two 
sister chromatids to spindle microtubules of the same pole, which is called syntelic. 
This erroneous form of attachment needs to be corrected to ensure proper 
chromosome segregation. A third form of incorrect connection can occur in regional 
centromere species, which have multiple spindle microtubules connected to one 
sister chromatid (Zinkowski et al., 1991, Nicklas, 1997, Bodor et al., 2014). This gives 
rise to the possibility of a merotelic attachment, where one or both sister chromatids 
are connected to spindle microtubules from both poles, rather than from one. The 
mechanism to ensure proper attachment is believed to be conserved, however, and 
involves a tension-regulated stabilisation of amphitelic connections (Nicklas and 
Koch, 1969, Cane et al., 2013). Only these are slightly pulled apart by microtubules 
and therefore build up a tension. Syntelic and merotelic attachments, on the other 
hand, fail to do so and are therefore resolved. A new spindle microtubule can then 
be bound and this attachment is tested again by the same mechanism. Eventually 
the correct form of attachment is made (Nicklas and Ward, 1994). 
 
 
Figure 7: Microtubule/kinetochore attachments during mitosis 
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Two forms of attachments are possible in point centromere species: Syntelic attachments, 
both sister chromatids are connected to microtubule of one spindle pole, do not build tension 
and are corrected, whereas the amphitelic attachment is stabilised. In regional centromeres 
multiple spindle microtubules are connected to the sisters, enabling also a merotelic 
attachment, where one or both sister is connected to spindle microtubules of both poles.  
 
Whilst this is the generally accepted model of tension-regulated error correction, 
there are still many unanswered aspects, especially concerning the more 
complicated scenario of a merotelic attachment (reviewed in Lampson and 
Grishchuk, 2017). In addition to this tension-regulated mechanism, other factors 
have been shown to influence error correction, including the back-to-back geometry 
of the sister kinetochores (Östergren, 1951, Nicklas and Ward, 1994, Anderson, 
2009).  
The molecular mechanism of error correction involves the conserved chromosome 
passenger complex (CPC), consisting of four subunits including the Aurora BIpl1 
kinase, INCENPSli15, SurvivinBir1 and BorealinNbl1p (see Table 1; Kaitna et al., 2000, 
Murata-Hori and Wang, 2002, Carmena et al., 2009). This complex acts at different 
locations at different times during mitosis and coordinates not only correction of 
chromosome-microtubule attachment errors, but also the activation of the SAC, 
establishment of a bipolar spindle and cytokinesis (reviewed in Carmena et al., 
2009). For its function in error correction, however, it localises to the inner 
kinetochore (Kawashima et al., 2010, Wang et al., 2010, Yoon and Carbon, 1999), 
whilst Aurora B targets include the outer kinetochore proteins Ndc80 and KNL1, as 
well as subunits of the Dam1 or Ska complex (Welburn et al., 2010, Keating et al., 
2009, Chan et al., 2012). Phosphorylation of these substrates reduces microtubule 
binding affinity and promotes catastrophic depolymerisation of the attached 
microtubules (Sarangapani et al., 2013, Umbreit et al., 2012, DeLuca and 
Musacchio, 2012, Zaytsev et al., 2014, Zaytsev et al., 2015). The current model is 
that Aurora B can only access its substrates when the kinetochore/microtubule 
attachment is wrong, and therefore not under tension. Once tension is applied Aurora 
B is spatially separated from its targets and unable to phosphorylate them (Liu et al., 
2009, Keating et al., 2009, Welburn et al., 2010, Krenn and Musacchio, 2015). 
Studies which support this model have shown that perturbing centromere localisation 
of the CPC disrupts error correction (Wang et al., 2010, Kelly et al., 2010) and 
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artificial targeting of Aurora B to the outer kinetochore decreases microtubule 
attachment (Liu et al., 2009). For stabilisation of microtubule attachment Aurora B 
substrates are dephosphorylated by the opposing protein phosphatase 1 (PP1; 
Francisco et al., 1994, Emanuele et al., 2008). PP1 is specifically recruited to the 
outer kinetochore through interaction with KNL1. In the presence of Aurora B, 
however, this binding site is phosphorylated, which disrupts PP1 localisation. 
Stabilisation through PP1 can therefore only occur in the absence of Aurora B (Liu 
et al., 2010). 
1.3.5 Spindle assembly checkpoint 
Besides above discussed error correction, the kinetochore also couples successful 
sister chromatid bi-orientation with the mitotic exit, a process called the spindle 
assembly checkpoint (SAC; reviewed in Joglekar, 2016). The SAC ensures that the 
cell only progresses with mitosis and subsequent cytokinesis when all sister 
chromatids are properly attached to spindle microtubules. This is facilitated by the 
recruitment of SAC proteins to unattached kinetochores, which generates the so-
called ‘wait-anaphase’ signal (McIntosh, 1991, Bernat et al., 1991, Spencer and 
Hieter, 1992). The progression from anaphase onwards is dependent on the 
anaphase promoting complex/cyclosome C (APC/C), which is activated by its 
cofactors Cdc20 and Cdh1 (Sudakin et al., 1995, Irniger et al., 1995, Schwab et al., 
1997, Hwang et al., 1998). Unattached kinetochores recruit various SAC proteins, 
which leads to the formation of the mitotic checkpoint complex (MCC) consisting out 
of four proteins, Bub3, Mad2, Mad3 and Cdc20 (see Table 1; Hardwick et al., 2000, 
Sudakin et al., 2001). This complex formation, therefore, depletes free cytosolic 
Cdc20 and also inactivates Cdc20 already bound by the APC/C, which subsequently 
leads to complete inactivation of APC/C (Nilsson et al., 2008, Izawa and Pines, 
2015). Besides inhibiting anaphase onset, the SAC also protects cohesion between 
the sister chromatids to inhibit segregation before proper attachment of all sister 
chromatids are made (Yamamoto et al., 1996, Musacchio, 2015, Lara-Gonzalez et 
al., 2012, Chen and Liu, 2014). 
The kinetochore proteins involved in the SAC component recruitment are Ndc80 and 
Spc105, as well as the kinase Mps1 (Kemmler et al., 2009, Hiruma et al., 2015, Ji et 
al., 2015, Dou et al., 2015). The latter binds to the CH domains of Ndc80, which are 
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also involved in Ndc80/microtubule interaction (DeLuca et al., 2003, DeLuca et al., 
2006). This competitive binding therefore favours a recruitment to unattached 
kinetochores. Bound Mps1 phosphorylates Spc105 at its MELT repeats, which leads 
to the recruitment of SAC proteins Bub3-Bub1, and subsequently Mad3, Cdc20, 
Mad1-Mad2 (Kemmler et al., 2009, Hiruma et al., 2015, Ji et al., 2015, Dou et al., 
2015, Dimitrova et al., 2016, Jia et al., 2016) and the formation of the MCC complex. 
In addition, Aurora B has been shown to promote Mps1 binding to Ndc80, coupling 
its error correction role to promoting SAC signalling on unattached or wrongly 
attached kinetochores (Krenn and Musacchio, 2015). 
Multiple mechanisms seem to disrupt SAC signalling once kinetochores reach a 
proper attachment. Firstly, upon end-on microtubule attachment Mps1 binding is 
disrupted, reducing the amount of bound Mps1 (Joglekar, 2016). Secondly, end-on 
attachment also leads to a different conformation of Ndc80 and Spc105, which 
spatially separates the two. Mps1, bound by Ndc80, therefore cannot phosphorylate 
Spc105 anymore (Wang et al., 2008, Joglekar et al., 2009, Wan et al., 2009, 
Schittenhelm et al., 2009, Aravamudhan et al., 2015), leading to dephosphorylation 
by PP1 bound directly by Spc105 (London et al., 2012). Additionally, other proteins 
have been indicating to play a role in SAC silencing, explaining the immediate 
response once kinetochores are properly attached (Espert et al., 2014, Sivakumar 
et al., 2016, Howell et al., 2001). 
 
1.4 The CBF3 complex and kinetochore establishment 
In budding yeast kinetochore establishment on the centromere starts with the specific 
binding of CBF3 (reviewed in McAinsh et al., 2003). Defects in CBF3 abolish 
kinetochore function (Goh, 1993, Sorger, 1994, He et al., 2001) and all other known 
kinetochore proteins, with the exception of Cbf1, are dependent on CBF3 for their 
recruitment (Sorger, 1994, He et al., 2001, Enquist-Newman et al., 2001, Janke et 
al., 2001, Jones et al., 2001). Despite this, CBF3 only directly interacts with Cbf1 and 
the COMA subunits of the Ctf19 complex (Ortiz et al., 1999, Cho and Harrison, 2012). 
All other dependencies are therefore indirect and dependent on CBF3s essential role 
in the localisation of the Cse4 nucleosome specifically to the centromere (explained 
in detail in 1.4.3). The centromere specific nucleosome is then recognised and bound 
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by Mif2CENP-C which acts as a central platform to recruit other kinetochore proteins 
(Carroll et al., 2010, Kato et al., 2013). Besides Mif2, some subunits of the Ctf19CCAN 
complex also recognise and interact with the centromere-specific nucleosome, a 
conserved interaction important for Ctf19CCAN stability at the centromere (Ortiz et al., 
1999, De Wulf et al., 2003, Carroll et al., 2009). Furthermore, Mif2 directly interacts 
with components of the Ctf19 and MIND complexes (Cohen et al., 2008, Hornung et 
al., 2014, Dimitrova et al., 2016). The latter is involved in recruiting the rest of the 
KMN network, Spc105 and Ndc80 complexes (Dimitrova et al., 2016). This 
hierarchical assembly of the kinetochore underlies cell-cycle dependent regulation 
but remains poorly understood (reviewed in McAinsh et al., 2003, Musacchio and 
Desai, 2017). Whilst the overall architecture and interaction of subunits is conserved, 
the mechanism by which the centromeric nucleosome is recruited is different 
depending on centromere type. As budding yeast kinetochore establishment is 
dependent on CBF3, it is crucial to understand how this complex functions on the 
centromere. 
1.4.1 CBF3 subunits and assembly 
The CBF3 complex was discovered in 1991, due to its ability to bind CDEIII in a 
sequence-specific matter (Lechner, 1991). It consists of four proteins, Ndc10, Cep3, 
Ctf13 and Skp1 (Figure 8; Lechner, 1991, Goh, 1993, Jiang, 1993, Lechner, 1994, 
Strunnikov et al., 1995, Doheny et al., 1993, Connelly and Hieter, 1996, Stemmann 
and Lechner, 1996). All four proteins have been shown to be essential for 
kinetochore function (Jiang, 1993, Doheny et al., 1993, Strunnikov et al., 1995, 
Connelly and Hieter, 1996). Both Ndc10 and Cep3 are homodimers in solution, 
whereas Skp1 and Ctf13, a F-box containing protein, form a heterodimer (Russell, 
1999, Purvis and Singleton, 2008, Perriches, 2014). Skp1, the only conserved CBF3 
protein, is better known as a subunit of Skp1/Cullin/F-box ubiquitin ligase family (SCF 
ligases) and also forms part of the RAVE complex (Deshaies, 1999, Seol et al., 
2001). Within the SCF ligase Skp1’s function is to connect the elongated scaffold 
subunit Cullin with a variety of F-box proteins (Zheng et al., 2002). The latter bind a 
range of substrates to be ubiquitinylated and therefore degraded in a proteasome 
dependent manner (Reitsma et al., 2017). Generally, F-box proteins also contain 
other protein/protein interaction domains, like WD40 or Leucin-rich repeats (LRRs), 
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and are classified accordingly (reviewed in Kipreos and Pagano, 2000). Multiple 
available crystal structures from the budding yeast and human Skp1 bound to 
different F-box proteins show that the very C-terminus of Skp1 is involved in the 
binding of the F-box (Figure 8; Schulman et al., 2000, Orlicky et al., 2010, Hao et al., 
2005, Kumanomidou et al., 2015, Li and Hao, 2010, Wong et al., 2017). Accordingly, 
the F-box is necessary for interaction between Ctf13 and Skp1 (Russell, 1999). 
Besides binding to Skp1 through the F-box domain, Ctf13 also interacts with the 
other two CBF3 subunits and therefore acts as the central part of CBF3 (Russell, 
1999). On its own it is inherently unstable and cannot be recombinantly expressed 
and purified (Russell, 1999, Perriches, 2014) which accounts for the difficulty in 
reconstituting CBF3 for functional or structural studies.  
Both Ndc10 and Cep3 have been shown to bind to DNA (explained in detail in 1.4.2). 
Cep3 has a N-terminal Gal4-like C6 zinc cluster (Gal4-domain), which is connected 
through the rest of the protein through a flexible linker (Lechner, 1994, Strunnikov et 
al., 1995, Espelin, 1997). A crystal structure, lacking the Gal4-domain, could verify 
that Cep3 is indeed a homodimer and shares some structural details with HEAT 
repeats (Figure 8, Purvis and Singleton, 2008, Bellizzi, 2007). Ndc10, the largest 
subunit of CBF3, contains 956 amino acids. Biochemical evidence showed that 
Ndc10 forms a homodimer in solution and therefore it compromises half of the mass 
of CBF3 (Russell, 1999, Perriches, 2014). It is predicted to be highly disordered 
especially in the C-terminal part, which includes the dimerization and a DNA binding 
domain, as well as interactions sites for Scm3 and Bir1 (more details below). The 
crystal structure of the monomeric N-terminal part of the protein (NTD; residues 1 to 
550) highlighted a surprising similarity with tyrosine recombinases, although both 
endonuclease as well as ligase activity is lacking (Figure 8; Perriches and Singleton, 
2012, Cho and Harrison, 2012). The co-crystallisation structure of the K.lactis Ndc10 
NTD equivalent also gave insight into the unspecific DNA binding activity of Ndc10 
and suggested that each Ndc10 monomer can bind a separate fragment of DNA, 
which might facilitate a loop formation at the centromere (Cho and Harrison, 2012). 
Furthermore, the NTD has been implicated to be important for interaction with other 
CBF3 subunits (Cho and Harrison, 2012) and the very C-terminus features a degron 
motif (Furth et al., 2011, Alfassy et al., 2013). 
Chapter 1 Introduction 
37 
 
 
Figure 8: The CBF3 complex and known crystal structures 
The schematic model shows the complex in the assumed stoichiometry of 2xNdc10, 2xCep3, 
1xCtf13 and 1xSkp1. Known crystal structures include Skp1 (3V7D), Cep3 Gal4∆ (2VEQ) 
and Ndc10 NTD (S.c.: 4ACO; K.l.: 3SQI). The construct used for Skp1 had the yeast-specific 
loop between residues 37 to 64 deleted and was co-crystallised with Cdc4 (F-box depicted 
in grey). The N-terminal Gal4-domains of Cep3 were deleted to enable crystallisation and 
the two available crystal structures of Ndc10 NTD are shown: the budding yeast protein 
without DNA (Ndc10 NTD – S.c.) and the K.lactis NTD equivalent co-crystallised with DNA 
(Ndc10 NTD +DNA – K.l.). 
 
The formation of the complex is believed to be stepwise occurring and tightly 
controlled involving phosphorylation, protein degradation and assembly factors 
(Lechner, 1991, Kaplan, 1997, Russell, 1999). The first step is assumed to be the 
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formation of the Ctf13/Skp1 heterodimer, which involves the Hsp90-Sgt1 chaperone 
complex (Kitagawa et al., 1999, Stemmann et al., 2002, Bansal et al., 2004). Sgt1 
binds both Hsp90 and Skp1, therefore linking it to both the SCF ligases and CBF3 
(Lingelbach and Kaplan, 2004, Willhoft et al., 2017). Interestingly, Sgt1 also 
specifically targets proteins with LRRs, a common feature of F-box proteins like Ctf13 
(Stuttmann et al., 2008, Taipale et al., 2014). Indeed, a weak but direct interaction 
exists between Sgt1 and Ctf13 (Bansal et al., 2004, Rodrigo-Brenni, 2004). Whilst it 
is clear that mutations obstructing the Sgt1-Skp1 interaction inhibit CBF3 complex 
formation, the molecular mechanism remains elusive (Bansal et al., 2004, Kitagawa 
et al., 1999, Lingelbach and Kaplan, 2004, Willhoft et al., 2017). Whereas most 
studies seem to conclude that Hsp90 is needed to form the Ctf13/Skp1 heterodimer 
by somehow activating Skp1 and/or Ctf13, others conclude that the presence of Sgt1 
is also needed for further complex formation (Stemmann et al., 2002, Bansal et al., 
2004, Rodrigo-Brenni, 2004). 
The second step of CBF3 formation is the binding of the Ctf13/Skp1 heterodimer to 
Cep3 and formation of the core CBF3 complex (Russell, 1999). As unbound 
Ctf13/Skp1 heterodimer is believed to be readily degraded in a ubiquitin-dependent 
manner, this step has been referred to as rate-limiting in the formation of CBF3 
(Russell, 1999, Kaplan, 1997). Accordingly, Ctf13 has been shown to degrade rapidly 
in vivo, whereas the other subunits are more stable (Kaplan, 1997). Furthermore, an 
early study suggested that Ctf13 needs to be activated by Skp1-dependent 
phosphorylation to be able to bind to Cep3 (Kaplan, 1997). This stands in agreement 
with the discovery that phosphatase treatment of purified CBF3 leads to a loss of 
protein/DNA complex formation (Lechner, 1991). However, a later study revealed 
that although Ctf13 and Skp1 contain two and four phosphorylations respectively, 
complete dephosphorylation of the heterodimer does not interfere with further 
complex formation (Stemmann et al., 2002). If phosphorylation, possibly of the other 
two CBF3 subunits, still plays a role in complex formation or activation is unclear. 
In the final step of complex formation Ndc10 binds to the core complex forming the 
DNA-binding active, full complex (Russell, 1999). As discussed in more detail in the 
next chapter, only this full complex is believed to be centromere-binding sufficient. 
Besides the full complex, some studies also suggest the existence of an extended 
complex incorporating a second Ndc10 dimer, which either binds the centromere up- 
or downstream of the normal CBF3 complex (Espelin, 1997, Espelin, 2003). 
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1.4.2 Centromere binding of CBF3 
CBF3 binds specifically to the CDEIII element of the point centromere (Figure 9). 
Mutational studies of the centromere revealed that a conserved CCG triplet in this 
element is essential for centromere function (Ng and Carbon, 1987, Hegemann et 
al., 1988). Mutations in this CCG triplet strongly affect binding of the CBF3 complex 
in vitro (Ng and Carbon, 1987, Lechner, 1991) and have been shown to interfere with 
the localization of Ndc10 and Mif2 to centromeric DNA in vivo (Meluh and Koshland, 
1997). 
Early studies have shown that all four subunits of CBF3 are needed to be able to 
bind the centromere (Sorger et al., 1995, Stemmann and Lechner, 1996, Kaplan, 
1997, Espelin, 1997, Pietrasanta, 1999), a surprising result as both Cep3 and Ndc10 
can bind DNA on their own (Espelin, 2003, Purvis and Singleton, 2008, Bellizzi, 2007, 
Perriches and Singleton, 2012, Cho and Harrison, 2012). Furthermore, DNA-protein 
crosslinking studies showed that only three of the four subunits, namely Ndc10, Cep3 
and Ctf13, are in direct contact with centromeric DNA (Figure 9; Espelin, 1997). 
Whereas there is no evidence that Ctf13 can bind to DNA on its own, Ndc10 has 
been shown to bind DNA non-specifically (Perriches and Singleton, 2012, Cho and 
Harrison, 2012). Cep3, on the other hand, accounts for the sequence-specificity 
involving the conserved and essential CCG triplet of CDEIII and its Gal4-domain 
(Espelin, 1997, Purvis and Singleton, 2008). Proteins containing this domain, usually 
bind as a dimer to a tandem or inverted repeat of a CCG triplet with each monomer 
contacting one triplet (Marmorstein et al., 1992, Marmorstein and Harrison, 1994, 
Liang et al., 1996, King et al., 1999). Although Cep3 forms a homodimer, only one 
CCG triplet is present in the centromere. A peculiar characteristic, which has led to 
a debate of how the homodimeric Cep3 is able to bind this single CCG triplet in the 
centromere. One hypothesis suggested, that Cep3 contacts a second, degenerate 
site upstream of the CCG triplet, as has been shown with crosslinking studies 
(Espelin, 1997). Mutation of this potential TGT triplet, however, did not influence 
DNA-binding of Cep3 (Purvis and Singleton, 2008) and structural studies will be 
necessary to answer this question, as well as elucidate how the whole CBF3 complex 
binds to the centromere. 
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Figure 9: Centromere binding of CBF3 
The consensus sequence of the budding yeast point centromere is shown, as well as bases 
important for CBF3 binding as shown with crosslinking studies (Espelin, 1997). 
 
CBF3 is also believed to have an impact in the overall structure of the point 
centromere by DNA looping and/or bending. DNA looping, as shown with 
chromosome conformation assays, is dependent on Ndc10, but not on outer 
kinetochore proteins (Anderson, 2009, Diaz-Ingelmo et al., 2015). Accordingly, 
Ndc10 can bind two individual stretches of DNA in vitro and an atomic force 
microscopy study has suggested that CBF3, upon binding, bends the centromeric 
DNA by about 55°, as well as being able to bind multiple DNA fragments (Cho and 
Harrison, 2012, Pietrasanta, 1999). Although CBF3 proteins are not conserved 
outside point centromere species, this DNA bending could depict a conserved 
function to the mammalian inner centromere protein CENP-B. The crystal structure 
of CENP-B DNA binding domain in complex with DNA has shown, that it too 
introduces a bend in the DNA, which could be important for its CENP-A nucleosome 
assembling ability (Okada et al., 2007). 
Another interesting aspect of CBF3 DNA binding is the fact that it needs to 
accommodate the additional proteins also found to bind to the short centromeric DNA 
(see 1.3.1). How all of these proteins simultaneously bind and possibly interact is still 
unclear and further studies are needed. 
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1.4.3 Interaction with Scm3 and Cse4 loading 
The localisation of Cse4 to the centromere is dependent on CBF3, although there is 
no direct interaction between the two (Measday et al., 2002, Ortiz et al., 1999). The 
domain essential for centromere targeting of Cse4CENP-A is the conserved CATD 
domain within the histone-fold (Black et al., 2004, Wieland et al., 2004). This domain 
is sufficient in human, whilst in budding yeast a short stretch of the long N-terminal 
tail of Cse4 is also needed for centromere targeting (Chen et al., 2000, Keith et al., 
1999). Both, however, are specifically bound by the conserved, centromere-specific 
histone chaperone HJURPScm3, an interaction essential for centromere localisation 
(Camahort et al., 2007, Stoler et al., 2007, Aravind et al., 2007, Sanchez-Pulido et 
al., 2009, Shuaib et al., 2010). Biochemical and structural studies showed a 
conserved interaction between the N-terminal part of HJURPScm3 and the CATD of 
CENP-ACse4 (Foltz et al., 2009, Hu et al., 2011, Zhou et al., 2011, Cho and Harrison, 
2011, Figure 10). 
 
Figure 10: Conserved Scm3/Cse4/H4 interaction 
Crystal structures of the human HJURP/CENP-A/H4 interaction (left; 3R45) and the K.lactis 
homologues, Scm3/Cse4/H4 (right; 2YFV). 
 
In regional centromere species an elaborate process of centromere licensing, which 
involves specific histone modifications, the presence of CENP-A, the function of the 
Mis18 protein complex as well as additional histone chaperones, is responsible for 
proper incorporation of new CENP-A (reviewed in Stellfox et al., 2013, Musacchio 
and Desai, 2017). In point centromere species, on the other hand, the conserved 
centromeric sequence and CBF3 are sufficient for correct Cse4 localisation (Ortiz et 
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al., 1999, Measday et al., 2002). This simpler process is believed to be facilitated 
through a direct interaction between the CBF3 subunit Ndc10 and the Cse4-specific 
chaperone Scm3 (Camahort et al., 2007, Cho and Harrison, 2011). However, the 
molecular mechanism of this interaction, as well as how it facilitates the incorporation 
of Cse4/H4 into the centromeric nucleosome and in fact the exact composition of this 
nucleosome, discussed in 1.2.1, remains unclear. 
1.4.4 Additional functions 
Beside its main function in specifying the centromere for kinetochore establishment 
and building a platform for kinetochore formation, CBF3 also is involved in the 
regulation of kinetochore function, as well as spindle stability. 
 
Involvement in SAC signalling: Most S.cerevisiae kinetochore mutants, which are 
defective in kinetochore-microtubule attachment, trigger the SAC and therefore lead 
to cell cycle arrest (Gardner, 2001). Ndc10-1 mutants, however, still complete 
anaphase with massive chromosome mis-segregation, although the cell fails to 
establish a functional kinetochore (Gardner, 2001, Goh, 1993). This, and the fact that 
they cannot maintain an arrest in the presence of microtubule-polymerization 
inhibiting drugs (Tavormina and Burke, 1998), shows that they are not checkpoint 
proficient. Accordingly, the CBF3 subunit Skp1 has been shown to directly interact 
with the SAC protein Bub1. This interaction, shown to be independent of Skp1’s 
function in the SCF ligases, recruits Bub1 to the centromere (Kitagawa et al., 2003). 
Furthermore, a specific Skp1 mutant could be constructed, which is deficient in Bub1 
interaction but does not affect chromosome segregation. This mutant was 
hypersensitive to microtubule destabilising drugs, a typical response of SAC 
checkpoint deficiency (Kitagawa et al., 2003). These studies suggest that CBF3 is 
important to recruit SAC proteins through its subunit Skp1. 
 
Involvement into CPC localisation: CBF3, through its subunit Ndc10, also interacts 
with Bir1, a component of the CPC (Cho and Harrison, 2012, Yoon and Carbon, 
1999). Bir1 therefore is coupled to the centromere, which has been shown to be 
crucial for CPC localisation and function in error correction (Shimogawa et al., 2009, 
Makrantoni and Stark, 2009). Interestingly, a different mechanism exists in regional 
centromere species, which lack CBF3, involving Shugoshin, which recruits Bir1 and 
specifically recognises phosphorylated H2A (Kawashima et al., 2010).  
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Involvement in spindle stability and cytokinesis: The first evidence of a CBF3 function 
outside of the centromere, came from the finding that Ndc10 moves to the spindle 
midzone during late anaphase and is important for spindle stability and cytokinesis 
(Bouck and Bloom, 2005). Interestingly, the same is true for the CPC (Thomas and 
Kaplan, 2007). As explained above, Ndc10 directly interacts with CPC through Bir1, 
which together with the identical localisation pattern indicates a co-migration of both 
complexes to the spindle midzone (see above; Thomas and Kaplan, 2007, Cho and 
Harrison, 2012, Gillis et al., 2005). Furthermore, defects in assembly or turnover of 
the CBF3 complex have been shown to cause defects in cytokinesis, indicating that 
not only Ndc10, but the whole CBF3 complex is involved (Gillis et al., 2005). Again, 
Bir1 mutant studies revealed similar defects, arguing for a co-functionality as well as 
co-migration of these two complexes (Gillis et al., 2005). It is unclear how CBF3 
localisation to the spindle midzone is regulated. 
 
Involvement in DNA-damage signalling: After sensing of DNA double-strand breaks 
the DNA-damage response increases chromatin mobility, a process believed to 
promote repair by homologous recombination (Krawczyk et al., 2012, Lottersberger 
et al., 2015, Dion et al., 2012, Mine-Hattab and Rothstein, 2012). In yeast the kinase 
Mec1 is essential for this process and one downstream target of Mec1 activity is the 
CBF3 subunit Cep3 (Dion et al., 2012, Mine-Hattab and Rothstein, 2012, Strecker et 
al., 2016). Cep3 is specifically phosphorylated on the S575 residue by Rad53, which 
is activated in a Mec1 dependent manner upon DNA damage. This phosphorylation 
seems to lead to detachment of kinetochore/spindle microtubule, which in turn 
increases chromatin mobility (Strecker et al., 2016).  
1.5 Project aims 
The aim of this thesis was the functional and structural characterisation of the 
budding yeast CBF3 complex. Being the initial factor of budding yeast kinetochore 
establishment, it is crucial to understand how this complex functions on the 
centromere and therefore influences budding yeast kinetochore establishment. For 
reasons described above budding yeast is one of the main model systems used for 
kinetochore studies. Structural and functional studies of CBF3, as well as attempts 
to reconstitute the full kinetochore have suffered from difficulties in recombinant 
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expression and purification of CBF3. An initial aim therefore was to overcome these 
difficulties and find a working recombinant expression and purification system for the 
full CBF3 complex. This was followed by structural, as well as functional studies to 
elucidate its composition, centromere binding activity, as well as interactions with 
other kinetochore proteins, especially its interaction with Scm3 and influence on 
Cse4 loading. 
 
1.6 Theory of single particle cryoEM 
To fully understand how a protein or protein complex folds, interacts and therefore 
functions structural biology is key. In the past X-ray crystallography was the 
workhorse for structural biology providing 3D-structures helping to understand how 
proteins work within the cell. The biggest limitation of this method, however, is the 
fact that one must produce a protein crystal to be able to achieve this high-resolution 
information and for many proteins and especially macromolecular assemblies this 
can be tricky or impossible (Egelman, 2016). Furthermore, a protein is stabilised in 
one particular conformation in the crystal lattice, providing therefore only one 
snapshot of a protein’s life. In recent years a new technique, cryo electron 
microscopy (cryoEM), is gaining more and more importance in structural biology, 
recognised last year by the award of the Nobel Prize in Chemistry to Jacques 
Dubochet, Joachim Frank and Richard Henderson (Nogales, 2018). CryoEM has a 
few significant advantages over crystallography. First, no crystallisation is needed, 
which opens up structural studies of proteins and big macromolecular assemblies, 
which have proven to be difficult to crystallise, as well as those which can only be 
purified in low yields. Second, proteins are imaged in solution, which does not restrict 
their conformational states and therefore multiple structures can be determined from 
one sample describing the function of the protein better than only one snapshot 
(Cheng et al., 2015, Scheres, 2016). Third, it is possible to image bigger 
macromolecular assemblies directly in the cell and still achieve low to medium 
resolution structures, which never would have been possible with crystallography 
(Jonic et al., 2008, Briggs, 2013, Oikonomou et al., 2016).  
Many achievements in recent years, including progress in detector quality, motion 
correction and image processing software, have given rise to a ‘resolution-revolution’ 
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with many cryoEM structures reaching a resolution below 3.5Å (Henderson and 
McMullan, 2013, Kuhlbrandt, 2014, Subramaniam et al., 2016, Vonck and Mills, 
2017, Liao et al., 2013). Furthermore, with resolutions good enough to visualise small 
molecules, like water or inhibitors, cryoEM is gaining momentum in the 
pharmaceutical industry for structure-based drug design (Boland et al., 2017, Zhu et 
al., 2018, Khoshouei et al., 2017, Fischer et al., 2015, Bartesaghi et al., 2018). 
1.6.1 The transmission electron microscope (TEM) – image formation 
The idea of a transmission microscope using electrons instead of light to form a 
higher resolution image comes from the Abbe’s equation. This equation specifies 
that the highest resolution obtainable ultimately is dependent on the wavelength of 
the imaging radiation. Therefore, it is not possibly to resolve anything under ~200nm 
with a light microscope. Many biological samples including proteins and protein 
complexes, however, are much smaller than this. Electrons, on the other hand, 
depending on their energy exhibit a wavelength in the picometer scale, enabling 
modern TEMs to reach a resolution of better than 1Å (Smith, 2008). 
For image formation electrons need to be accelerated to form a parallel, high energy 
beam, which then can interact with the sample leading to scattering of the said 
electrons. Two different forms of scattering can occur: elastic and inelastic scattering. 
Elastically scattered electrons only change their moving direction but not their energy 
as they interact with an atom of the specimen. Depending on the scattering angle, 
they either are excluded by the objective aperture and therefore contribute to 
amplitude contrast (high angles) or they are focused back to their original point by 
the objective lens, where they interact either positively or negatively with the 
unscattered beam and therefore produce phase contrast (low angles). Whilst 
perfectly focussed images produce no phase contrast, the higher the defocus the 
better the phase contrast of low resolution details of the image. However, high 
defocus also leads to a loss of high resolution details, giving rise of the need of 
careful balancing of contrast and high-resolution information loss. Inelastic scattering 
occurs when the incoming electron hits an electron from the specimen, which leads 
not only to a change of moving direction but also to a change in energy. These 
electrons are removed by an energy filter and therefore contribute to amplitude 
contrast. As electrons interact very weakly with a biological sample, the overall 
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amplitude contrast is negligible and phase contrast, produced by defocusing, is the 
main contributor to the image (Orlova and Saibil, 2011, Frank, 2006). 
Magnification of the electrons forming the image is achieved by electromagnetic 
lenses. These lenses consist of a wire coil through which current flows. The current 
creates a magnetic field, which influences the travel path of electrons opening the 
possibility to focus and magnify in the same way an optical lens does. A TEM usually 
has multiple electromagnetic lenses to magnify the image, which together with 
deflectors form the projector lens system. Through adjusting the current which flows 
through each of these lenses, one can adjust the magnification. Besides the projector 
lenses a TEM also incorporates an objective lens system and a condenser lens 
system, to facilitate focussing of the image, as well as condensing the beam onto a 
specific area of the specimen respectively (Frank, 2006, Orlova and Saibil, 2011). 
1.6.2 Sample preparation 
One of the difficulties to overcome in imaging biological samples with a TEM is that 
electrons can only travel in high vacuum. Therefore, the sample needs to be 
prepared in a way to withstand these conditions. Traditionally protein or other 
biological samples, like viruses, could only be imaged by staining and subsequent 
drying of the sample. As outlined below, this limits the achievable resolution to about 
20Å (Ohi et al., 2004). Another possibility to conserve the sample for use in the high 
vacuum is freezing it and imaging at low temperature to maintain the frozen state. 
This, however, was complicated by the fact that frozen water molecules are 
crystalline, which both damages biological molecules and produces a high 
background in the TEM image. An important achievement, proposed in 1940 and 
finally realised in 1980/81, was the vitrification of water (Brüggeller and Mayer, 1980, 
Dubochet and Booy, 1981, Dubochet and McDowall, 1981). The idea is simple, cool 
water rapidly enough that the molecules have no time to crystallise. Vitrified water, 
in contrast to the crystalline form, is amorphous and this glass-like appearance is key 
for both maintaining a biological molecule in its native state as well as being able to 
visualise it without overwhelming background. Up to now, both these methods of 
sample preparation are crucial for structural studies with cryoEM and are explained 
in more detail below. 
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Negative stain: Proteins or protein complexes, given they fulfil a minimum size 
requirement, can be quickly and easily visualised in a TEM by using a heavy metal 
stain. Carbon coated grids are used as a support for the protein sample to adhere 
to. The stain fixes the protein and after blotting away the stain and drying the grid, a 
thin layer stays behind outlining the protein particles (De Carlo and Harris, 2011). 
The micrograph obtained from such a grid, will show the stain as dark background 
and particles appear lighter surrounded by a dark contour. As one is imaging the 
stain rather than the protein particle, only the overall shape of protein can be 
visualised and no high-resolution information can be obtained. Also, the protein will 
be flattened to some degree as it loses its hydration shell when the grid dries (Kiselev 
et al., 1990). However, negative stain is very useful, if not essential, in judging particle 
quality and concentration and can be used to obtain initial low-resolution models 
(Passmore and Russo, 2016). 
Grids for negative stain imaging can be coated with carbon in-house or can be bought 
already coated with carbon. Before use grids are glow discharged or plasma cleaned. 
This changes the surface of the grids from hydrophobic to hydrophilic, and therefore 
allows protein solution to be pipetted on the grid and protein molecules to adhere on 
the carbon surface (Aebi and Pollard, 1987).  
 
Cryo freezing: For high resolution structure determination, a protein or protein 
complex needs to be vitrified in a thin layer of buffer to retain its natural hydrated 
state and to be able to image it in the high vacuum of the TEM. To achieve this, the 
protein solution is added on a carbon or gold grid with a holey support film and after 
excess is blotted away it is rapidly frozen by plunging it into liquid ethane cooled to 
liquid nitrogen temperatures (Dubochet et al., 1988, Passmore and Russo, 2016). 
On an ideal grid, the protein is frozen in random orientations in a thin layer of ice 
within the holes of the grid, whereas the ice thickness is only slightly thicker than the 
protein specimen itself. Thin ice is preferable as it ensures a good signal-to-noise 
ratio (Orlova and Saibil, 2011). Many specimens, however, exhibit unwanted 
behaviour on the air-water interphase, such as preferred orientation or complete 
degradation (Glaeser and Han, 2017). To avoid these problems, one can try different 
adjustments in sample preparation including imaging in thicker ice, using a carbon 
or graphene support or including surfactants in the buffer to protect the specimen 
from the air-water interface. Once the best freezing conditions are established it is 
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advisable to collect a small dataset on a low-end microscope to establish if the 
specimen shows preferred orientation, before collecting on a high-end microscope. 
1.6.3 Direct electron detectors and data collection 
A major contributor to the ‘resolution-revolution’ was the advent of direct electron 
detectors in 2012 (Kuhlbrandt, 2014, McMullan et al., 2014, Bai et al., 2015). Before, 
either film or scintillator-based digital cameras such as charge-coupled device (CCD) 
were used for data collection. Film was generally preferred, as it performs better in 
recording high-resolution frequencies than a CCD camera, measured as detective-
quantum-efficiency (DQE) and modulation transfer function (MTF). Image 
acquisition, however, is slow and high defocus is needed to achieve enough contrast 
(Wu et al., 2016). Direct detectors have two main advantages. First, their DQE and 
MTF is generally significantly higher than either film or CCD cameras and second, 
due to the high frame rate of direct detectors it is possible to record multiple frames 
per exposure, also called a movie stack (Campbell et al., 2012, Li et al., 2013, 
McMullan et al., 2014, Ruskin et al., 2013, Zheng et al., 2017, Scheres, 2014). The 
latter is especially important as it allows to correct for beam-induced movement of 
the specimen, as well as weighting of high- and low-resolution frequencies of 
different frames according to radiation damage (Brilot et al., 2012, Bai et al., 2015). 
Radiation damage is one of the limitations of cryoEM, as the imagining electrons 
severely destroy biological samples in a short frame of time (Baker and Rubinstein, 
2010).  
CryoEM data for single particle analysis (SPA) is collected without tilting the 
specimen, a method used for tomography (Jonic et al., 2008). An automated 
software is used to collect data for multiple days to reach the required number of 
particles (Tan et al., 2016). Typically, a pixel size of ~1Å is chosen, which 
theoretically allows to resolve features as small as ~2Å, which represents the Nyquist 
frequency. Dose rate should be optimised depending on camera used and 
parameters such as defocus value, use of a phase plate, camera type are dependent 
on the specimen, especially its size (Wu et al., 2016).  
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1.6.4 Data processing 
High-resolution structure determination with cryoEM would not be possible without 
sophisticated image processing software. The first step in a typical SPA workflow 
has already been mentioned and is the global motion correction of the movie stack, 
as well as batch correction for local movements and weighting according to radiation-
damage. To minimise processing time, one can easily do these corrections on-the-
fly as soon as movies are collected using automated software like for example 
Scipion (de la Rosa-Trevin et al., 2016). 
Subsequently, another correction according to the contrast transfer function (CTF) 
has to be done (Penczek et al., 1997, Zhang, 2016, Mindell and Grigorieff, 2003, 
Rohou and Grigorieff, 2015). This originates from the way a TEM modifies and 
therefore distorts an image (Frank, 2006). Depending on the exact defocus value it 
over- or underrepresents values as a function of spatial frequency, losing some 
information altogether. By estimating the exact defocus value, software can correct 
for this effect and by collecting images at different defocus values lost information 
can be restored. 
Once images are corrected, particles need to be recognised and picked, a process 
carried out automatically due to the typical large size of datasets (up to millions of 
particles). Sophisticated SPA reconstruction algorithms align and compare these 
randomly orientated particles and group them depending on their similarity, a 
process called 2D classification. As particles of one group are averaged together the 
signal-to-noise ratio is significantly improved. These 2D projections are then used to 
iteratively reconstruct the original 3D shape, by determining the unknown 
orientations of the 2D projections (Frank, 2006, Orlova and Saibil, 2011). 
Classification, both in 2D and 3D, is also a powerful tool in sorting out junk particles 
and in differentiating between different conformations of heterogeneous datasets. 
The most used software packages implementing all steps from particle picking to 3D 
reconstructions are Eman, Relion and CryoSparc (Tang et al., 2007, Scheres, 2012, 
Punjani et al., 2017). 
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Chapter 2. Materials & Methods 
2.1 Molecular Cloning 
2.1.1 Restriction-free cloning 
Restriction-free (RF) cloning is a simple method to insert a DNA fragment into any 
position of a DNA plasmid without use of restriction enzymes and ligation (van den 
Ent and Lowe, 2006). The sequence one wishes to insert, is amplified with 
overhangs, which are complementary to 5’ and 3’ of the insertion site of the plasmid. 
This so-called megaprimer is then used in a second PCR, which amplifies around 
the whole plasmid. Primers can be automatically designed using a webserver (Bond 
and Naus, 2012). One can use genomic, cDNA or another plasmid containing the 
gene of interest as a template and start/stop codon can be removed or added by 
simply changing the primer for the first PCR. The megaprimer is gel purified 
(QUIquick Gel Extraction Kit, Qiagen) before being used in the second reaction. 
Dpn1 treatment is used to digest parental plasmid DNA for 1hr at 37C, after which 
5l is transformed into chemical competent XL1 cells. Cells are plated on the 
appropriate antibiotic-containing plates and grown overnight. Single colonies are 
picked and insertion is tested by colony PCR (see 2.1.6). ONCs are grown from 
positive clones and plasmid DNA is extracted (Quigen Miniprep kit) and sequenced 
(see 2.1.7). 
 
1st PCR 
5x Phusion HF Buffer 10l 
dNTPs (10mM)  5l 
fw primer (10M)  2l 
rv primer (10M)  2l 
template (30-50ng/l) 1l 
Phusion polymerase  1l 
H2O     29l 
Total volume   50l 
2nd PCR 
5x Phusion HF Buffer 10l 
dNTPs (10mM)  2.5l 
plasmid (40ng/l)  1l 
megaprimer*   x l* 
Phusion polymerase  1l 
H2O     x l** 
Total volume   50l 
 
      * Molar ratio of plasmid to megaprimer 1:40 
      **up to 50l
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PCR program 
98C  30sec   
98C  30sec 
55C  30sec  30x 
72C  ~30sec/kbp  
72C  ~1min/kbp 
4C   
PCR program 
98C  30sec  
98C  30sec 
50C  1min  18x 
72C  12min* 
4C   
* unless over 6kbp, then 2min/kbp 
 
 
2.1.2 Gibson assembly cloning 
Gibson assembly cloning (Gibson et al., 2009) can be used to join two or more DNA 
fragments together, independent of restriction enzyme sites or sequence. It uses 
overlapping DNA fragments, produced by PCR, and a cocktail of three different 
enzymes: an exonuclease, to create single strand 3’ overhangs; a polymerase to fill 
in the gaps in the annealed DNA; and a DNA ligase which joins annealed fragments 
covalently.  
Both commercially available Gibson Assembly (NEB) and NEBuilder HiFi DNA 
Assembly Cloning kit (NEB) were used as specified in their protocols. Plasmid was 
either linearized with restriction enzymes (if suitable ones were present) or via PCR, 
and primers were designed as described in the protocols.  
 
Insert/Vector-linearization PCR 
5x Phusion HF buffer 10l 
dNTPs (10mM)  5l 
fw primer (10M)  2l 
rv primer (10M)  2l 
template (50ng/l)  1l 
Phusion polymerase  1l 
H2O     29l 
Total volume   50l 
PCR program 
98C  30sec   
98C  30sec 
55C  30sec  25x 
72C  ~30sec/kbp  
72C  ~1min/kbp 
4C   
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2.1.3 Traditional cloning 
In traditional cloning a gene of interest can be inserted into a multiple cloning site 
(MCS) of a plasmid, by using restriction enzymes to create small complementary 
overhangs, which then can be annealed and ligated. The insert therefore has to be 
amplified with primers adding the desired restriction site, to enable to cut both 
plasmid and insert with the same restriction enzymes. Despite being a reliable 
method, it can only insert DNA fragments at existing restriction sites in the plasmid, 
but nowhere else. Also, a seamless insertion of a DNA fragment of interest cannot 
be achieved. This method was used, however, when cloning genes into the 
bidirectional yeast expression vectors, as there was the need to insert genes 
between flanking sequences identical at both MCSs. This made above mentioned 
cloning methods unusable. 
 
Insert PCR 
5x Hi-Fi Buffer  10l 
dNTPs (10mM)  5l 
fw primer (10M)*  2l 
rv primer (10M)*  2l 
template (30ng/l)  1l 
Velocity polymerase  1l 
H2O     29l 
Total volume   50 
PCR program 
98C  2min   
98C  30sec 
53C  30sec  25x 
72C  ~30sec/kbp  
72C  ~1min/kbp 
4C   
 
* Primers contain required restriction sites and overhangs 
 
The quality and quantity of PCR product is checked by agarose gel electrophoresis, 
and subsequently purified (QUIquick PCR purification kit, if amplification yielded 
single band, or QUIquick gel extraction kit, if contamination bands are visible). Both 
insert and plasmid is digested with appropriate restriction (NEB) enzymes for 2-4hrs 
at the applicable temperature. Cut plasmid is then treated with alkaline phosphatase 
(CIP, NEB) to avoid re-ligation, and both insert and plasmid is separated via agarose 
gel electrophoresis and purified using the QUIquick gel extraction kit. T4 DNA ligase 
is used to ligate insert and plasmid at RT for at least 4hrs or ON, and ligation mix is 
then transformed into XL1 cells, checked by colony PCR and sequenced. 
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Restriction digest 
Enzyme A  2l 
Enzyme B  2l 
Insert or plasmid ~5g 
Appropriate buffer* 3l 
H2O   xl** 
Total volume  30l 
Ligation reaction 
Plasmid  xl*** 
Insert   xl*** 
T4 Ligase buffer 0.5l 
T4 DNA Ligase 0.5l 
H2O   xl** 
Total volume  5l 
* a buffer is chosen in which both enzymes exhibit 100% activity. If a double digest is not 
possible, insert and plasmid are cut subsequently. 
** appropriate amount to make up to total volume 
*** Plasmid and insert are used in a molar ratio of 1:3 
2.1.4 Site-directed mutagenesis 
Site-directed mutagenesis creates specific point mutations in DNA, to establish 
single or double mutations in protein sequence or mutations in DNA sequence (e.g. 
centromere, promoter, etc.) The method, described by Carey et al., 2013, involves a 
PCR reaction with complementary primers, which contain the desired mutations. 
Primers were designed using the webtool PrimerX 
(http://www.bioinformatics.org/primerx/). Parental DNA was digested by Dpn1 at 
37C for 1hr after the PCR reaction, and the product is then separated with agarose 
gel electrophoresis to confirm the size. Subsequently, the mix is directly transformed 
into XL1 cells, plated on selective plates, and mutations are verified by sequencing.  
 
Mutagenic PCR 
10x Pfu Buffer  5l 
dNTPs (10mM)  2.5l 
fw primer (10M)  2l 
rv primer (10M)  2l 
template (50ng/l)  0.5l 
Pfu polymerase  1l 
H2O     37l 
Total volume   50l 
PCR program 
95C  1min   
95C  30sec 
55C  1min  18x 
68C  ~2min/kbp  
72C  ~1min/kbp 
4C   
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2.1.5 Deletion PCR 
A PCR-based deletion method described in Hansson et al., 2008, was used to create 
constructs with deletions of any size. The method uses only one round of PCR with 
primers designed exactly starting and ending at the last/first base outside the DNA 
to be deleted. Therefore, it is a sequence independent and simple method. To 
facilitate re-ligation of the PCR product, a blunt-end creating polymerase is used and 
parental plasmid DNA is digested using Dpn1 for 1hr at 37C. DNA is then purified 
using the QUIquick PCR purification kit (Qiagen) and DNA product length is verified 
with agarose gel electrophoresis. 5’ ends are phosphorylated by treatment with T4 
polynucleotide kinase for 1hr at 37C. T4 DNA ligase is added to the mix and 
incubated for at least 3hrs, or overnight at RT. Ligated DNA is subsequently 
transformed in XL1 cells, plated on selective plates and single colonies are tested by 
colony PCR and sequencing (see 2.1.6 and 2.1.7). 
 
Deletion PCR 
5x Hi-Fi Buffer  10l 
dNTPs (10mM)  5l 
fw primer (10M)  2l 
rv primer (10M)  2l 
template (30ng/l)  1l 
Velocity polymerase  1l 
H2O     29l 
Total volume   50l 
PCR program 
98C  1min   
98C  30sec 
55C  30sec  22x 
72C  ~1min/kbp  
72C  ~2min/kbp 
4C   
 
 
5’ Phosphorylation 
/Ligation reaction 
PCR product (purified)  8l 
T4 ligase buffer (with ATP)  1l 
T4 Polynucleotide kinase  1l 
Total volume    10l 
 
 incubate 37C for 1 hr; then add 1l T4 DNA ligase and incubate 3hrs-ON at RT 
Chapter 2 Materials and Methods 
 
55 
 
2.1.6 Colony PCR 
Colony PCR is a quick method to screen for successful insertion of the desired DNA 
piece after cloning. There is no need for plasmid purification, as cells can be directly 
added to the PCR mix to amplify the region which should contain the insert. ONCs 
can then be grown only from positive clones, for subsequent plasmid purification and 
sequencing. Colony PCR can be performed on single clones, or on multiple clones. 
The latter being useful if cloning efficiency is low. MangoTaq DNA polymerase 
(Bioline) was used, as it allows to directly load the PCR mix onto an agarose gel after 
amplification to further speed up the whole procedure. 
 
Colony PCR 
10x MangoTaq buffer 5l 
MgCl2 (10mM)  1l 
dNTPs (10mM)  2l 
fw primer (10M)  1l 
rv primer (10M)  1l 
MangoTaq polymerase 0.75l 
H2O     14.25l 
Total volume   25l 
PCR program 
94C  5min   
94C  30sec 
53C  30sec  22x 
72C  ~30sec/kbp  
72C  ~1min/kbp 
4C   
 
 add a small amount of cells with a  
sterile pipette tip or inoculating loop 
 
2.1.7 DNA Sequencing 
DNA sequencing was carried out by the Francis Crick Institute’s Genomics 
Equipment Park, using the BigDyeTM Terminator Cycle Sequencing kit (Thermo 
Fisher Scientific) and capillary Sanger sequencing on an ABI Prism 3730. 
Sequencing results were compared against the sequence of interest with SnapGene 
software to exclude any mutations as well as check on correct in-frame insertion. 
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2.1.8 Agarose gel electrophoresis 
Agarose gel electrophoresis is a method used to separate DNA fragments according 
to their size by applying an electric field. The negatively charged DNA migrates 
through an agarose gel towards the positive pole. Small fragments pass through the 
gel faster than big ones. Ethidium bromide is used to detect DNA, as it intercalates 
into the major groove and fluoresces when excited with UV light. After separation, it 
is possible to re-extract and purify DNA bands from the gel (QUIquick gel extraction 
kit, Qiagen). Depending on the sizes of DNA one wishes to separate, the 
concentration of agarose lies between 0.8%-2%. Agarose is dissolved in an 
appropriate volume of Tris/Borate/EDTA (TBE) buffer by heating in a microwave. The 
mixture is left to cool, before adding ethidium bromide solution (10mg/ml, 1:25k 
dilution) and a gel is cast in the running chamber. After the gel has solidified, DNA 
samples are prepared with 5x DNA loading buffer blue (Bioline) and run with 80V for 
20-30min. DNA is visualised with UV light in a Gel DocTM EZ Imager (BioRad). 
 
2.2 Bacterial protein expression 
Bacteria are the simplest of the available expression systems. Time needed from 
cloning to testing of constructs is short and growing bacteria is also cheaper than 
other expression systems. Cells can be grown to high density and mutant, 
expression-optimised strains are commercially available. However, not all higher 
eukaryotes’ proteins can be successfully expressed, as bacteria cells cannot perform 
all posttranslational modifications (PTMs) and they often lack cofactors needed to 
properly fold the protein of interest. 
2.2.1 Transformation 
Expression plasmid with desired gene(s) under the control of a T7 promoter were 
transformed into chemically competent E.coli BL21 (DE3) cells, by adding 0.5l of 
~100ng/l plasmid to 50l of cells. The mixture is incubated for 20min on ice, before 
being heat shocked at 42C for 45sec. The cells are briefly put back on ice and 700l 
SOC media is added. Cells are then grown for 1hr at 37C, 300rpm and subsequently 
plated on LB-Agar plates containing the appropriate antibiotic. Co-expression of two 
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genes was done using an expression plasmid with two MCSs, both under the control 
of a T7 promoter. Co-expression of more than three genes was achieved by co-
transformation of multiple plasmids, carrying different selective markers and plating 
on LB-Agar plates containing all these antibiotics. 
2.2.2 Expression 
An overnight culture (ONC) is grown from one single clone of a fresh transformation 
in LB-media with the appropriate antibiotic(s). Expression in bacteria can be done at 
different temperatures; 37C, the optimal temperature for growth of E.coli, or at lower 
temperature, usually between 16C to 18C. The latter can help to properly fold the 
protein of interest, as it provokes a slowed down metabolism. However, slightly toxic 
proteins, such as histones, need to be expressed quickly at 37C.  
 
Expression at 37C: 200-600l of ONC is added to one litre of the expression culture, 
grown in LB-media with added antibiotics. A total of 2-10 litre, depending on 
expression levels, are used per expression. The expression culture is grown at 37C 
and 220rpm to an OD600 of 0.6 and subsequently it is induced by adding 0.5ml of 
0.5M IPTG to every litre of culture. Protein is expressed for 4hrs, at 37C and 
220rpm, before being harvested via centrifugation at 3000g, 4C, 10min. 
 
Expression at 16C: 100l of ONC is added per one litre of expression culture at 
noon and the cells are grown to an OD600 of 0.4 at 37C, 220rpm. Temperature is 
then lowered to 16C, and after one-hour cells are induced by adding IPTG, as 
described above. Protein is expressed for 16hrs, before harvesting the cells through 
centrifugation, as mentioned above. 
To wash the cells from residual expression media, they are resuspended in a small 
amount of appropriate lysis buffer and pelleted again through centrifugation. Cell 
pellets are then either flash-frozen in LN2 or processed immediately.  
2.2.3 Cell lysis 
Cells are resuspended in 5-10 times the amount of lysis buffer (e.g. 5g of cells to 25-
50ml of lysis buffer), supplemented with EDTA-free protease inhibitor cocktail set III 
(Millipore) and lysed through sonification. Therefore, cell suspension is placed on 
wet ice, to allow for sufficient cooling during the 6x30sec of sonication at step 6 with 
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a Branson Sonifier 450. Between each pulse cells are rested for 30sec, to avoid 
overheating. The lysate is subsequently centrifuged at 30,000g for 50min, to 
separate soluble from insoluble proteins and from cell debris. Supernatant was 
transferred into a fresh beaker and filtered with a 5m syringe filter. 
2.2.4 Protein expression trials 
Due to high expression yields in bacteria, one can test the expression levels in a 
small-scale culture, without any purification necessary. The lysate can simple be 
separated on an SDS-PAGE, to check if the recombinant protein is expressed and 
compare level of expression between different induction temperatures or other 
factors (e.g. length of induction, IPTG concentration, cell density or between different 
constructs). To do this, an ONC is grown from a single colony in 5ml of LB-media 
supplemented with the appropriate antibiotic(s). A 10ml expression culture is 
inoculated to an OD600 of 0.3 with a suitable amount of ONC. For an induction at 
37C, the culture is grown until it has reached an OD600 of 0.6 and is then induced 
with a final concentration of 250M IPTG and protein is expressed for 4hrs, before 
cells are harvested via centrifugation and lysed via sonification. For an induction at 
16C, cells are grown to an OD600 of 0.5, then cooled to 16C and induced once they 
reached an OD600 of 0.6, as described above. 
 
2.3 Budding yeast protein expression 
Many yeasts can be used as an expression system for recombinant eukaryotic 
proteins. It is easy to handle and quick to genetically modify. It can perform 
posttranslational modifications, such as phosphorylations, which are frequent on 
eukaryotic proteins. Yet, it is relatively cheap to grow and expression can easily be 
upscaled by using fermenters. Whilst several yeast expression systems exist from 
various genera, like Pichia, Kluyveromyces or Saccharomyces, budding yeast itself 
was chosen here to express the CBF3 proteins and to ensure proper complex 
formation.  
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2.3.1 Lithium acetate yeast transformation 
Generally, yeast expression plasmids can either be self-propagating or integrated 
into the genome. The latter was used in these studies and they were kindly provided 
from John Diffley. Each of these plasmids has a bidirectional Gal1-10 promoter to 
accommodate two genes of interest and a selective marker. The expression strain, 
also provided from John Diffley, has several amino acid auxotrophies. Once 
transformed, the selective marker can complement for one auxotrophy, meaning 
positive clones can survive on minimal media without addition of one particular amino 
acid, whereas the original strain cannot. To facilitate integration, the plasmid is cut 
somewhere in the selective marker and introduced into the cells, which will integrate 
the plasmid spontaneously via homologous recombination. The lithium acetate 
(LiAc) method was used to introduce the plasmid DNA into the cells. Lithium acetate, 
in combination with PEG makes the cell wall porous to facilitate DNA uptake, which 
requires a single-strand carrier DNA, as well as the plasmid DNA of interest. To make 
the competent cells, a 5ml ONC is grown in YP-media with added 2% Glucose as 
carbon source. A 50ml day culture (YP-media plus glucose) is inoculated with 600l 
of ONC and grown for 4hrs. Log phase cells are then harvested via centrifugation at 
2000g, washed once with water and once with freshly made LiAc/TE buffer. Cells 
are pelleted and resuspended in a final amount of 150-200l of LiAc/TE buffer. 2g 
of cut plasmid (the 20l restriction digest reaction can be used directly) is mixed with 
5l of salmon sperm DNA, which has been boiled for 5min and then cooled down on 
ice. 50l of cells are added to the DNA mix, vortexed for 5sec, before adding 300l 
of LiAc/TE/PEG solution and vortex for another 5sec. The mix is then incubated for 
30min at 30C 300rpm and subsequently heat-shocked at 45C for 15min. Cells are 
briefly put on ice, before being gently pelleted at 1500g for 30sec. The supernatant 
is removed and cells are gently resuspended in 300l of 1M Sorbitol. 100l of cell 
suspension is plated per YN-Agar plate lacking the appropriate amino acid. As a 
control, 50l of cells are transformed with carrier DNA only, and plated on two plates, 
one lacking the amino acid and the other containing the amino acid. Cells are grown 
for 3 days at 30C and 8 colonies are restreaked on a fresh plate and grown for 
another 24hrs before being tested for integration.  
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10x TE buffer  
pH 7.5 
100mM Tris-HCl 
10mM EDTA 
Sterile filter; store at RT 
 
50% PEG4000 
50g PEG4000 
dissolve in 100ml H2O 
Sterile filter; store at RT 
 
1M Lithium-Acetate 
dissolve 20.4g LiAc-
dihydrate in H2O to 200ml 
end-volume  
Sterile filter; store at RT 
 
LiAc/TE buffer 
1ml 1M LiAc 
1ml 10x TE buffer 
8ml H2O 
make fresh before use 
LiAc/TE/PEG 
100μl 1M LiAc 
100μl 10x TE buffer 
800μl 50% PEG 
make fresh before use 
 
 
 
 
 
2.3.2 Integration PCR 
To check if the plasmid has integrated correctly, that is at the right locus, not as a 
tandem repeat and the full plasmid rather than only the selective marker, a yeast-
specific colony PCR is performed. Primers are designed to anneal just before and 
after the integration site in the genome and in the vector before and after the selective 
marker. If both these fragments are successfully amplified, the plasmid has positively 
integrated. To exclude clones with tandem integration, a third PCR reaction is set up, 
using the two primers on the vector. A PCR product is only possible, if there is a 
tandem repeat of the vector in the genome, and those clones are excluded. 
 
Integration PCR 
10x MangoTaq buffer 5l 
MgCl2 (10mM)  1l 
dNTPs (10mM)  1.5l 
fw primer (10M)  1l 
rv primer (10M)  1l 
Template*   1l 
MangoTaq polymerase 0.5l 
H2O     14l 
Total volume   25l 
PCR program 
94C  5min   
94C  30sec 
54C  30sec  35x 
72C  1.5min  
72C  5min 
4C   
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* As yeast cells are hardier than bacteria, they cannot be added straight into the PCR mix. 
Instead a small amount of cells are resuspended in 20l 15mM NaOH and boiled for 5-10min. 
Cell debris is then removed by a short centrifugation at 3000g and 1l of supernatant is used as 
a template for each PCR reaction. 
 
2.3.3 Expression 
Positive clones, without tandem integration, are re-streaked on the appropriate 
selective plate, to avoid carrying over of non-transformed yeast cells. This is 
important as the expression culture is grown in YP-media, rather than selective 
media, and therefore, also non-transformed cells can multiply. Similarly, as the 
selective pressure is lifted, it is possible for the integrated plasmid to be lost. 
Therefore, it was attempted to inoculate the expression culture with a large number 
of cells, grown on a selective plate overnight, to reduce the time the cells grow in YP-
media. As selective plates contain glucose as a carbon source and genes under the 
Gal1-10 promoter are fully repressed under this growth condition, it can also be 
beneficial, especially if the recombinant expressed genes are slightly toxic for the 
cells. For a 5-litre expression, cells from one plate are collected and resuspended in 
a small amount of YP-media. 2.5-litre of YP-media supplemented with 2% raffinose 
is inoculated with these cells in the evening and grown overnight at 30C, 220rpm. 
Cells should be at an OD600 of around 2 the next morning. Every culture is diluted 
with the same amount of YP-media and expression is induced by adding galactose 
to a final concentration of 2%. As yeast cells consume more oxygen than bacteria, 
only 500ml of culture is grown in each of the 2-litre conical flask. Protein is expressed 
for 4hrs and cells are subsequently harvested by centrifugation at 3000g, 4C, 10min. 
The cell pellets are washed once with lysis buffer and pelleted again via 
centrifugation. An equal amount of lysis buffer, supplemented with EDTA-free 
protease inhibitor cocktail set III (Millipore) is added and cells resuspended. The 
suspension is frozen, by adding it drop-by-drop into LN2 to produce the so-called 
‘popcorn’, which is ready for cell lysis, or can be stored at -80C. 
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2.3.4 Cell lysis 
Yeast cells are more difficult to lyse than bacteria due to their robust cell wall. 
Sonication is only successful if the cell wall is enzymatically removed beforehand. 
This, however, is only feasible for a small amount of cells, whereas mechanical lysis 
is commonly used for large scale yeast cultures. Here, cells were mechanically lysed 
with a SPEX freezer mill 6875D (AXT). Popcorn, as well as a cooled, metal impactor, 
is added into the precooled freezer mill containers. The freezer mill, cooled to LN2 
temperature, rapidly shakes the container to crunch the popcorn and break the cells. 
After six cycles of shaking and pausing to avoid overheating, the popcorn has 
converted to cell powder, which can either be stored at -80C or used directly. 
 
2.4 Baculovirus/insect cell protein expression 
Over the last three decades insect cells have gained more and more importance as 
an expression system for eukaryotic proteins and protein complexes. A genetically 
engineered baculovirus carrying the genes of interest is used to infect the cells and 
therefore, induce recombinant protein expression. Insect cells represent a 
sophisticated expression system and are capable of all PTMs, while at the same time 
are still easier to handle and to grow to a high cell number than mammalian cells.  
2.4.1 MultiBac system 
The MultiBac system (Fitzgerald et al., 2006) is specifically designed for multiprotein 
complex expression in insect cells. Each transfer vector has two MCSs under the 
control of the two baculoviral promoters. Multiple vectors can be combined, either by 
transfer of expression cassettes or by in vitro Cre-fusion, allowing for flexibility of 
testing multiple gene combinations. A bacmid is produced from the vectors, 
facilitated by specialised cells, and purified bacmid can be used to generate the virus. 
This virus can infect multiple large-scale insect cell cultures for protein expression. 
Codon-optimised genes of all four CBF3 subunits were cloned into the two MCSs of 
a donor and an acceptor vector, as described in 2.1.2, with the only exception being 
that the donor vector has to be transformed in PIR1 rather than XL1 cells, as it carries 
a different origin of replication. Insertion was verified via sequencing and the two 
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vectors were combined through incubation with Cre-recombinase for 1hr at 37C and 
subsequent heat inactivation for 10min at 70C. 5l was transformed into XL1 cells 
and a miniprep is made from one single clone. 
 
Cre-recombination: 
Donor vector + genes 500ng 
Acceptor vector + genes 500ng 
Cre buffer (10x)  1l 
Cre recombinase  1l 
H2O     xl* 
Total volume   10l 
* appropriate volume to make up to total volume 
 
Transposition is conducted in DH10MultiBac cells. 5l of recombined plasmid is 
transformed in 50l of cells, which are subsequently grown in 900l of SOC medium 
for 5hrs. 30l of cells are plated on LB-Agar plates containing the appropriate 
antibiotics, 0.5mM IPTG and 42g/ml XGAL. The last two components are added to 
allow for blue/white screening, as the Tn7 transposition element is embedded in the 
LacZ gene. Therefore, positively transpositioned cells lose this gene and fail to 
produce blue colouring. For bacmid preparation a ONC is grown from a white, 
positive colony, and cells are pelleted via centrifugation. Cells are lysed using 250l 
P1 buffer from a miniprep kit (Qiagen). Cell debris and proteins are precipitated by 
addition of 250l P2 and 350l N3 buffer and removed by centrifugation at 13,000g 
for 10min at RT. All subsequent steps are performed in a tissue culture hood and all 
solutions used are sterile filtered to avoid any contaminations. The cleared 
supernatant is transferred into a sterile 1.5ml Eppendorf tube and again centrifuged 
to ensure no cell debris is carried over. 800l isopropanol is added and the mixture 
is incubated on ice for 10min. DNA is pelleted at 13,000g, for 15min at 4C, and 
supernatant carefully removed. The bacmid DNA pellet is air-dried in the tissue 
culture hood and subsequently dissolved in 30l H2O and can be stored at -20C or 
used immediately.  
Transfection, to produce virus is carried out in Sf21 cells in 6-well plates. 2ml of 5x105 
cells in antibiotic-free media are added per well and left to settle for one hour. In the 
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meantime, 5l of bacmid is mixed with 100l of antibiotic-free media and 10l of 
Gene Juice transfection reagent (Novagen) is diluted in 100l of antibiotic-free 
media, before both are added together and incubated for 45min. After this incubation 
800l antibiotic-free media is added to the now ready to use transfection mix. The 
media in the 6-well plates is carefully withdrawn and replaced immediately with 1ml 
of the transfection mix. Cells are incubated for 5-6hrs at 28C. Transfection mix is 
carefully withdrawn and 2ml of media supplemented with antibiotics is added 
dropwise to the cells. Cells are incubated at 28C for 72hrs. After this, cells are 
resuspended and added to 50ml of fresh Sf21 cells, diluted to a cell density of 
1.8x106. This culture is grown for 3 days or until cell viability has dropped to 70-80% 
due to virus production. Cells are harvested via centrifugation at 1000g, 4C for 
10min and the media, containing the virus, is carefully transferred into a new black 
falcon tube and a final concentration of 2% FBS is added. Virus can then be stored 
in the cold room or frozen.  
2.4.2 Infection and protein expression 
Fresh virus needs to be produced before every large-scale infection for protein 
expression. Therefore, 100ml of 1.8x106 Sf21 cells are infected with 50l of virus 
stock and grown for 3 days until cell viability has dropped to 70-80%. Cells are 
harvested via centrifugation at 1000g, 4C for 10min and the supernatant is used to 
infect a large-scale culture of HiFi cells, diluted to a cell density of 2 x106 in media 
supplemented with antibiotics. Infected cells are grown 3 days to allow for protein 
expression. Cells are harvested by centrifugation, and cell pellet can be shock-frozen 
or used immediately.  
2.4.3 Cell lysis 
Pellet is resuspended in 50ml lysis buffer with added EDTA-free protease inhibitor 
cocktail set III (Millipore) and 5l Benzonase is added to digest insect cell DNA. Cells 
are lysed through sonification as described in 2.2.3. Lysate is centrifuged at 30,000g 
for 50min to remove cell debris and supernatant is filtrated with a 5m syringe filter, 
before being used immediately for purification. 
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2.5 Protein purification 
Typical recombinant protein purification uses a number of characteristics of the 
protein of interest to separate it from the cell lysate. Usually, as a first step affinity 
purification is performed, using a N- or C-terminal tag, which was fused to the protein 
of interest for this exact purpose. Depending on purity, a number of other purification 
steps can be performed, including another affinity purification step, anion/cation 
exchange chromatography, which exploits the charge of the protein of interest, or 
size exclusion chromatography, using size differences to separate proteins. The 
latter also provides an insight on quality of the protein sample, as aggregation or a 
mixed oligomeric state can be detected, as well as protein complex formation can be 
judged. To assess purity, samples are separated via SDS-PAGE, and 
chromatographies are run using an ÄKTA protein purification system (GE 
Healthcare), which allows to track protein and DNA contaminations through UV 
measurements at 280nm and 254nm respectively. Every purification protocol has to 
be optimised for the protein of interest, and protocols used in this thesis are described 
in detail below. 
2.5.1 Proteins expressed in bacterial 
Histones: In contrast to human, all four budding yeast histones can be co-expressed 
and purified as octamers for the reconstitution of nucleosomes or other uses 
(Kingston et al., 2011). This is possible with the canonical (H3, H4, H2A and H2B), 
as well as the centromeric (Cse4, H4, H2A and H2B) octamer. As over-expression 
of histones is toxic to the bacteria cells, expression was carried out at 37C for 4hrs. 
Nonetheless, expression levels are reasonably high and 2-4litre culture per 
purification was sufficient. Histones can be purified untagged via a 5ml HiTrap 
Heparin HP (GE Healthcare) column, followed by a size-exclusion chromatography 
to separate DNA from the octamer. Cells were lysed in lysis buffer, loaded onto the 
Heparin column, which was subsequently washed with buffer A containing 0.5M salt 
to wash of most impurities. Histones were then eluted with a gradient from 0.5M salt 
(buffer A) to 2M salt (buffer B). Histone octamer bind most stably to the Heparin 
column and therefore elute last. The octamer is most resilient after this purification 
step and can be shock frozen, or directly further purified. To separate the octamer 
from residual E.coli DNA, it is subjected to size exclusion chromatography (Superdex 
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200, 10/300 GL; GE Healthcare) in 2M salt (GF buffer). After this last step, the pure 
octamer is concentrated via a 5kD Vivaspin 20 concentrator (Sartorius) to a final 
concentration of 7-8M and must be used immediately, due to its instability without 
DNA present. The same procedure was used to purify the octamer containing the 
canonical H3, as well as the centromeric full-length Cse4 or Cse4 HFD, which only 
contains the histone fold domain, but not the long, non-conserved N-terminal tail.  
 
Lysis Buffer 
20mM HEPES, pH 8 
100mM NaCl 
1mM DTT 
0.1mM EDTA 
 
Buffer A 
20mM HEPES, pH 8 
500mM NaCl 
1mM DTT 
0.1mM EDTA 
 
Buffer B/GF 
20mM HEPES, pH 8 
2M NaCl 
1mM DTT 
0.1mM EDTA
Mif2 constructs: Two constructs of Mif2 were expressed and purified: Mif2-530, as 
used in Xiao et al., 2017, which has a N- and C-terminal deletion, and Mif2-end which 
only has the N-terminal deletion but includes the last 19 amino acids (see Table 8 
for details). Both constructs were purified with the same procedure, using a N-
terminal his tag for affinity purification with a 5ml HisTrap HP (GE Healthcare) as the 
first step. Therefore, lysate was loaded onto the column and washed with lysis buffer 
until the UV baseline was steady. As Mif2 binds strongly to DNA, the column was 
washed with 3CV salt wash buffer, before protein was eluted with a shallow gradient 
from lysis buffer to buffer B, which contains 500mM imidazole. Collected fractions 
are run on SDS-PAGE to identify those containing the Mif2 protein. Fractions are 
pooled and subjected to anion exchange chromatography with a 1ml Poros 50 HQ 
(Thermo Fisher) column. Protein is loaded onto the column, washed with buffer C, 
and eluted with a salt gradient from buffer C to buffer D. Fractions are again tested 
with SDS-PAGE and those containing the Mif2 protein are pooled. Anion exchange 
is particularly useful to separate any remaining DNA contaminations, as DNA binds 
very strongly to the anion exchange resin and elutes after the protein. Pooled protein 
is concentrated using a 30kD Vivaspin 20 concentrator (Sartorius), and subjected to 
size exclusion chromatography using a Superdex 200 10/300 GL (GE Healthcare) 
column in GF buffer. Notably, size-exclusion showed a salt dependency on protein 
stability/aggregation of both Mif2 constructs, exhibiting a good elution profile in 
300mM but not in 150mM salt. Protein is concentrated using a 30kD Vivaspin 20 
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concentrator (Sartorius), 4% glycerol is added and it is shock-frozen in LN2 and 
stored at -80C. 
  
Lysis buffer 
50mM HEPES, pH 7.5 
150mM NaCl 
1mM TCEP 
10mM Imidazole 
5% glycerol 
Salt wash buffer 
50mM HEPES, pH 7.5 
1M NaCl 
1mM TCEP 
2.5% glycerol  
 
Buffer B 
30mM HEPES, pH 7.5 
150mM NaCl 
1mM TCEP 
500mM Imidazole 
Buffer C 
20mM HEPES, pH 7.5 
120mM NaCl 
1mM DTT  
 
Buffer D 
20mM HEPES, pH 7.5 
1M NaCl 
1mM DTT 
 
GF buffer 
10mM HEPES, pH 7.5 
300mM NaCl 
1mM DTT 
Ndc10 constructs: Ndc10 constructs expressed in bacteria included the NTD, CTD, 
CTDshort and centralCTD (see Table 8). NTD, for which the crystal structure was 
determined, was already expressed and purified by a former lab member (Perriches, 
2014), and pure frozen protein was used for assays. All other constructs were 
expressed and purified. CTD had a N-terminal his tag followed by a sumo tag, for 
affinity purification and improved solubility respectively. CTDshort and centralCTD 
contained a N-terminal his-tag for affinity purification. Lysate was loaded onto a 5ml 
HisTrap HP (GE Healthcare) column and was subsequently washed with lysis buffer, 
until the UV baseline was steady. Protein was eluted with an imidazole gradient from 
lysis buffer to buffer B. SDS-PAGE was used to assess which fraction contains the 
Ndc10 constructs and these fractions were pooled. His-tag was cleaved by adding a 
1:100 dilution of 1mg/ml Sumo or TEV protease and incubation overnight at 4C. 
Anion exchange chromatography using a 1ml Poros 50 HQ (Thermo Fisher) or Mono 
Q 5/50 GL (GE Healthcare) column was used to separate the Sumo or TEV protease, 
cleaved tag and other protein and DNA contaminations. Protein was diluted with NS 
buffer to a final salt concentration of 150mM, subsequently loaded onto the column, 
which was washed with buffer C and eluted with a salt gradient from buffer C to D. 
Fractions containing the protein were pooled and concentrated with a 10kD Vivaspin 
20 concentrator (Sartorius). Lastly, size exclusion chromatography was performed, 
using a HiLoad 16/60 Superdex 200 (for CTD) or 75 (for the other two constructs; 
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GE Healthcare) in GF buffer. Protein fractions were pooled, concentrated and either 
used immediately or shock-frozen in LN2 with 4% glycerol.  
 
Lysis buffer 
50mM Tris-HCl, pH 8 
400mM NaCl 
1mM TCEP 
10mM Imidazole 
5% glycerol 
Buffer B 
20mM Tris-HCl, pH 8 
200mM NaCl 
1mM TCEP 
500mM Imidazole 
 
Buffer C 
20mM Tris-HCl, pH 8 
150mM NaCl 
1mM TCEP 
 
 Buffer D 
20mM HEPES, pH 7.5 
1M NaCl 
1mM TCEP 
GF buffer 
20mM Tris-HCl, pH 8 
150mM NaCl 
1mM TCEP 
NS buffer 
20mM Tris-HCl, pH 8 
1mM TCEP 
 
 
Scm3: N-terminal his-tagged Scm3 was expressed for interaction studies with 
Ndc10. Lysate was loaded onto an equilibrated 5ml HisTrap HP (GE Healthcare) 
column and washed until the UV baseline became steady. Bound protein was eluted 
with an imidazole gradient from lysis buffer to buffer B and fractions were run on a 
SDS-PAGE. Fractions with Scm3 protein were pooled and incubated at 4C, 
overnight with 0.5ml TEV protease (1mg/ml) to remove the his-tag. Protein was 
diluted with an appropriate volume of NS buffer to reduce the salt concentration to 
100mM. It was subsequently loaded on a Mono Q 5/50 GL (GE Healthcare) column, 
washed with buffer C and eluted with a salt gradient from buffer C to D. This step 
was crucial to remove DNA impurities. Protein peak fractions were pooled and 
concentrated to 5ml with a 10kD Vivaspin 20 concentrator (Sartorius) and 
subsequently run on a HiLoad 16/60 Superdex 75 (GE Healthcare) in GF buffer. 
Protein quality was tested with SDS-PAGE, protein was pooled and used either 
immediately or shock-frozen in LN2 with 4% glycerol. 
 
Lysis buffer 
50mM Tris-HCl, pH 8 
150mM NaCl 
1mM TCEP 
10mM Imidazole 
Buffer B 
20mM Tris-HCl, pH 8 
150mM NaCl 
1mM TCEP 
500mM Imidazole 
Buffer C 
20mM Tris-HCl, pH 8 
100mM NaCl 
1mM TCEP 
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Buffer D 
20mM HEPES, pH 7.5 
1M NaCl 
1mM TCEP 
GF buffer 
20mM Tris-HCl, pH 8 
150mM NaCl 
1mM TCEP 
NS buffer 
20mM Tris-HCl, pH 8 
1mM TCEP 
 
 
Scm3 NTD and Ndc10 CTD co-expression: N-terminal his-tagged Scm3 NTD and 
Ndc10 CTD (see Table 8 for details) were co-expressed in bacteria and cells were 
lysed in lysis buffer. Proteins were co-purified with a 5ml HisTrap HP (GE Healthcare) 
column by loading the lysate and washing the column with lysis buffer until UV 
baseline was steady. Proteins were eluted with an imidazole gradient from lysis 
buffer to buffer B. The his-tag from Scm3 was cut at 16C for 2hrs at 120rpm. Protein 
was diluted to 150mM salt concentration with NS buffer, to be able to load it onto a 
Mono Q 5/50 GL (GE Healthcare) column, equilibrated with buffer C. Non-bound 
protein was washed off the column with buffer C, and bound fraction was eluted with 
a salt gradient from buffer C to D. This step is particularly useful to separate excess 
Scm3 and also partly the Ndc10 CTDshort degradation, as well as DNA impurities. 
Peak fractions were pooled and concentrated with a 5kDa Vivaspin 20 concentrator 
(Sartorius). Size exclusion chromatography with a HiLoad 16/60 Superdex 75 (GE 
Healthcare) in GF buffer was performed to separate impurities, as well as Scm3 
NTD/Ndc10 CTD complex from individual proteins. Fractions were tested with SDS-
PAGE, pooled and concentrated. Concentrated protein was either immediately used 
or flash-frozen with 4% glycerol. 
 
Lysis buffer 
50mM Tris-HCl, pH 8 
300mM NaCl 
1mM TCEP 
10mM Imidazole 
Buffer B 
20mM Tris-HCl, pH 8 
300mM NaCl 
1mM TCEP 
500mM Imidazole 
Buffer C 
20mM Tris-HCl, pH 8 
150mM NaCl 
1mM TCEP 
 
 Buffer D 
20mM Tris-HCl, pH 8 
1M NaCl 
1mM TCEP 
GF buffer 
10mM Tris-HCl, pH 8 
200mM NaCl 
1mM TCEP 
NS buffer 
20mM Tris-HCl, pH 8 
1mM TCEP 
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Cse4/H4/Scm3: This complex can be co-expressed and purified with a N-terminal 
his-tag on Cse4 via affinity purification with a 5ml HisTrap HP (GE Healthcare) 
column. Fractions containing all three proteins are pooled and tag is cleaved 
overnight at 4C with addition of 250l TEV protease (1mg/ml). Protein solution is 
diluted with NS buffer to ~350mM salt concentration. To separate impurities, as well 
as DNA contaminations, anion exchange chromatography with a Mono Q 5/50 GL 
(GE Healthcare) or 1ml Poros 50 HQ (Thermo Fisher) column is performed. 
Fractions are tested with SDS-PAGE and these containing all three proteins are 
pooled, concentrated and flash-frozen for further use. It should be noted that, whilst 
co-expression and purification is possible, proteins are not very stable and the yield 
is limiting.  
 
Lysis buffer 
50mM HEPES, pH 7.5 
500mM NaCl 
1mM DTT 
20mM Imidazole 
10% Glycerol 
Buffer B 
20mM HEPES, pH 7.5 
300mM NaCl 
1mM DTT 
500mM Imidazole 
 
Buffer C 
20mM HEPES, pH 7.5 
350mM NaCl 
1mM DTT 
 
 Buffer D 
20mM HEPES, pH 7.5 
1M NaCl 
1mM DTT 
 
NS buffer 
20mM HEPES, pH 7.5 
1mM DTT 
 
 
 
 
 
 
2.5.2 Proteins expressed in yeast 
CBF3, CBF3 core, and all other CBF3 constructs: All CBF3 constructs used in this 
thesis (see Table 8) have been purified with the same procedure described here. All 
four CBF3 genes, as well as Gal4 and Sgt1, are co-expressed and processed to cell 
powder. Cell powder is dissolved in twice the volume of lysis buffer (e.g. 50ml falcon 
of cell powder in 100ml lysis buffer), supplemented with protease inhibitor cocktail 
set III (Millipore). The addition of phosphatase inhibitor (50mM NaF) to the lysis buffer 
is essential for the purification of the whole complex (i.e. not lacking Ndc10) but also 
to obtain a good yield of both core and full complex. After the cell powder is fully 
dissolved, lysate is briefly sonicated with a Branson Sonifier 450 at step 2, four times 
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for 10sec on wet ice, to shear DNA. To remove insoluble proteins and cell debris, it 
is subsequently centrifuged at 30,000g for 50min at 4C. StrepTrap HP (GE 
Healthcare) column is used as a first purification step. Therefore, Cep3 was tagged 
on the C-terminus, which seemed to be the only position to enable full complex 
purification. The column is washed with water, regenerated with 2CV 0.5M NaOH, 
before being washed with water and equilibrated with lysis buffer. Lysate is loaded 
at 2.5ml/min, and the column is washed with lysis buffer, supplemented with protease 
inhibitor cocktail set III (Millipore), until the baseline is just steady. As Ndc10 is not 
very stably bound, it is not advisable to wash longer. Protein is eluted with 30ml lysis 
buffer supplemented with 20mg Desthiobiotin and the peak fraction is pooled and 
loaded onto a 5ml HiTrap Heparin HP (GE Healthcare) column immediately. Heparin 
purification is performed to separate a prominent high molecular weight impurity, 
which otherwise co-elutes on size exclusion chromatography, due to a similar size. 
It also offers the advantage of separating excess Cep3 (especially prominent without 
co-expression of Sgt1) and Ndc10 from the core complex (see next paragraph for 
more details). SDS-PAGE is used to assess which fraction contain core and Ndc10, 
and said fraction are pooled together. To purify only the core complex, fractions 
containing Ndc10 can be omitted at this step. 250g TEV protease is added to cut 
the tag overnight at 4C. The complex is further purified by 1ml Poros 50 HQ (Thermo 
Fisher) column. This step allows for the removal of residual DNA, as well as a second 
prominent impurity around 100kDa and 50kDa, identified as glutaminyl- and 
methionyl-tRNA synthetase and their cofactor ARC1 by mass spectrometry. 
Alternatively, Mono Q 5/50 GL (GE Healthcare) can be performed, which offers the 
additional advantage in separating the core from the full complex, if eluted with a 
shallow gradient. CBF3 proteins are pooled and concentrated using a 100kDa 
Vivaspin 20 concentrator (Sartorius) at 4000g, 4C and subsequently, size exclusion 
chromatography with a Superose 6 10/300 GL (GE Healthcare) is performed to 
separate aggregations from the full and core complex. Salt concentration is kept at 
300mM, as both complexes are salt sensitive and buffers with lower salt show 
extensive aggregation. For structural studies protein is used immediately after size 
exclusion chromatography, for assays it was concentrated if necessary and shock 
frozen with 4% glycerol. 
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Lysis buffer: 
50mM HEPES, pH7.5 
250mM NaCl 
1mM DTT 
50mM NaF 
10% glycerol 
0.02% NP-40 
Buffer B: 
30mM HEPES, pH 7.5  
1M NaCl  
1mM DTT  
10mM NaF  
5% Glycerol  
0.02% NP-40 
Buffer C: 
20mM HEPES, pH 7.5  
200mM NaCl 
1mM DTT 
5mM NaF 
 
 
Buffer D: 
20mM HEPES, pH 7.5 
1M NaCl 
1mM DTT  
2.5mM NaF 
NS Buffer: 
30mM HEPES, pH 7.5 
1mM DTT 
10mM NaF 
 
GF Buffer: 
10mM HEPES, pH 7.5 
300mM NaCl 
1mM DTT 
 
Ndc10 FL and Cep3: Untagged Ndc10 full-length and tagged Cep3 full-length, used 
for assays, were derived through expression of the full complex and separated during 
purification as described above. For Cep3 it was crucial to express the CBF3 proteins 
without simultaneous co-expression of Sgt1, as this yields a high percentage of 
excess Cep3. The Heparin step is used to separate both Ndc10 and Cep3 from the 
core complex. Excess Cep3 does not bind to the 5ml HiTrap Heparin HP (GE 
Healthcare) column and can therefore be collected in the flow-through. Ndc10 binds 
strongest to the Heparin column and can be separated during elution with a shallow 
salt gradient. Both proteins must be pooled and further purified as soon as possible 
after the Heparin run, as they are inherently unstable and degrade rapidly. To 
separate protein and DNA contamination, anion exchange chromatography with a 
1ml Poros 50 HQ (Thermo Fisher) column is performed and protein is pooled and 
subsequently concentrated as soon as the peak elutes. Protein is shock-frozen with 
4% glycerol at the required concentration and stored at -80C. 
 
Buffers – same as CBF3 purification 
 
Skp1/Ctf13: Co-expressed N-terminal tagged Skp1 and untagged Ctf13 (with 
additional co-expression of Gal4 and Sgt1) was purified via a similar protocol as the 
full CBF3 complex. StrepTrap HP (GE Healthcare) column was used as initial affinity 
chromatography step. Lysate was loaded and column washed with lysis buffer until 
the UV baseline was steady. Although proteins eluted very pure, an anion exchange 
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chromatography with a 1ml Poros 50 HQ (Thermo Fisher) column was performed to 
further separate contaminations. Therefore, protein was diluted with NS buffer to a 
salt concentration of 200mM, loaded and eluted with a salt gradient from buffer C to 
D. Protein was pooled and concentrated with a 30kDa Vivaspin 20 concentrator 
(Sartorius) and subsequently run on a Superdex 200 10/300 GL (GE Healthcare) 
column in GF buffer. Here it should be noted, that similar to the full CBF3 or core 
complex Skp1/Ctf13 is sensitive to salt concentration and was therefore kept in a 
buffer containing 400mM salt. Size exclusion in a buffer with 150mM salt leads to 
complete aggregation, whereas the elution profile with 300mM salt shows some 
aggregation, a highly asymmetric peak, as well as disruption of the two proteins. 
Protein was pooled, concentrated and either used immediately or shock-frozen with 
4% glycerol. 
 
Buffers – same as CBF3 purification, except GF buffer 
GF Buffer: 
10mM HEPES, pH 7.5 
400mM NaCl 
1mM DTT 
 
2.5.3 Proteins expressed in insect cells 
CBF3: CBF3 expressed in insect cells was subjected to affinity purification with a 5ml 
StrepTrap HP (GE Healthcare) column. Lysate was loaded onto the column and 
washed with lysis buffer until the baseline was steady. Bound protein was eluted 
using 30ml of lysis buffer complemented with 0.7mg/ml desthiobiotin. Collected 
fractions were tested for expression with SDS-PAGE. 
 
Lysis buffer: 
50mM HEPES, pH7.5 
150mM NaCl 
1mM DTT 
5mM EDTA 
5mM NaF 
7% glycerol 
0.02% NP-40 
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2.6 Nucleosome reconstitution 
Nucleosomes can be reconstituted in vitro from histone octamers and DNA 
fragments. Generally, one would use a strong positioning DNA sequence, such as 
the 147bp Widom 601 sequence (Lowary and Widom, 1998) to enhance nucleosome 
formation. As CBF3 binds sequence-specifically to the centromere, however, 
nucleosomes were reconstructed with both the centromeric sequence and the 
Widom 601 sequence (see Table 9 for exact sequences used). Histone octamers 
and DNA are mixed in 2M salt buffer and salt concentration is slowly decreased to 
force spontaneous nucleosomes formation.  
2.6.1 DNA-Preparation 
Two common methods are used to produce enough DNA for nucleosome refolding 
purpose. DNA is either cloned into a bacterial plasmid with flanking restriction sites, 
plasmid DNA is purified in large scale and the desired DNA fragment is cut out of the 
plasmid and purified, or DNA can be amplified via PCR on a large scale and then 
purified. The latter was used in this thesis, as it also allows for easy tagging of the 
DNA by the use of biotinylated primers. Both budding yeast centromere DNA and 
Widom 601 DNA was amplified in large scale with appropriate primers, in-house 
purified Pfu polymerase (5mg/ml) and optimised PCR parameters. PCR quality is 
checked via a 2% agarose gel electrophoresis and PCR product is pooled and 
filtered with a 0.2m syringe filter.  
 
PCR (for four 96-well plates) 
1M Tris-HCl, pH 8  800l 
3M KCl   133l 
1M MgCl2   80l 
10% Triton   400l 
H2O     37.4ml 
 mix well 
20mg/ml BSA (NEB)  200l 
dNTPs (25mM)  400l 
fw primer (500M)  80l 
rv primer (500M)  80l 
template (250ng/l)  48l 
Pfu polymerase  10l 
Total volume   40ml 
 
PCR program 
98C  2min   
98C  30sec 
53C  30sec  30x 
72C  30sec  
72C  2min 
4C   
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DNA is precipitated at -20C overnight by adding 3M NaAcetate to a final 
concentration of 10% and 2.5x ice-cold 100% EtOH. DNA is pelleted via 
centrifugation at 5000g, 4C for 30min. Supernatant is carefully decanted and DNA 
pellet is resuspended in 50-100ml buffer A and loaded onto an equilibrated Poros 50 
HQ (Thermo Fisher Scientific) column. Column is washed with 20CV buffer A, 
followed by a wash with 22% buffer B to elute residual dNTPs and primers. DNA is 
then eluted with a gradient from 22% to 45% buffer B in 15CV. Collected fractions 
are tested on an agarose gel, DNA is pooled accordingly and concentration is 
measured with a Nanodrop 1000 spectrophotometer (Thermo Fisher Scientific). DNA 
is again precipitated as described above, pelleted via centrifugation and the DNA 
pellet is dissolved in H2O to a final concentration of 3-4mg/ml. 
 
Buffer A 
10mM Tris-HCl, pH 8 
1mM EDTA 
 
Buffer B 
10mM Tris-HCl, pH 8 
1mM EDTA 
2M NaCl
 
2.6.2 Nucleosome formation 
Nucleosomes can spontaneously form in vitro. Therefore, both histone octamers and 
DNA, prepared in a buffer containing 2M salt, are slowly dialysed to reduce the salt 
concentration. As mentioned before, this is most efficient with a strong positioning 
sequence, but also possible with other DNA sequences, like the centromere. 
Prepared DNA and Histone octamers, expressed and purified as described in 2.5.1, 
are mixed in a molar ratio of 1:1 in a final volume of 100l. Salt concentration is kept 
at 2M salt and a final concentration of 10mM DTT is added. The mix is pipetted 
carefully in a 2K Slide-A-Lyzer MINI Dialysis Device (Thermo Fisher Scientific) and 
dialysed against 700ml 2M salt buffer for 30-60min. Salt concentration can then be 
lowered either gradually by pumping a buffer containing no salt (NS buffer) into the 
dialysis container, or by stepwise dialysis. Both methods were used in this thesis, 
and no difference in results was noticed. The former, uses a peristaltic pump at 
around 3.5ml/min flow rate and dialysis was performed overnight, followed by dialysis 
against 700ml of final buffer for 1hr. For the latter, dialysis is performed against 700ml 
of 1M salt buffer overnight, with subsequent dialysis for 2-3hrs each against 700ml 
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of 0.8M, 0.66M, 0.3M and 0.2M buffer, followed by a last dialysis step against the 
final buffer overnight. Both dialyses were performed at 4C and nucleosomes were 
carefully pipetted from the dialysis unit and into a fresh Eppendorf. To remove any 
precipitation sample was centrifuged at 4000rpm, 4C for 2min. 
 
Dialysis buffers 
10mM HEPES, pH7.5 
2M/1M/0.8M/0.66M/0.3M/0.2M/0.12M (final buffer) or 0M (NS buffer) 
1mM DTT 
 
2.6.3 Native-PAGE 
To ensure nucleosome formation, samples can be run on a native PAGE. This will 
separate any remaining free DNA and nucleosomes, whereas the latter migrates 
higher due to its bigger size. 10l nucleosome sample is mixed with 2l DNA-loading 
buffer and run on a 0.8% agarose gel for 20min at 80V. Both buffer and gel are 
precooled and placed on ice during the run to prevent heating of the gel/sample. As 
control a sample containing only free DNA is run on the same gel. To visualise DNA, 
gel is incubated for 20-30min with 50ml H2O containing 2l EtBr and subsequently 
imaged with UV light in a Gel DocTM EZ Imager (BioRad). Afterwards, to visualise 
proteins, the gel is stained with InstantBlue (Expedeon). Alternatively, a 6% DNA 
retardation gel (Invitrogen) can be used, and run with precooled 1xTBE buffer for 
40min at 220V. 
 
2.7 Protein analysis 
2.7.1 SDS-PAGE 
SDS-PAGE (Sodium dodecyl sulfate – polyacrylamide gel electrophoresis) is an 
analytical method to separate proteins according to their size in an electric field. Both 
commercial available and home-made gels were used. The latter were prepared 
following the recipe shown below and kept in the fridge for up to one week. 12.5μl 
protein sample was mixed with 5μl protein loading buffer and heated at 98°C for 2min 
before loading. Unless stated otherwise, 2.5μl of PageRulerTM Plus Prestained 
Protein Ladder (GE Healthcare Life Sciences) was used as a marker. Gels were run 
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at 220V for 45min in SDS-running buffer (homemade gels) or 1x MOPS running 
buffer (commercial gels), before being stained with InstantBlue (Expedeon). 
 
10% Separating gel 
375mM Tris-HCl (pH 8.8) 
10% polyacrylamide (37.5:1) 
0.1% SDS 
0.05% TEMED 
0.1% APS 
15% Separating gel 
375mM Tris-HCl (pH 8.8) 
10% polyacrylamide (37.5:1) 
0.1% SDS 
0.05% TEMED 
0.1% APS 
 
4% Stacking gel 
125mM Tris-HCl (pH 6.8) 
4% polyacrylamide (37.5:1) 
0.1% SDS 
0.1% TEMED 
0.1% APS 
~0.05% Bromophenol blue 
 
2.7.2 Protein concentration measurement 
Protein concentration was measured with a Nanodrop 1000 spectrophotometer 
(Thermo Fisher Scientific). For pure protein, both molecular weight and extinction 
coefficients were provided for a more accurate calculation of concentration. 
2.7.3 SEC-MALS 
Size exclusion coupled with multi-angle light scattering is used to determine the 
molecular mass and therefore oligomeric state of proteins and protein complexes. 
200g of either core or full CBF3 complex were injected onto a Superose 6 Increase 
10/300 (GE Healthcare) column, protein is separated due to its mass and injected 
into a Dawn 8+ MALS system (Wyatt). Data was analysed using Astra software.  
2.7.4 AUC 
Analytical ultra-centrifugation can be used to determine the mass of a protein and 
therefore the oligomeric state, by measuring the sedimentation velocity of a protein 
in solution. It can also be used to test interaction between different proteins, 
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especially if this interaction is weak and cannot withstand more stringent methods 
like size exclusion chromatography. In principle, an AUC is a normal ultra-centrifuge 
fitted with a high-speed camera and a special rotor which features an optical window 
to observe the sample during the run.  
AUC was conducted with the Ndc10 CTDshort construct to measure its oligomeric 
state and test if this construct likely aggregates. Measurements were made in low 
salt buffer with 0.9, 0.6 and 0.3mg/ml, as well as in high salt buffer with 1, 0.8, 0.4 
and 0.2mg/ml and centrifugation at 35,000rpm, at 16C for 20hrs.  
 
Low salt buffer: 
20mM Tris-HCl, pH 7.5 
150mM NaCl 
1mM TCEP 
 
High salt buffer: 
20mM Tris-HCl, pH 7.5 
400mM NaCl 
1mM TCEP 
 
2.7.5 Phos-tag SDS-PAGE 
Phos-tag reagent is a simple and effective way to identify phosphorylated proteins 
via SDS-PAGE. The reagent is included into the gel and interacts with phospho-
groups. Therefore, phosphorylated proteins exhibit a shift towards higher molecular 
weight. The reagent was used accordingly to manufacture’s recommendation with a 
12% polyacrylamide SDS gels (see 2.7.1 for details). During the casting 100M 
Phos-tag and 200M MnCl2 were included into the separating gel. Untreated and 
phosphatase treated samples with added 3l of SDS loading buffer, were boiled and 
10l was run at 220V for 45min in SDS-running buffer. Gels were stained with 
InstantBlue (Expedeon). 
 
Phosphatase reaction: 
Core (0.3mg/ml) 8l 
 phosphatase 0.5l 
H2O   1.5l 
Total volume  10l 
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2.7.6 Western blot 
Western blot coupled to SDS-PAGE allows for detection of specific proteins in a 
heterogeneous sample, even if the protein of interest is only present in very small 
amounts. Antibodies are used for detection, usually in a combination of primary, 
which is specific against the protein or protein tag, and secondary antibody, which is 
specific against the former and allows for detection via immunofluorescence or 
radioactivity. Denatured proteins are separated via SDS-PAGE and transferred from 
the gel to a nitrocellulose membrane using the iBlot (Invitrogen). Protein bands on 
the membrane are temporarily stained with Ponceau S solution to check on the 
quality of the transfer. The membrane is destained with water, and washed with PBS 
supplemented with 0.1% Tween-20 (PBS-Tween), before being blocked for 30min 
with 5% milk in PBS-Tween on a shaking platform at RT. The membrane is washed 
once with PBS-Tween and incubated with HA-tag antibody, diluted 1:5000 in PBS-
Tween and 2% milk for 1hr at RT, shaking. Primary antibody is decanted and can be 
stored for a short time at 4C, or for a longer period at -20C and reused up to three 
times. The membrane is washed three times with PBS-Tween for 5min at RT, 
shaking and is then incubated with secondary anti-mouse HRP antibody (GE 
Healthcare) for detection for 1hr at RT, shaking. Secondary antibody is decanted and 
membrane is again washed for three times as described above. Shortly before 
detection, the membrane is placed on a clear film and 1ml of freshly mixed 
Amersham ECLTM Western Blotting Detection reagents (GE Healthcare) solution is 
added. Membrane is placed in an ImageQuantTM LAS 4000 imager (GE Healthcare) 
and exposed for 30sec to 5min depending on signal strength. 
 
2.8 Protein/protein and protein/DNA interaction studies 
2.8.1 Pull-down assay 
A pull-down assay is an in vitro interaction assay, used to confirm known protein-
protein interactions or find new ones. The principle is to use a tagged bait protein, 
which can be affinity purified using the appropriate resin, to capture prey protein(s), 
which are untagged, and can only be co-purified if they interact with the bait protein. 
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These assays can be done using co-expressed proteins and purifying straight from 
the lysate, or by using already purified proteins. 
 
CBF3 mutant pull-down assay with co-expression in yeast: To test the influence of 
mutations in Skp1 (Skp1 NY_KK) and Cep3 (Cep3 SA or SE; see Table 8 for details) 
on complex formation, a pull-down assay with co-expressed proteins was conducted. 
As expression in yeast is not high enough to see recombinant proteins on SDS-
PAGE of the lysate, all proteins, except for Ctf13, were HA-tagged. This enabled 
detection via HA-tag antibody and western blot. Ctf13 was not tagged as both N-
terminal or C-terminal tagging disrupted complex formation, as tested with wild-type 
proteins. Co-expression of mutant and wild-type CBF3, as control, was done as 
described in 2.3.3. An equal amount of cell powder was used for both mutants and 
control and cell lysate was incubated with Streptavidin agarose beads (Invitrogen) 
for 20min. Beads were gently pelleted via centrifugation, supernatant was removed 
and beads were washed three times with lysis buffer. Beads were resuspended 
directly in SDS-loading buffer and proteins were visualised via SDS-PAGE and 
western blot with HA-tag antibody. In the case of the Skp1 NY_KK mutant, to enable 
the Coomassie visualisation of endogenous Skp1, a large-scale pull-down using a 
5ml StrepTrap HP (GE Healthcare) column with co-expressed mutant and wild-type 
CBF3 was conducted. Eluate was separated via SDS-PAGE and both InstantBlue 
(Expedeon) stained and a western blot with HA-tag antibody was prepared.  
 
Lysis buffer: 
50mM HEPES, pH7.5 
250mM NaCl 
1mM DTT 
50mM NaF 
10% glycerol 
0.02% NP-40 
 
Ctf13/Skp1 pull-down from co-expressed proteins in yeast: To elucidate if two 
potential phosphorylation sites on Skp1 (S162 and T177) influence the binding of 
Ctf13, both proteins were co-expressed (see Table 8) with a 2xstrep-tag on the N-
terminus of Skp1 to facilitate a pull-down. An equal amount of cell powder of co-
expressed wild-type or mutant Skp1 and Ctf13 was dissolved in 60ml lysis buffer. 
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Lysate was loaded onto a 5ml StrepTrap HP (GE Healthcare) column, washed with 
10CV lysis buffer and subsequently eluted with 30ml lysis buffer containing 20mg 
Desthiobiotin. Fractions were examined with 12% SDS-PAGE and Coomassie stain.  
 
Lysis buffer: 
50mM HEPES, pH7.5 
250mM NaCl 
1mM DTT 
50mM NaF 
10% glycerol 
0.02% NP-40 
 
CBF3 core formation pull-down assay with purified proteins: A pull-down assay with 
purified tagged Cep3 and untagged Skp1/Ctf13 (wild-type, Skp1 and Skp1 NY_KK; 
see Table 8) was performed to test in vitro complex formation. All three proteins were 
expressed and purified as described in 2.3.3 and 2.5.2. 50l Cep3 (0.4mg/ml) and 
35l of the different Skp1/Ctf13 complexes (0.5mg/ml) were mixed and incubated for 
5min on ice. 50l Cep3 mixed with 35l reaction buffer, and 35l of the different 
Skp1/Ctf13 complexes mixed with 50l reaction buffer, was used as controls. A 
12.5l aliquot was taken from each reaction to serve as an input sample for SDS-
PAGE. 10l Streptavidin agarose beads (Invitrogen), equilibrated with reaction 
buffer, was added to the rest of each reaction and binding of protein was facilitated 
by incubation for 1hr at 4C on a shaking platform. Beads were pelleted by gentle 
centrifugation at 3000rpm for 20sec and washed three times with 150l reaction 
buffer. Beads, as well as lysate aliquots, were mixed with 5l SDS loading buffer, 
boiled for 5min and loaded on a 12% SDS-PAGE.  
 
Reaction buffer: 
10mM HEPES, pH7.5 
300mM NaCl 
1mM DTT 
 
CBF3 formation pull-down assay with purified proteins: To elucidate CBF3 complex 
formation of the core with Ndc10 the same, above mentioned protocol was used. As 
input, 40l of core (0.5mg/ml) was mixed with 132l of Ndc10 full-length (0.3mg/ml), 
50l of Ndc10 NTD (0.5mg.ml) or 50l Ndc10 CTD (0.5mg/ml). As controls the same 
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amount of core or different Ndc10 constructs with added reaction buffer were used. 
Everything else was conducted as described above. 
 
2.8.2 ITC 
Isothermal titration calorimetry (ITC) is a quantitative method to study protein-protein 
interactions. It utilises thermal changes, which occur during a binding reaction - heat 
is either produced (exothermic) or consumed (endothermic). Both proteins, Scm3 
and Ndc10 CTD/CTDshort were purified as described in 2.5.1. The last purification 
step, the size exclusion chromatography, was conducted using the exact same buffer 
for all proteins. Scm3 peptides (Table 2) were synthesised by the Peptide Chemistry 
STP and dissolved also in the same buffer. Matching of the buffer is important as 
even slight differences in buffer composition lead to strong background signals. 
Ndc10 CTD or CTDshort was pipetted into the experiment cell at a concentration of 
25M and Scm3 or Scm3 peptides were prepared in the syringe at 221M. 
Measurements were done on a MicroCal iTC200 (Malvern). Both reference and 
experiment cell were heated to 16C and 20 injections were conducted per run. As 
a control, Scm3 was titrated into buffer only. Data was analysed with Origin software.  
 
Table 2: Scm3 peptides 
N-terminal peptides used for ITC measurements. Mutated residues are highlighted in bold. 
Hydrophobicity and pI were calculated using ProtParam webserver. The former is a grand 
average of hydrophobicity values, calculated by adding hydropathy values of all residues and 
dividing by the total number of residues (therefore, the more positive this score the more 
hydrophobic). 
Name Sequence Hydrophobicity pI 
WT KTNKKISKRRSLKNLHGALKGLLKES -0.989 11.3 
Mutant 1 KTNKKISKRRSLKNLHGAAKGLLKES -1.063 11.3 
Mutant 2 KTNKKISKRRSAANLHGALKGLLKES -0.852 11.26 
Mutant 3 KTNKKISKRRSLKNLHGALKGAAKES -1.137 11.3 
Mutant 4 KTNKKISKRRSAANLHGAAKGAAKES -1.074 11.26 
 
2.8.3 Crosslinking MS 
Crosslinking coupled with mass spectrometry is an increasingly used method, to get 
a better understanding of protein/protein interactions, especially if some other 
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structural or biochemical data is present and can be used for validation. Both CBF3 
and core complex were purified as described in 2.5.2. Straight after size-exclusion 
chromatography protein at 0.38mg/ml was crosslinked with DSSO, a crosslinker 
which can be cleaved in a mass spectrometer and gives a characteristic pattern used 
to identify crosslinked peptides. Therefore, 80l of protein was mixed with 0.8l of 
DSSO (Thermo Fisher Scientific; one vial is dissolved in 25.7l of DMSO) and 
incubated at 37C, 700rpm for 30min. The mixture is subsequently quenched by 
addition of 0.25% final concentration of hydroxylamine for 15min, 37C, 700rpm and 
stored at -20C. All further sample preparation, mass spectrometry and data 
processing were done solely by the Proteomics STP. 
2.8.4 Peptide array 
A peptide array can be used to identify potential stretches of residues important for 
protein/protein interaction. The array consists of a collection of peptides from protein 
A, whereas thousands of copies of each peptide are immobilised on a membrane in 
spots next to each other. This membrane is then incubated with protein B, to facilitate 
the binding to spots of peptides important for the interaction. After excess of protein 
B is washed off, it is detected with an appropriate antibody.  
A peptide array membrane of Ndc10 was ordered from the Francis Crick Institute’s 
Peptide Chemistry STP. It was designed to contain spots of 20 amino acid-long 
peptides, which are shifted by one amino acid each (e.g. spot 1: residue 1 to 20; spot 
2: residue 2 to 21, etc.). Due to the size of Ndc10, two membranes were needed to 
accommodate all the peptides and two copies of each membrane were produced to 
allow for a control. Before use the membranes were prepared by incubation with 
stripping buffer B for 1hr at RT on a shaking platform, followed by washing with H2O 
for three times. Membranes are then equilibrated with incubation buffer, before 
adding 200g of Strep-tagged core complex per membrane and incubation overnight 
at 4C on a shaking platform. Control membranes are incubated with buffer only. To 
facilitate detection of bound core complex, membranes are washed three times with 
incubation buffer plus 0.1% Tween-20 and blocked for 30min at RT with incubation 
buffer plus 0.1% Tween-20 and 2% milk. A 1:7000 dilution of primary strep-tag 
antibody (Bioworld Technologies) in incubation buffer plus 0.1% Tween-20 and 0.5% 
milk is added and incubated for 1hr at RT shaking. Unbound primary antibody is 
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washed off for three times with incubation buffer plus 0.1% Tween-20, before a 
1:7000 dilution of secondary Anti-mouse  antibody (GE Healthcare) in incubation 
buffer plus 0.1% Tween-20 and 0.5% milk is added and incubated for 1hr at RT, 
shaking. The membranes are subsequently washed for three times, before detection. 
Membranes are placed on clear film in a western blotting cassette, whereas care is 
taken to not let them dry. Per membrane, 5ml of freshly mixed Amersham ECLTM 
Western Blotting Detection reagents (GE Healthcare) solution is added. In the dark 
room, a photosensitive film is placed on the membranes and exposed for 30sec, 
before being developed in an automated developer. For reuse of the membranes, 
they can subsequently be stripped and stored dry in -20C. Therefore, membranes 
are once washed with H2O and subsequently incubated with stripping buffer A for 
1hr at 55C, 100rpm before being washed with H2O again. Membranes are then 
incubated in stripping buffer B at room-temperature for 1hr on a shaking platform, 
washed once with H2O, once with 20% EtOH and are then air-dried. Dry membranes 
can be stored at -20C wrapped in filter paper and plastic. 
 
Stripping buffer A: 
8M Urea 
1% SDS 
100mM -mercaptoethanol 
Stripping buffer B: 
50% EtOH 
10% glacial acid 
 
Incubation buffer: 
10mM HEPES, pH 7.5 
300mM NaCl 
1mM DTT 
 
2.8.5 EMSA 
Electrophoretic mobility shift assays (EMSAs) are used to study Protein/DNA 
interactions. DNA and protein are mixed and run on an agarose or polyacrylamide 
native gel. Due to the increased size of the protein/DNA complex one can detect a 
shift of the DNA if compared to free DNA. In this thesis, solely agarose gels were 
used, as both CBF3 and core complex were unable to penetrate polyacrylamide gels, 
possibly due to their size. 10l of samples containing protein and DNA, being either 
-Protein Phosphatase (NEB) treated or untreated, were mixed with 0.5l of 5x DNA 
loading buffer blue (Bioline) and immediately loaded onto a precooled 0.8% agarose 
gel (without added EtBr). The gel was placed on ice and run at 80V for 20min in 
chilled 1x TBE buffer. DNA is stained with EtBr solution (50ml H2O plus 2l EtBr) for 
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20-30min and imaged with UV light with a Gel DocTM EZ Imager (BioRad). 
Subsequently, it can be stained with InstantBlue (Expedeon) to visualise proteins. 
 
Phosphatase reaction: 
Core/CBF3 (0.3mg/ml) 5l 
Reaction buffer  2.5l 
100mM MnCl2  1l 
 phosphatase  0.5l 
56bp CEN3 (0.01 g/l) 1l 
total   10l 
Reaction buffer:  
10mM HEPES, pH 7.5 
300mM NaCl 
1mM DTT 
 
 
 
 
2.8.6 Analytical size exclusion chromatography 
Size exclusion chromatography separates proteins according to their size, as well as 
shape and can therefore be used to determine if two proteins of interest are 
interacting. If there is an interaction, the size will increase significantly, given the two 
interaction partners are big enough. This will result in a shift of elution towards bigger 
size/earlier elution time.  
 
Scm3 and Ndc10 CTD: 337g Scm3 (full length) and 256.5g of Ndc10 CTD were 
mixed in a total volume of 0.5ml. Protein mixture was injected and run on a Superdex 
200, 10/300 GL (GE Healthcare) column, due to their expected size of ~120kDa (for 
a Ndc10 CTD homodimer plus a Scm3 monomer) or ~146kDa (for a Ndc10 CTD 
homodimer plus a Scm3 homodimer). 
 
Scm3 and Ndc10 CTDshort: 750g Scm3 (full-length) and 810g CTDshort were 
mixed in a total volume of 0.5ml. As the expected size of a Scm3 or a CTDshort 
homodimer is ~50kDa, a Superdex 75, 10/300 GL (GE Healthcare) column was 
used. 
 
2.9 Structural studies 
As explained in 1.6, different methods exist to elucidate a structure of a protein. Here, 
both crystallisation trials, as well as single particle cryoEM was used. 
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2.9.1 Crystallization trials 
Crystallisation of a protein or protein complex requires a pure and concentrated 
sample and a condition of precipitants to force crystallisation and prevent 
aggregation. The condition needed is not known and therefore, extensive trials are 
conducted with commercial or home-made screens. Once an initial hit is found, these 
conditions can be optimised until a crystal is achieved which gives a sufficient 
diffraction pattern. Here, three different proteins/complexes were tested for 
crystallisation: the CBF3 core (wild-type or Gal4Δ) complex, Ndc10 CTDshort and 
Ndc10 CTD bound to Scm3 NTD. Concentrated proteins were set up with different 
screens (see Table 3, Table 4, Table 5 and Table 6 for details) using a Matrix Hydra 
(Thermo Scientific) to suspend reservoir solutions and a Mosquito HTS (TTP 
Labtech) to pipette 400nl drops of protein and reservoir. Screens were kept and 
imaged in a Rock Imager (Formulatrix) either at room temperature or 4C and drops 
were inspected using the Rockmaker software (Formulatrix). Optimisation screens 
were designed with the same and mixed using a Formulator (Formulatrix). Crystals 
were cryo-protected with a range of protectants, frozen and stored in LN2. Diffraction 
pattern was recorded at Diamond Light Source. 
 
Table 3: Screens used for crystallisation trials of CBF3 core 
 
Protein 
concentration 
Screen Drop size Ratio 
protein:reservoir 
Incubation 
temperature 
1.5 mg/ml * Natrix 400nl 1:1 RT and 4°C 
1.5 mg/ml * Proplex 400nl 1:1 RT and 4°C 
1.2 mg/ml PACT 400nl 3:1 RT 
1.2 mg/ml JSCG+ 400nl 3:1 RT 
1.2 mg/ml Morpheus 400nl 3:1 RT 
1.2 mg/ml PGA 400nl 3:1 RT 
1.2 mg/ml Proplex 400nl 3:1 RT 
1.65 mg/ml * PACT 400nl 3:1 RT 
1.65 mg/ml * JCSG+ 400nl 3:1 RT 
1.65 mg/ml * Morpheus 400nl 3:1 RT 
1.65 mg/ml * (NH4)2SO4 400nl 3:1 RT 
* marks occasions which were set up without and with 27bp CEN3 DNA in a 1:1 molar ratio. 
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Table 4: Screens used for crystallisation trials of CBF3 core Gal4Δ 
 
Protein 
concentration 
Screen Drop size Ratio 
protein:reservoir 
Incubation 
temperature 
2 mg/ml  Natrix 400nl 1:1 and 3:1 RT  
2 mg/ml  Proplex 400nl 1:1 and 3:1 RT  
2 mg/ml  Clear Strategy I 400nl 1:1 and 3:1 RT 
2 mg/ml  JSCG+ 400nl 1:1 and 3:1 RT 
 
 
Table 5: Screens used for crystallisation trials of Ndc10 CTDshort 
 
Protein 
concentration 
Screen Drop size Ratio 
protein:reservoir 
Incubation 
temperature 
10 and 20 mg/ml JSCG I 400nl 1:1 RT and 4°C 
10 and 20 mg/ml JSCG II 400nl 1:1 RT and 4°C 
10 and 20 mg/ml JSCG III 400nl 1:1 RT and 4°C 
10 and 20 mg/ml JSCG IV 400nl 1:1 RT and 4°C 
10 and 20 mg/ml Natrix 400nl 1:1 RT and 4°C 
10 and 20 mg/ml PACT 400nl 1:1 RT and 4°C 
10 and 20 mg/ml PEG I 400nl 1:1 RT and 4°C 
10 and 20 mg/ml PEG II 400nl 1:1 RT and 4°C 
10 and 20 mg/ml Wizard I-II 400nl 1:1 RT and 4°C 
10 and 20 mg/ml Wizard III-IV 400nl 1:1 RT and 4°C 
 
 
 
Table 6: Screens used for crystallisation trials of Ndc10 CTD and Scm3 NTD 
 
Protein 
concentration 
Screen Drop size Ratio 
protein:reservoir 
Incubation 
temperature 
5 and 2.5 mg/ml JSCG I 400nl 1:1  RT and 4°C 
5 and 2.5 mg/ml JSCG II 400nl 1:1  RT and 4°C 
5 and 2.5 mg/ml JSCG III 400nl 1:1  RT and 4°C 
5 and 2.5 mg/ml JSCG IV 400nl 1:1  RT and 4°C 
5 and 2.5 mg/ml Natrix 400nl 1:1  RT and 4°C 
5 and 2.5 mg/ml PACT 400nl 1:1  RT and 4°C 
5 and 2.5 mg/ml PEG I 400nl 1:1  RT and 4°C 
5 and 2.5 mg/ml PEG II 400nl 1:1  RT and 4°C 
5 and 2.5 mg/ml Proplex 400nl 1:1  RT and 4°C 
5 and 2.5 mg/ml Wizard I-II 400nl 1:1  RT and 4°C 
5 and 2.5 mg/ml Wizard III-VI 400nl 1:1  RT and 4°C 
6.8 mg/ml JSCG+ 400nl 1:1 and 3:1 RT and 4°C 
6.8 mg/ml PACT 400nl 1:1 and 3:1 RT and 4°C 
6.8 mg/ml Pi-PEG 400nl 1:1 and 3:1 RT and 4°C 
6.8 mg/ml MIDAS 400nl 1:1 and 3:1 RT and 4°C 
6.8 mg/ml Morpheus 400nl 1:1 and 3:1 RT and 4°C 
6.8 mg/ml PGA 400nl 1:1 and 3:1 RT and 4°C 
6.8 mg/ml PEG I  400nl 1:1 and 3:1 RT and 4°C 
6.8 mg/ml PEG II 400nl 1:1 and 3:1 RT and 4°C 
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2.9.2 Negative stain EM 
Straight after size exclusion chromatography CBF3 and core complex was, if 
necessary, diluted to a concentration of ~0.02 or 0.01mg/ml respectively. Copper 
400 mesh coated with carbon (EM Resolution) were glow discharged with a K100X 
system (Quorum Technologies) for 30sec at 45mPa. 4l of protein sample was 
pipetted on the carbon side of the grid and incubated for 1min. For staining four 60l 
drops of 2% uranyl acetate are prepared on parafilm, nearly all of the protein solution 
is blotted away with filter paper (Whatman 2) and immediately after the grid is washed 
in one drop after the other for 10sec each. The grid is removed from the last drop 
and blotted dry with filter paper. After completely air-drying, it can be stored in a grid 
box indefinitely. Care has to be taken when handling the grid at all times, as for their 
fragile nature. 
Negative stained grids were imaged with a 120kV G2 Spirit Twin TEM (FEI) at room 
temperature with a single-tilt side entry holder and a CCD camera. Core data was 
recorded manually and with a defocus range from -1 to -2m. 
2.9.3 CryoEM  
Core and core S was diluted to 0.1mg/ml straight after size exclusion. 56bp CEN3 
DNA was added to the latter in a molar ratio of 1:1.2 (protein to DNA). The sample 
was frozen in liquid ethane using a Vitrobot or a manual plunge freezer. For the latter, 
protein was added to the glow discharged grids, held with a tweezer connected to 
the plunge freezer, incubated for 30sec and blotted with filter paper (Whatman 2) per 
hand. The Vitrobot was used as per instructions, at either 90% humidity or without 
humidifying at room temperature. A range of grids was tried for screening, namely 
C-flat (EMS), lacey carbon grids (EM Resolutions) and copper 1.2/1.3 400mesh or 
2/2 200 mesh Quantifoil grids. After plunge freezing, grids were transferred and 
subsequently stored in LN2.  
Screening of ice thickness and particle appearance was conducted on a 120kV G2 
Spirit Twin TEM (FEI) with a 626 Gatan side-entry cryo-holder in low-dose mode. In 
addition, screening was conducted at the Imperial College London’s Electron 
Microscopy Center, with a CM200 TWIN (Phillips), a Tecnai G2 Spirit (FEI) and a 
200kV Tecnai F20 G2 (FEI) all with a 626 Gatan side entry cryo-holder and a CCD 
camera. Once the right freezing conditions were established, data was collected on 
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Krios Titan microscopes (FEI) with a Gatan K2 camera both at eBIC (Diamond Light 
Source) and in-house. Data collection parameters for all three datasets are outlined 
in Table 7.  
 
Table 7: CryoEM data collection parameters for all three datasets 
 
 1st Dataset Core 2nd Dataset Core 1st Dataset CoreS 
Microscope Titan Krios (FEI) Titan Krios (FEI) Titan Krios (FEI) 
Camera K2 Summit (Gatan) K2 Summit (Gatan) K2 Summit (Gatan) 
Voltage (keV) 300 300 300 
Defocus range (μm) -2 to -4 -1.5 to -3.5 -1.5 to -3.5 
Magnification 130,000 x 130,000 x 130,000 x 
Pixel size (Å/pixel) 1.08 1.078 1.08 
Dose rate (e-/pixel/s) 5.4 6.3 6.3 
Movies 1608 8755 4000 
Frames per movie 25 25 25 
Total exposure time (sec) 10 10 10 
Total accumulated dose 
(e-/Å2) 
50 54 54 
Particles after autopicking  ~180k ~3.5 million ~890k 
Particles contributing to 
final reconstruction 
72,771 209,751 200,184 
Sharpening B-factor (Å2) -150 -150 -150 
Final resolution (Å) 5.7 3.6 3.9 
 
2.9.4 Image processing  
Negative stain data of the core complex was processed with EMAN2. Particles were 
picked automatically and quality control of picking was conducted manually. 2D 
classes were calculated and a subset of good classes was chosen. With an initial 
model derived from the lowpass-filtered Cep3 crystal structure, a 3D reconstruction 
was calculated.  
The first core dataset was entirely processed within Relion2.0 using standard 
procedures (Scheres, 2016). In the case of both the 2nd core and core Skp1 dataset, 
movies were directly fed into Scipion1.1 and motion corrected with MotionCor2 on 
the flow by the cryoEM facility. The output was then fed into Relion2.1 and processed 
within Relion, as well as Cryosparc. 3D densities were manually inspected in UCFS 
Chimera (Pettersen et al., 2004). Local resolution calculation was done from within 
the Relion GUI with ResMap. Overall resolution was calculated by Fourier shell 
correlation (FSC) and the 0.143 criterion (Rosenthal and Henderson, 2003) and map 
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anisotropy was estimated using 3DFSC (Tan et al., 2017). Fitting of crystal structures 
was done manually in Chimera, treating the entire crystal structures as rigid bodies. 
Re-building of models was carried out in Coot (Emsley and Cowtan, 2004) and real-
space refinement was done using phenix.refine (Adams et al., 2004). 
 
2.10 In vivo analysis of Skp1 
While in vitro studies of proteins are crucial to understand its functions, it does not 
always reflect on processes happening in vivo. For example, a protein might get 
phosphorylated by a specific kinase in vitro, however, in the cell they are spatially or 
temporarily separated and therefore this reaction never takes place. Therefore, a 
finding in vitro should always be confirmed or brought into context in vivo. Similarly, 
an observation in vivo could be misleading and one needs to confirm said 
observation in vitro. An example for the latter would be, a protein deleted in vivo 
showing differences in phosphorylation status of the cell, however, only in vitro 
studies with purified components can distinct between said protein being a kinase or 
phosphatase itself or having an indirect influence.  
2.10.1 Tagging of endogenous proteins 
Both constructed strains were of the W303a (MATa; ade2-1; his3-11,15; leu2-3,112; 
trp1-1; can 1-100; ura3-1) background and C-terminal tagging was performed by 
gene targeting using PCR products. Vectors containing either an PK6- or HA-tag, as 
well as a selective marker, were kindly provided from Frank Uhlmann’s laboratory. 
The tag and selective marker are amplified with PCR using primers including 
overhangs complimentary to the very end, as well as just downstream of the gene of 
interest. The stop codon is excluded. PCR product is then transformed (see 2.3.1) 
and will integrate after the gene and therefore fuse the tag to the gene. Correct 
insertion is tested by integration PCR (see 2.3.2) with primers complimentary to a 
genomic sequence before and after the integration site, paired with primers 
complimentary to the inserted sequence. Unlike vectors for recombinant expression 
of genes of interest, those used for endogenous tagging have selective markers 
derived from a different species (e.g. K.lactis). This avoids targeting of the PCR 
product to the selective marker gene in the genome. Gene replacement to construct 
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the Skp1 strain was done using a modified version of the HA-tag vector, in which 
the Skp1 sequence, with the 37-64 loop deleted, was cloned fused to the HA-tag. 
Primers to amplify the product used for transformation were then designed to include 
the Skp1 gene and replace the entire endogenous gene. Insertion was tested by 
integration PCR, as mentioned above. 
2.10.2 Cell cycle arrest and time-course experiment 
To be able to test behaviour of a protein during the cell cycle one must synchronise 
all cells in a culture. Different protocols are available to arrest cells in different stages 
of the cell cycle. Here, cells were arrested in G1 by addition of alpha factor. After 
removal of this pheromone cells will synchronously move through one or two cell 
cycles and samples can be taken at specified time-points depending on the doubling 
time of the constructed strains. The doubling time was determined by growing an 
ONC in YP-media complemented with 2% glucose at 25°C and 200rpm, inoculating 
a 200ml day-culture to an OD600 of 0.2 and measuring cell density every hour after 
the culture has reached an OD600 of 0.3. The resultant growing curve is used to 
determine the doubling time in the log phase of growth.  
A 450ml culture is inoculated in the evening and grown over night at 25°C, 200rpm 
in YP-media with 2% glucose to reach an OD600 of 0.2 to 0.3 the next morning. Alpha 
factor is added to an end concentration of 2µg/ml three times spaced by one hour 
each. 30mins after the third alpha factor dose, cells are visualised under the 
microscope to check for arrest. Arrested cells exhibit a distinctive shape, called 
shmoo. Once more than 90% of cells are shmooing, cells are washed with three 
times 400ml of fresh YP-media to remove any excess alpha factor. To do so cell 
suspension is poured in a sterile vacuum filter unit (Millipore) and whilst the media 
passes through the 0.22µm filter, cells are collected on top. Once all media has 
passed through wash media is added and also filtered through. After the washing, 
cells collected on the filter are resuspended in pre-warmed 450ml YP-media plus 2% 
glucose and transferred into a 2-litre conical flask. For three hours two samples, one 
for the CoIP and one for FACS analysis, are collected every 15min. After one hour 
cells are visualised under the microscope again, to check if cells have started to bud. 
Once more than 90% of cells are budding, another dose of alpha factor is added to 
the remaining cultures to arrest them in G1 again, after completing one cell cycle. 
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Another dose of alpha factor is added after 30min and cells are again tested for 
shmoo. In total 12 samples are collected. 
2.10.3 Fluorescence-activated cell sorting (FACS) 
To determine DNA content and therefore cell cycle stages of each time point, 1ml of 
cells are collected in a pre-chilled Eppendorf tube. Cells are pelleted for 1min, 4000g 
at 4°C. The media is decanted and 1ml of ice-cold 70% EtOH is added to fixate the 
cells. Samples are kept at 4°C for over the weekend until further processing. Cells 
are quickly spun down again and the supernatant is decanted. Cells are resuspended 
in 1ml of 50mM Tris/HCl, pH7.5 containing 0.1mg/ml RNase A (Sigma-Aldrich). Cells 
are incubated at 37°C, 200rpm overnight to digest all RNA. The next morning cells 
are pelleted and supernatant is decanted. Cells are resuspended in 400µl of FACS 
solution supplemented with 50µg/ml propidium iodide (1mg/ml solution in water, 
Sigma-Aldrich). Cell suspension is briefly sonicated with a Branson Sonifier 450 at 
step 6 for 5sec to prevent clumping of cells. Samples are then measured with a 
FACSCalibur (Becton Dickinson) according to standard protocol for haploid yeast 
cells. Data is visualised with FlowJo software. 
 
FACS solution: 
10ml Tris/HCl, pH 7.5 from 1M stock 
2.1ml NaCl from 5M stock 
3.9ml MgCl2 from 1M stock 
34ml H2O 
 
2.10.4 CoIP 
At each time-point 30ml of cells are collected in a pre-chilled 50ml Sarsted tube and 
pelleted by centrifugation at 4000g, 5min at 4°C. Media is decanted and cells are 
resuspended in 1ml pre-chilled H2O and transferred into 2ml cell breaker tubes. Cells 
are pelleted again via centrifugation, supernatant is decanted and cells are shock-
frozen in LN2. After FACS measurement, showing a successful synchronisation/cell 
cycle passage, samples are processed for the CoIP.  
Cells are resuspended in 400µl of lysis buffer with added benzonase and complete 
protease inhibitor, glass beads (Sigma) are added and cells are broken using a cell 
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breaker at 4°C. Cell breakage is determined with an optical light microscope and 
after more than 60% of cells are successfully broken lysate is collected and insoluble 
material as well as cell debris is separated by centrifugation at 13 000g, 10min at 
4°C. Soluble supernatant is transferred into a fresh Eppendorf and protein 
concentration is measured with Bradford reagent and absorbance at 595nm. A total 
of 3.1mg of cell extract is used for the CoIP and the appropriate amount is transferred 
into a 1.5ml Costar tube (Corning) and the volume is normalised. A total cell extract 
sample is taken and mixed with SDS-loading buffer and frozen at -80°C. To preclear 
the cell extract for CoIP 20µl of unspecific antibody, coupled to Dynabeads is added 
and incubated on a shaker wheel at 4°C for 30min. Beads are collected on a 
magnetic rack and cleaned cell extract is transferred into a fresh Costar tube, mixed 
with 20µl of protein A dynabeads with coupled antibody and incubated on a wheel 
for 1hr, 4°C. Beads (bound fraction) are collected on a magnetic rack, washed three 
times for 10min, 4°C on the wheel and resuspended in 25µl of SDS-protein loading 
buffer and samples are frozen at -80°C.  
 
Lysis buffer:  
50mM HEPES, pH7.5 
200mM NaCl 
1mM DTT 
50mM NaF 
1mM MgCl2 
0.1mM Vanadate 
10mM ß-glycerophosphate 
 
2.10.5 Phos-tag SDS-PAGE and western blot 
Frozen samples are thawed and briefly spun down. Total cell extract samples are 
boiled for 5min, 98°C, while bound fraction samples are only heated to 60°C for 5min 
to avoid excessive background signal from the heavy and light chain of the antibody. 
10µl of samples are loaded onto a 12% Phos-Tag gel (see 2.7.5 for recipe) and run 
for 45min, 220V. Proteins are blotted on an activated PVDF membrane with the Mini 
Trans-Blot® Cell system (BioRad) using 1x transfer buffer (BioRad) chilled with a 
cooling element to avoid overheating. HA-tagged Skp1 is visualised via western blot 
(for procedure see 2.7.6) with a primary HA-tag antibody (Abcam) and secondary 
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anti-rabbit HRP conjugated antibody (GE Healthcare). Blots are developed in the 
dark room using an automated developer (Abnova) for 10sec each. 
2.11 Protein constructs and DNA fragments used in this study 
The following two tables summarise all DNA fragments used and all protein 
constructs described. 
Table 8: Protein constructs used in this study 
All tags contained a TEV site to be cleavable with TEV protease, except for sumo-tags, which 
can be cleaved with sumo protease without any additional introduced residues. 
 
Name Mutation/Deletion tag 
CBF3SΔ 
full complex, including Skp1 
residues 37 to 64 deleted 
C-terminal 2xstrep on Cep3 
Cep3 n.a. 
C-terminal 2xstrep or HA and C-
terminal 2xstrep 
Cep3 2xmut or M3 
combination of Cep3 LL_SA and 
Y_S 
HA and C-terminal 2xstrep 
Cep3 LL_SA or M1 
L319 and L320 mutated to serine 
and alanine, respectively 
HA and C-terminal 2xstrep 
Cep3 SA S575 mutated to alanine C-terminal 2xstrep on Cep3 
Cep3 SE S575 mutated to glutamic acid C-terminal 2xstrep on Cep3 
Cep3 Y_S or M2 Y325 mutated to serine HA and C-terminal 2xstrep 
core core complex (Cep3, Ctf13, Skp1) C-terminal 2xstrep on Cep3 
core Gal4Δ 
core complex with Cep3 residues 
1-46 deleted 
C-terminal 2xstrep on Cep3 
coreSΔ 
core complex, including Skp1 
residues 37 to 64 deleted 
C-terminal 2xstrep on Cep3 
Ctf13 n.a. n.a. 
Mif2-530 
residues 1 to 255, and 531 to end 
deleted 
N-terminal his 
Mif2-end residues 1 to 255 deleted N-terminal his 
Ndc10 na 
na or N-terminal HA, or C- or N-
terminal 2xStrep 
Ndc10 centralCTD residues 551-745 N-terminal his tag 
Ndc10 CTD residues 551-end N-terminal sumo tag or n.a. 
Ndc10 CTDshort residues 746-end N-terminal his tag 
Ndc10 degronMut degron mutated, as in N-terminal his 
Ndc10 NTD 
residues 1-551 (this construct was 
available already purified) 
n.a. 
Ndc10 Δ10 last 10 amino acids deleted N-terminal his 
Scm3 n.a. N-terminal his tag 
Scm3 NTD residues 1 to 95 N-terminal his tag 
Skp1 n.a. n.a. or N-terminal 2xstrep or HA 
Skp1 NY_KK 
N139 and Y140 mutated to two 
lysines 
N-terminal 2xstrep or HA 
Skp1 SA 
Phosphomutant: S162 mutated to 
alanine 
N-terminal 2xstrep 
Skp1 SATA 
Phosphomutant: S162 and T177 
both mutated to alanine 
N-terminal 2xstrep 
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Skp1 SE 
Phosphomutant: S162 mutated to 
glutamic acid 
N-terminal 2xstrep 
Skp1 SETD 
Phosphomutant: S162 and T177 
mutated to glutamic and aspartic 
acid, respectively 
N-terminal 2xstrep 
Skp1 TA 
Phosphomutant: T177 mutated to 
alanine 
N-terminal 2xstrep 
Skp1 TD 
Phosphomutant: T177 mutated to 
aspartic acid 
N-terminal 2xstrep 
SKP1Δ residues 37 to 64 deleted N-terminal 2xstrep 
 
Table 9: Sequences of DNA fragments used in this study 
Highlighted features are the conserved CCG triplet (red), the second suggested TGT triplet 
(blue) and CDEI and CDEIII (bold). All fragments were used as double stranded DNA. In the 
case of 56bp and 33bp fragments, both strands were purchased from Sigma, mixed in an 
equal molar ratio, heated to 98C and cooled stepwise to facilitate annealing. Longer DNA 
pieces were made as described in 2.6.1. 
 
Name Sequence 
56bp WT CEN3 5’-TATTAGTGTATTTGATTTCCGAAAGTTAAAAAAGAAATAGTAAGAAAT 
ATATATTT-3’ 
33bp wild-type 
CEN3  
5’-AAATATTAGTGTATTTGATTTCCGAAAGTTAAA-3’ 
33bp CCG 
mutant CEN3 
5’-AAATATTAGTGTATTTGATTTGATAAAGTTAAA-3’ 
 
33bp TGT 
mutant CEN3 
5’-AAATATTAGAACATTTGATTTCCGAAAGTTAAA-3’ 
33bp double 
mutant CEN3 
5’-AAATATTAGAACATTTGATTTGATAAAGTTAAA-3’ 
147bp Widom 
601 DNA 
5’-ATCGAGAATCCCGGTGCCGAGGCCGCTCAATTGGTCGTAGACAGC 
TCTAGCACCGCTTAAACGCACGTACGCGCTGTCCCCCGCGTTTTAACC
GCCAAGGGGATTACTCCCTAGTCTCCAGGCACGTGTCAGATATATACA
TCCGAT-3’ 
147bp CEN3 
DNA 
5’-AAATAGTACAAATAAGTCACATGATGATATTTGATTTTATTATATTTTT 
AAAAAAAGTAAAAAATAAAAAGTAGTTTATTTTTAAAAAATAAAATTTAAA
ATATTAGTGTATTTGATTTCCGAAAGTTAAAAAAGAAATAGTAAGAA-3’ 
185bp CEN3 
DNA 
5’- CAAATAAGTCACATGATGATATTTGATTTTATTATATTTTTAAAAAAA 
GTAAAAAATAAAAAGTAGTTTATTTTTAAAAAATAAAATTTAAAATATTAG
TGTATTTGATTTCCGAAAGTTAAAAAAGAAATAGTAAGAAATATATATTT
CATTGAATGGATATATGAAACGTTTACTGGTGGAAG -3’ 
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2.12 Bioinformatics 
Multiple sequence alignments were done using the webserver Clustal Omega 
(Sievers et al., 2011; https://www.ebi.ac.uk/Tools/msa/clustalo/), as well as NCBI 
web tools. 
 
Graphical rendering of sequence conservation and secondary structure elements 
derived from a pdb file were created with the ESPript webserver (Robert and Gouet, 
2014; http://endscript.ibcp.fr/ESPript/ESPript/index.php). 
2.13 Solutions and buffers 
LB media (or agar) 
10g/l bacto Tryptone, 5g/l yeast extract, 10g/l NaCl, (15g/l difco agar) 
PBS 
8g/l NaCl, 0.25g/l KCl, 1.437g/l Na2HPO4, 0.25g/l KH2PO4 
SDS/Protein loading buffer 
10% SDS, 10mM -mercaptoethanol, 20% Glycerol, 0.2M Tris-HCl pH 6.8, 0.05% 
Bromophenol blue 
SDS-running buffer  
25mM Tris HCl, 200mM glycine, 0.1% SDS 
SOC media 
20g/l bacto tryptone, 5g/l yeast extract, 0.584g/l NaCl, 0.186g/l KCl, 2.033g/l 
MgCl2.6H2O, 2.464g/l MgSO4.7H20, 2.603g/l glucose 
1xTBE 
10.8g/l Trizma base, 5.5g/l boric acid, 2ml 0.5M EDTA 
YN-media (or agar) 
67g/l Difco yeast nitrogen base (w/o) amino acids), (20g/l difco agar) 
YP-media (or agar) 
10g/l yeast extract, 20g/l bacto peptone, (20g/l Difco agar) 
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Chapter 3. Results 1: Establishment of a successful 
expression system for CBF3 
Despite its crucial role in budding yeast kinetochore establishment and its 
requirement for in vitro kinetochore reconstitution, it has remained difficult to express 
and purify CBF3, especially in high yields needed for structural studies. These 
difficulties most likely arise from posttranslational modifications essential for complex 
assembly, as well as from the necessity of assembly factors (see introduction 1.4.1).  
The first and very crucial step in my work, therefore, was to establish a reliable and 
high-yield expression system and a working purification pipeline for CBF3. Although 
Cep3, Skp1, and subdomains of Ndc10 can be readily expressed in E.coli, it has 
been proven difficult to express Ctf13, or any sub complex containing Ctf13 in 
bacteria. To circumvent this problem, I tested co-expression of all four subunits both 
in budding yeast itself, as well as with the baculovirus/insect cell system. 
3.1 Co-expression in insect cells 
The baculovirus/insect cell expression system is often chosen for recombinant 
expression of protein complexes and when posttranslational modifications, such as 
phosphorylation, are needed. It also offers a high level of protein expression, which 
makes it a valuable tool for structural studies. 
To test if the complex can be expressed and also formed in insect cells, codon-
optimised genes were cloned in the Multibac system vectors (see 2.4.1), the virus 
was produced and a 4-litre culture infected. However, no expression of CBF3 and 
only a weak expression of the tagged Cep3 subunit could be detected (Figure 11A). 
This points towards the necessity of yeast-specific assembly factors needed for 
complex formation, with Sgt1 being a likely possibility (see introduction 1.4.1).  
Simultaneous expression of Sgt1, however, was not tested, as below described co-
expression in budding yeast was successful. 
3.2 Co-expression in budding yeast 
To circumvent issues with either lack of assembly factors or essential 
posttranslational modifications, a co-expression in budding yeast itself was 
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attempted. Therefore codon-optimised genes were cloned into inducible yeast 
expression vectors kindly provided by John Diffley. All four proteins could be 
detected with SDS-PAGE/Coomassie stain after affinity purification, however, still 
with a rather low yield (Figure 11B). 
 
 
Figure 11: CBF3 expression tests 
SDS-PAGE/Coomassie stain of a StrepTrap purification from CBF3 expressed in insect cells 
(A) and yeast (B). In both cases the full lysate (Lys), wash fraction (Wash) and the eluate 
fractions (Eluate) were run, as well as a molecular weight marker (M). * indicates that Cep3 
is C-terminal tagged. C SDS-PAGE/Coomassie stain of a typical Heparin purification with 
yeast expressed protein without simultaneous co-expression of Sgt1. Excess Cep3, found in 
the load, does not bind to Heparin column and is therefore in the flow-through (FT), whereas 
the core complex and Ndc10 both bind, but elute separately from each other. The last lane 
shows concentrated Cep3 from the flow-through, which was used for further purification of 
Cep3 alone. D SDS-PAGE/Coomassie stain of a StrepTrap elution of CBF3 co-expressed 
with Sgt1, showing no excess of Cep3 and a higher overall yield of the other CBF3 subunits. 
 
As all genes are under the control of the Gal4 promoter, endogenous Gal4 can 
become a limiting factor of expression. Therefore, Gal4 was co-expressed 
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simultaneously, which indeed improved the yields considerably (Figure 11C). 
Similarly, as an excess of the tagged Cep3 subunit was observed, it was tested if co-
expression of Sgt1, a known assembly factor (see introduction 1.4.1), could further 
improve the yield and remove any excess of the tagged subunit Cep3, as shown in 
Figure 11D. Notably, the addition of phosphatase inhibitor in the lysis buffer was 
essential to be able to pull out the full complex, as well as a to achieve a good yield. 
3.3 Purification of CBF3 
Although all four subunits were present in the initial affinity purification, Ndc10 
seemed to be able to readily dissociate from the core complex, as it was also found 
in the wash, suggesting a weak interaction (Figure 12A).  
Further purification was achieved by heparin, to exclude any excess of Cep3 as well 
as impurities (Figure 12B). Interestingly, this step also led to the separation of Ndc10 
and the core complex, again speaking for a weak interaction between the two. 
However, this separation proved to be a useful way to separately purify the core 
complex and full-length Ndc10. The latter on its own is very unstable and readily 
degrades. Furthermore, any attempts to express and purify either N- or C-terminal 
tagged Ndc10 alone in budding yeast proved to be unsuccessful. As described in the 
introduction (see 1.4.1) Ndc10 features a degron motif at the very C-terminus. To 
test if the protein can be stabilised for purification by inactivation of this motif, both a 
deletion or a mutation of this motif, as described in Furth et al., 2011 and Alfassy et 
al., 2013, was cloned and tested. However, there was still no notable expression of 
full-length Ndc10 alone in budding yeast. 
For further purification of the full complex, Ndc10 and the core is pooled together and 
subjected to anion exchange chromatography. For purification of the core complex 
only, Ndc10 is omitted at this step. Anion exchange chromatography is crucial to 
separate co-purified DNA, as well as some prominent protein impurities (Figure 12C). 
Finally, size exclusion chromatography is performed, which separates core and full 
CBF3 complex due to their size difference. The unstable nature of Ndc10 proved to 
be the limiting factor for the yield of the full complex, and the stable core complex is 
therefore present in excess. Both complexes, however, show a promising elution 
profile and expected stoichiometry of 2xNdc10, 2xCep3, 1xCtf13 and 1x Skp1, as 
judged by band intensities after SDS-PAGE/Coomassie stain (Figure 12D).  
 
Chapter 3 Results 
 
100 
 
 
Figure 12: Purification of CBF3 
A Typical elution profile of initial Strep-Tactin affinity purification and SDS-PAGE of lysate 
(Lys), wash (W) and elution fractions. The whole elution peak, as indicated in A was pooled 
for further purification. B Typical elution profile of heparin column and SDS-PAGE of load, 
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wash (W) and elution fractions. As in the first step, the whole elution peak as indicated in B 
was pooled. C Elution profile of anion exchange chromatography, as well as SDS-PAGE of 
load, flow-through (FT) and elution peak fractions. At this step the protein peak was pooled 
without including the DNA peak at ~130ml. D Final step; size exclusion chromatography with 
a Superose 6 10/300 column and SDS-PAGE of load and the two peak fractions 
corresponding to the full complex (first peak) and core complex (second peak). M… 
molecular weight marker 
 
Both full and core complex exhibit sensitivity to salt concentration and start 
aggregating in buffers containing less then 250mM NaCl. The final buffer therefore 
was 10mM HEPES, pH 7.5, 300mM NaCl and 1mM DTT. 
The stoichiometry was further verified by molecular weight measurement with SEC-
MALS. The predicted masses of the full and the core complex, in above-mentioned 
stoichiometry are ~445kDa and ~220kDa respectively. SEC-MALS analysis of the 
core complex consistently showed an experimental mass of ~230kDa, supporting 
the predicted mass (Figure 13A). Analysis of the full complex produced somewhat 
less consistent results, however, it showed a mass between ~450 to ~500kDa 
(Figure 13B), also consistent with the predicted stoichiometry. 
 
 
Figure 13: SEC-MALS of the core and full CBF3 complex 
SEC-MALS curve of one of two measurements of the core complex (A) and the full CBF3 
complex (B). Measurements were conducted in duplicates and whilst the core complex had 
a consistent reading, the full complex did not and the second measurement showed a mass 
of ~500kDa. 
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Chapter 4. Results 2: Structural studies of CBF3 
After the successful establishment of an expression and purification system and 
given the promising size exclusion profiles of both the full and core CBF3 complex, 
structural elucidation of the CBF3 complex was attempted. Whereas in the past X-
ray crystallography dominated as a method for structure determination, more 
recently cryoEM has emerged as a more and more powerful tool, especially if one is 
interested in bigger protein complexes with low yields. Given the, for cryoEM, rather 
small size of the core (~220kDa), both crystallisation trials, as well as negative stain 
EM screening was performed. On the other hand, due to limiting yield and the 
instability of Ndc10, only negative stain EM was considered for the full CBF3 
complex. 
 
4.1 Crystallisation trials of the core complex 
Core complex was concentrated to 1.2-1.5mg/ml and a variety of standard 
crystallisation screens were set up with and without 27bp CEN3 dsDNA. Further 
concentration was not possible due to aggregation. Small crystalline needles could 
be observed after 24 hrs in a few conditions only without DNA and at RT (Figure 14A 
and B). Optimisation of crystal conditions was attempted, with limited success and 
SDS-PAGE analysis of the crystals showed that Cep3 and Ctf13 degrade almost 
completely and only Skp1 remains (Figure 14C-I). Given that the flexible Gal4-
domains of Cep3 have to be removed in order to crystallise Cep3 alone (see 
introduction 1.4.1), the same construct was used, to co-express a CBF3 complex 
lacking these domains (henceforth called CBF3 Gal4Δ or core Gal4Δ). Co-
expression and purification were identical to the full length CBF3. Furthermore, core 
Gal4Δ could be further concentrated, to about 2mg/ml, before aggregation was 
observed, indicating a more stable nature of this construct. Crystallisation trials, 
however, did not show any improvement and no crystals could be obtained. Trials 
were concluded, as the core complex appears to be too unstable for crystallisation, 
as well as tending to aggregate hindering protein concentration. 
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Figure 14: Core initial crystalline needles and optimisation 
A-B Two initial hits of crystalline needles with 1.5mg/ml protein, without DNA and incubated 
at RT. Conditions are specified in the images. C-H Crystals after optimisation with conditions 
specified in the images. I SDS-PAGE/Coomassie stain of pooled crystals from conditions 
without (A) and with (B) precipitation. Usual migration height of the three proteins is indicated. 
 
4.2 Negative stain EM of CBF3 and core complex 
Given the unsuccessful crystallisation trials, both the full CBF3 and core complex 
were subjected to negative stain EM, which is a quick and easy method to test for 
suitability for structural elucidation by cryoEM. To be successful candidates, 
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proteins/protein complexes need to form distinct particles, with no or little orientation 
bias.  
Dilutions of CBF3 and core were stained with uranyl acetate straight after size 
exclusion chromatography and imaged using a 120kV TEM. Whilst images of the 
core complex showed nice, uniform and distinct particles (Figure 15A), the whole 
complex looked less promising. Indeed, it seemed to be comprised of core particles 
and additional diffuse density, which must account for unstructured Ndc10 (Figure 
15B). Buffer optimisation was attempted to improve CBF3 particles. Neither pH 
changes, nor salt concentration or salt type, nor type of buffer made any 
improvements, judged by both size-exclusion profile, as well as negative stain EM. 
This might not be very surprising given the predicted high disorder of Ndc10 
especially in its C-terminal domain (Perriches, 2014). Attempts to improve full CBF3 
particles by either changing Ndc10 constructs or binding it to centromeric DNA are 
described in 5.3.  
 
 
Figure 15: Negative stain analysis of CBF3 core and full complex 
Typical micrograph of (A) core and (B) full CBF3 complex. The latter is comprised out of core 
particles (red circle) and additional diffuse density, assumable unstructured Ndc10 (red 
arrows). 
 
To get a better understanding of the suitability of the core for high-resolution 
structural cryoEM, a small dataset of ~300 micrographs of negative stained core was 
collected with the in-house 120kV screening microscope. Particles were picked and 
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processed with EMAN2. 2D classes looked promising with many different 
orientations present, and a ~40Å 3D model could be generated by using the low-
pass filtered Cep3 crystal structure (2VEQ) as an initial model (Figure 16A and B).  
 
Figure 16: Image processing of 
negative stained core complex 
A Unsorted 2D classes of core 
complex as processed with EMAN2. 
B 3D reconstruction of negative 
stained core complex in a side (left 
image) and front (right image) 
orientation at a resolution of about 
40 Å, revealing the overall shape of 
the core complex.  
 
 
 
 
 
 
 
 
 
 
4.3 CryoEM analysis of the core complex 
After promising negative stain imaging and reconstruction of the core complex, 
freezing conditions had to be established. As described in introduction (see 1.6.2), 
one needs a protein/protein complex to be frozen in a very thin amorphous ice layer, 
without any major orientation bias, to be able to perform data collection as well as 
3D reconstruction. Therefore, protein was prepared as described before and cryo 
grids were frozen with both a FEI Vitrobot, as well as a manual plunge freezer. Whilst 
grids prepared with the Vitrobot exhibited nice uniform and thin ice, the protein was 
either absent or could only be detected as dark precipitate (Figure 17A), pointing to 
a potential sensitivity of the core complex with the air-water interface. 
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Figure 17: CryoEM analysis of CBF3 core complex 
A Images of either empty holes or holes exhibiting denatured protein of grids prepared with 
a Vitrobot. B Successful freezing conditions of core complex using a manual plunge freezer 
and open-hole Quantifoil grids. The left panel shows nice particles in thick ice and an 
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overview of those holes in a lower magnification. The right panel shows micrographs from 
an area with thinner ice, in which the particles are sub-optimal, pushed to the side and 
degraded in the centre. 
 
To avoid this problem, both ultra-thin carbon and graphene oxide support on holey 
carbon grids was tested. In both cases, however, no improvement was seen. 
Nevertheless, intact core complex could be detected on open-hole grids frozen with 
a manual plunge freezer (Figure 17B). This home-made apparatus produced overall 
much thicker ice than could be achieved with the Vitrobot, which was thought to make 
the difference in particle quality. The final freezing condition, therefore, was 0.1mg/ml 
protein solution straight after size exclusion chromatography frozen with a manual 
plunge freezer in liquid ethane, after 30sec incubation time on glow-discharged 
1.2/1.3 400mesh or 2/2 200mesh Quantifoil copper grids. 
4.4 Structural insights into CBF3 core 
After successful screening of freezing conditions, data was collected for high 
resolution structure determination with cryoEM. In total two datasets, both on Titan 
Krios microscopes with Gatan K2 cameras, were collected: the first, at the Electron 
Bio-Imaging Center (eBIC) at Diamond Light Source, and the second in-house, after 
the establishment of the Francis Crick Institute’s cryoEM facility (for details of data 
collections see Table 7). The first dataset, collected at eBIC, resulted in a 5.7Å 
cryoEM map, using a final particle number of 72,771. As reducing the particle number 
further resulted in a sharp drop in resolution, it was believed to be able to achieve 
higher resolution, if particle number would be increased. Therefore, the second 
dataset was collected, resulting in an initial set of 3 million particles. After multiple 
rounds of 2D classification, good class averages were obtained with clear secondary 
structure visible. 3D reconstruction, using the low pass filtered crystal structure of 
Cep3, showed some orientation bias, however, a final map of 3.6Å overall resolution 
could be obtained (Figure 18A-F). 3D classification didn’t show any significant 
conformational heterogeneity and resolution anisotropy was assessed using 3DFSC 
(Tan et al., 2017; Figure 18E). The full image processing workflow is represented in 
Figure 19. 
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Figure 18: CryoEM data of CBF3 core complex 
A An example micrograph recorded with a Titan Krios microscope and Gatan K2 camera. B 
Selected 2D classes of different orientations. C Plot of orientation distribution of particles 
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used for final reconstruction of the second dataset. D Comparison of the final cryoEM density 
map of the first and second dataset. E Assessment of resolution anisotropy in the final 
reconstruction of the second dataset calculated with 3DFSC (Tan et al., 2017). F Fourier 
shell correlation (FSC) curve, used to calculate the overall resolution limit of 3.6Å of the 
second dataset. Blue curve.. masked; green curve.. unmasked; black curve.. corrected and 
red curve.. phase randomised. 
 
 
Figure 19: Processing workflow of the core wild type data 
Overview of the image processing steps undertaken to achieve the 3.6Å map of the wild type 
core from the 2nd dataset collected in house. 
Chapter 4 Results 
 
110 
 
4.4.1 Overall structure of CBF3 core 
The final map allowed for easy docking of the two known crystal structures, Cep3 
(2VEQ; N-terminal Gal4-domain deleted), and Skp1 (1NEX), leaving additional free 
density accounting for the unknown Ctf13 protein (Figure 20A, B and E). The latter 
forms a tightly associated dimer with Skp1, involving the Skp1 F-box binding C-
terminus, as expected, and exhibits the typical arc-shape of a Leucine-rich-repeats 
(LRRs) protein (Figure 20C).  
Together they bind on the outside lower edge of the Cep3 crescent, forming a central 
channel of about 30Å diameter in the overall shape (Figure 20B). The crystal 
structure of Skp1 fits directly into the EM density map, with two exceptions: a 
previously unresolved, extended loop (residues 105 to 112), which is in contact with 
Ctf13; and the C-terminal helices, which are involved in F-box interaction and exhibit 
a difference conformation in the cryoEM reconstruction. Interestingly, the binding of 
the Skp1/Ctf13 heterodimer stabilises the adjacent Gal4-domain of Cep3, whereas 
the second Gal4-domain is not resolved in the map, indicating that it remains flexible 
(Figure 20D). The rest of the Cep3 structure matches closely with the crystal 
structure, with another exception being a previously unresolved loop at the Ctf13 
interaction surface. All these features are explained in more detail further below. 
Extra features of Cep3 and Skp1 proteins were built and sequence assigned and 
Cep3 and Skp1 models were refined using real-space refinement (Table 10). 
Deposition accession codes are EMD-4163 (EMDB database) and 6F07 (PDB).  
 
Table 10: Refinement statistics for Cep3 and Skp1 structures 
 Cep3 Skp1 
CC_Mask 0.77 0.78 
rmsd (bonds, Å) 0.01 0.01 
rmsd (angles, ) 0.90 0.92 
Rama favoured 94.3 91.9 
Rama allowed 5.7 8.1 
Rama outlier 0 0 
Clash score 3.33 3.5 
Molprobity 1.51 1.63 
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Figure 20: CBF3 core cryoEM map 
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A CryoEM density coloured according to subunits. B Coloured density with fitted crystal 
structures of Cep3∆ (blue; 2VEQ) and Skp1 (red; 1NEX). C Top view of density map, showing 
Skp1/Ctf13 heterodimer with overall features. D Side view showing the one stabilised Gal4-
domain in blue and indicating the position of the second, still flexible and therefore unresolved 
Gal4-domain. E Schematic diagram of the four CBF3 subunits, colour coded as in the density 
maps with Ndc10 in grey. It is also indicated which parts of the subunits have been solved 
by crystallography before. F Dissected view of the core map to better illustrate how the 
individual subunits interact. 
Note: Part of this figure was adjusted from Leber et al. 2018. 
4.4.2 First structural insights into the subunit Ctf13 
As described previously, Ctf13 on its own is a very unstable protein and eluded 
structural determination up to now. Our cryoEM structure, hence, provides the first 
insights into the shape of Ctf13: the N-terminal F-box forms a part of a small helical 
domain, which runs into seven LRRs, which are capped by a helical insertion distal 
to the F-box domain (Figure 21A and B). Ctf13 therefore, belongs to the family of F-
box proteins containing LRRs (FBXLs), like Skp2. 
 
 
Figure 21: The structure of Ctf13 
A Overview showing the three main elements of the Ctf13 structure: F-box domain, LRRs 
and helical insertion. B Colour coded cryoEM map in two views, overlaid with the LRRs from 
the Skp2 crystal structure (1FQV), to highlight the typical arc-shape of this domain.  
Note: This figure was adjusted from Leber et al. 2018. 
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Despite clearly displaying this overall conformation, there is a high variability in the 
quality of the density map in this region. Only a few areas show clear side chain 
density, whereas the rest of the map does not. Even more critically, the connectivity 
between helices in the F-box domain, as well as in the external loops of the LRRs is 
unclear (Figure 22A-F), making reliable secondary structure and sequence 
assignment difficult, and a full atomic model could not be built. Instead a simple poly-
alanine model was generated, with sequence only assigned to the N-terminal F-box, 
the helical insertion and the very C-terminus (Figure 23A and B).  
 
Figure 22: Local resolution and difference in quality of the cryoEM map 
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A EM density coloured after local resolution in two views. B Detailed view of broken density 
of Ctf13, making reliable tracing of the backbone impossible. C Example of a Ctf13 helix with 
clear side chain density. D In contrast, example of a Ctf13 helix with lower local resolution, 
where side chain density is lost completely. E Typical quality of density in the Skp1 subunit. 
F Typical density with visible side chains in the Cep3 heterodimer. 
Note: This figure was adjusted from Leber et al. 2018. 
 
 
Figure 23: Incomplete model of Ctf13 
A Ribbon diagram colour coded depending on sequence assignment (pink), poly-alanine 
chains (grey and brown) and areas where the connectivity is unclear (only brown). B 
Schematic representation of the Ctf13 model. Note: This figure was adjusted from Leber et 
al. 2018. 
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4.4.3 Skp1/F-box interaction  
Skp1, as described in the introduction, is better known in the context of the SCF 
(Skp1/Cullin/F-box) ubiquitin ligases. There it acts as a linker between Cullin and a 
variety of substrate-binding F-box proteins. A number of crystal structures are 
available of Skp1 (both human and budding yeast) bound to different F-box proteins. 
While all of these structures exhibit the same Skp1/F-box binding mechanism, there 
is a clear difference in the core cryoEM map (Figure 24A-C). While the same three 
C-terminal helices of Skp1 (6, 7 and 8) are involved, they show a more closed 
conformation, with the loop, connecting helices 7 and 8, shortened and folded. 
Equally to the crystal structures, the very N-terminus of the F-box of Ctf13 hooks 
underneath the Skp1 6 helix. Helices 2 and 3, however, reveal a different 
orientation of the F-box. The distinction in this mode of binding might not be very 
surprising, taking in account the substantial sequence difference between the F-box 
of Ctf13 and the consensus F-box sequence (Figure 24D). 
 
Figure 24: Skp1/F-box interaction 
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A-B Difference between the binding of Skp1 to the F-box of Ctf13 (A) and Skp2 (B). The 
cryoEM density (light yellow and pink) is overlaid with the models shown as ribbon diagrams.  
C Detailed view of Skp1 (orange) binding to the F-box of Ctf13 (pink). D Detailed view on the 
newly resolved 103 to 112 Skp1 loop contacting both the LRRs and the F-box of Ctf13. E 
Sequence alignment of Ctf13 with the F-box consensus sequence. F Sequence alignment of 
Skp1 from different species, highlighting the conserved 103-112 loop shown in D. 
Note: Part of this figure was adjusted from Leber et al. 2018. 
 
In addition to the differences in the F-box binding, a previously unresolved loop of 
Skp1 (residues 105-112) is structured in the cryoEM map. It contacts not only the 
LRRs of Ctf13 but surprisingly also the F-box. Although Ctf13 only exists in point 
centromere species, this loop is widely conserved (Figure 24E and F), suggesting 
there could be other F-box proteins bound in a similar fashion. 
4.4.4 Interactions between Cep3, Ctf13 and Skp1 
Besides giving insights into above discussed Ctf13 structure and new mode of F-box 
binding, the cryoEM map also provides first insights into how the three subunits 
interact. As already mentioned a heterodimer of Ctf13 and Skp1 binds to one of the 
two Cep3 monomers. Interestingly, the potential binding site of the other monomer 
remains free. The stoichiometry observed, therefore, agrees with the experimental 
data mentioned in 3.3. To investigate if a potential second Skp1/Ctf13 heterodimer 
would be able to bind this other site, the core density was superimposed with a mirror 
image of itself, aligning the two Cep3 densities. This showed a large steric clash 
between the two Ctf13 proteins, explaining the existing stoichiometry of 2x Cep3, 1x 
Skp1, 1x Ctf13 (Figure 25A and B). 
 
Figure 25: Structural rationalisation of stoichiometry 
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A-B Two views of the cryoEM density map with a hypothetical second Skp1/Ctf13 
heterodimer (black/grey) superimposed on the ‘unbound’ Cep3 monomer, showing a steric 
clash (red ovals). Note: This figure was adjusted from Leber et al. 2018. 
 
Interaction surfaces between Ctf13 and the other two subunits are vast and conform 
well with previous biochemical studies (Russell, 1999), which suggested that Ctf13 
interacts with all other subunits and therefore forms the central part of CBF3. 
Whereas its interaction with Skp1 is through the N-terminal F-box and also via the 
C-terminal part of the LRRs, it binds to Cep3 via multiple surfaces spread over the 
entire length of the protein (Figure 26A and B). Consistently Russell, et al. 1999 
showed that the two important regions of Ctf13 for the interaction with Skp1 are the 
N-terminal F-box and a C-terminal region, whereas most of the tested constructs 
showed some binding to Cep3, implying an extended binding interface. 
 
 
Figure 26: Interaction between the subunits 
A Extensive interaction surfaces between Ctf13 and Cep3. B Two interaction sites between 
Ctf13 and Skp1. In both cases the EM density map is shown, colour-coded by subunit (Cep3.. 
light green, Skp1.. light yellow; Ctf13.. light pink), as well as the atomic models for Cep3 
(green ribbon diagram) and Skp1 (red ribbon diagram). As no full atomic model could be built 
for Ctf13 only the EM density is shown. Note: This figure was adjusted from Leber et al. 2018. 
 
Another notable trait of the core structure is that not only Ctf13 binds to both other 
subunits, but so does Skp1, placing it too into the centre of the CBF3 core structure. 
Interestingly, Skp1 binds to Cep3 through the same interface than it does to the SCF 
ligase subunit Cullin, highlighting additional similarities to this complex (Figure 27A-
C; see 1.4.1). Indeed, mutant interaction studies could confirm involvement of the 
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same residues of Skp1 (N139 and Y140) shown to interrupt Skp1/Cullin interaction 
(Zheng et al., 2002). Co-expression and Strep pull-down from the lysate of Ndc10, 
Cep3, Ctf13 and a Skp1 construct with residues N139, Y140 mutated to two lysine 
(Skp1 NY_KK), showed that the mutated Skp1 cannot form a complex with the other 
subunits, and that it effectively gets replaced by endogenous Skp1. The wild-type 
HA-tagged Skp1, on the other hand, interacts with the others (Figure 27C and D).  
 
 
Figure 27: Similarity with interaction site of Skp1 to Cullin and Cep3 
A Back-view of core structure with the Cep3 dimer in green, Skp1 in orange and Ctf13 in 
pink. B Same view of the core structure with Cul1 (dark grey) and Skp1 (blue) from the crystal 
structure of the SCF ligase (PDB: 1LDK) showing a vast sterical clash between Cep3 and 
Cul1, emphasising that both Cep3 and Cul1 bind at the same interface to Skp1. C Detailed 
view of the two Skp1 residues (N139, Y140) which are important in the interaction between 
Skp1 and Cullin (Zheng et al., 2002) as well as Cep3. D Coomassie stain (left panel) of 
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eluates and western blot (right panel) of flow-through, lysate and eluates showing that only 
HA-tagged wild-type (WT) Skp1, but not the N139, Y140 mutant (M) can form a complex. 
Mutant Skp1 gets replaced by endogenous Skp1 (eSkp1), which is migrating faster due to 
the lack of HA-tag. The asterisks indicate HA-tagged proteins. Note: Part of this figure was 
adjusted from Leber et al. 2018. 
 
As already mentioned before, the Gal4-domain adjacent to the Skp1/Ctf13 
heterodimer is stabilised and therefore resolved in the cryoEM map. The density was 
of sufficient quality to visualise the Zn2Cys6 cluster, trace the connecting loop and 
assign the correct amino acid sequence (Figure 28A and B).  
 
 
Figure 28: The stabilised Gal4-domain and its influence on DNA binding 
A Overview of the stabilised Gal4-domain, showing the cryoEM density map in grey, and the 
ribbon diagrams of Ctf13 (pink), Skp1(orange) and Cep3 (green). The 6 cysteines are 
highlighted in yellow. B Detailed top view, highlighting the positions of the zinc ions. C 
Detailed view of superposition of Hap1 (blue) bound to DNA on the stabilised Gal4-domain, 
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showing a steric clash between DNA and Ctf13. D Overview of the previous showing the 
whole core cryoEM map. Note: This figure was adjusted from Leber et al. 2018. 
 
Both Skp1 and Ctf13 contact the Gal4-domain, which must account for this stabilising 
effect. The second Gal4-domain, on the other hand, is not resolved in the map, which 
is not surprising given it is connected to the rest of the protein through a rather long 
(14 residues), flexible linker. To examine how this interesting, novel feature might 
influence the DNA binding ability of CBF3 core, the crystal structure of the 
homologous Hap1 domain bound to DNA (King et al., 1999) was superimposed on 
the stabilised Gal4-domain. This allows to trace the likely path of DNA and shows 
quite clearly a severe clash between the DNA and the LRRs of Ctf13 (Figure 28C 
and D). Skp1/Ctf13 therefore seem to lock this Gal4-domain in an inactive position, 
leaving the second still flexible Gal4-domain to bind to the CCG triplet in the 
centromere. 
 
Finally, a conserved loop of Cep3 (residues 303-337) is stabilised in the cryoEM 
map, whereas it is unresolved in the crystal structure of Cep3. Moreover, it is only 
structured on the monomer bound by Skp1/Ctf13 and not the other monomer. Both 
these findings suggest that this loop might be involved in the interaction between 
Cep3 and Ctf13 and therefore is getting stabilised upon binding (Figure 29A). 
Mutation studies of conserved residues of this loop (residues L319, L320 and Y325, 
Table 8), however, showed no influence on complex formation (Figure 29B and C) 
as determined with recombinant expression of the mutants and pull-down studies 
from the lysate. Given the vast interaction surface between Cep3 and Ctf13, shown 
in Figure 26A, this might not be surprising. It might not even exclude that these 
residues are important for the interaction between Cep3 and the Skp1/CTf13 
heterodimer. 
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Figure 29: Mutational studies of the Cep3 303-337 loop 
A Comparison of the crystal (green) and cryoEM (brown) structure of Cep3. The newly 
resolved 303-337 loop and Gal4-domain of the cryoEM structure are coloured in magenta. B 
Sequence alignment of Cep3 homologues. Red box: fully conserved residues; red font: 
conserved residues. C Western blot with Ha-tag antibody of lysate and streptavidin pull down 
eluate from cells co-expressing all four CBF3 subunits, with either wild-type or mutant Cep3. 
Mutations in Cep3 were L319 and L320 to serine and alanine, respectively (M1), Y325 to 
serine (M2) or a combination of both (M3). Mutations did not interrupt complex formation. 
Note: Part of this figure was adjusted from Leber et al. 2018. 
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Chapter 5. Results 3: Functional studies of CBF3 
The cryoEM structure discussed in the previous chapter gave rise to many questions 
about functionality of the core as well as the full complex. Biochemical studies were 
conducted to better understand how CBF3 binds to the centromere and how it might 
get assembled. It was also attempted to find conditions in which structural studies of 
the full or core complex bound to the centromere would be feasible.  
 
5.1 DNA-binding of CBF3 
CBF3 binds sequence-specifically to the CDEIII of the point centromere. Both Ndc10 
and Cep3 have been shown to exhibit DNA binding. The former, however, binds 
sequence non-specifically and it is the Gal4-domains of the Cep3 homodimer, which 
account for the specificity (see 1.4.1). The canonical recognition sequence for these 
motifs is a CCG/GGC triplet, and as all known Gal4-domain containing transcription 
factors are dimers (see 1.4.2), they bind to a site containing either a direct or inverted 
repeat of this sequence. However, there is only one conserved CCG/GGC triplet in 
the point centromere. A recurrent question in the field therefore is, how CBF3, having 
two copies of the Gal4-domain, is binding to a single, asymmetric site on the 
centromere. Also, it has been suggested that to be able to bind to the centromere all 
four subunits have to be present (Sorger et al., 1995, Stemmann and Lechner, 1996, 
Kaplan, 1997, Espelin, 1997, Pietrasanta, 1999), which given the fact that both 
Ndc10 and Cep3 can bind DNA on their own is surprising (Bellizzi, 2007, Purvis and 
Singleton, 2008, Cho and Harrison, 2012, Perriches and Singleton, 2012). 
5.1.1 Dephosphorylated core can bind the centromere on its own  
To test if CBF3 core complex can bind to centromeric DNA without Ndc10 present, 
EMSA studies were conducted. At first, in agreement with above mentioned studies 
no binding activity of the core complex could be detected. However, in an attempt to 
test different hypothesis about complex formation and activity, it was found that core 
complex can bind centromeric DNA, but only if pre-treated with Lambda Protein 
Phosphatase (Figure 30A). This surprising and new finding suggests a possible 
regulation of DNA-binding activity through phosphorylation. Previous studies of 
CBF3, however, have only pinpointed phosphorylation important for complex 
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assembly. One should note that the core cryoEM structure presented in this thesis 
represents the DNA-binding inactive state of the core complex.  
In agreement with previous results, DNA binding is facilitated by the Gal4-domains, 
as a construct lacking this domain shows no DNA binding activity with or without 
Lambda phosphatase treatment (Figure 30A). It was also confirmed that the binding 
is sequence-specific, as shown with a DNA-competition experiment. DNA with the 
CCG/GGC triplet mutated, failed to compete out a labelled wild-type CEN3 probe, 
underlining its importance for DNA-binding. Wild-type or DNA with the potential 
second TGT triplet mutated, on the other hand, was able to compete out the probe 
(Figure 30B).  
 
 
Figure 30: DNA-binding studies 
A EMSA comparing wild-type core (CoreWT) with core lacking the N-terminal Gal4 domain 
(CoreΔGal4). Controls include free DNA (lane), reactions without λ-phosphatase (λ-PP) 
treatment (lane7 and 14), protein alone (lane 8 and 15) and DNA alone with λ-PP (lane 16). 
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B EMSA to test for sequence specificity. Labelled centromeric DNA was competed with wild-
type, a CCG mutant, a TGT mutant and a double mutant. See table XX for sequences of 
DNA used. C Phos-tag SDS-PAGE/Coomassie stain of core complex without and with 
increasing amounts of time of λ-PP treatment. D EMSA demonstrating the λ-PP treatment 
dependency of core complex for DNA binding, and the lack of the same for a construct 
lacking an N-terminal Skp1 loop (residues 37-64). Note: This figure was adjusted from Leber 
et al. 2018. 
 
Mass spectrometry analysis, carried out by the Francis Crick’s Proteomics STP, 
found some evidence of phosphorylation on all four subunits. To identify which 
subunit is dephosphorylated by Lambda phosphatase, Phos-tagTM SDS-PAGE was 
used. The Phos-tagTM reagent produces a shift of phosphorylated proteins in the gel. 
Untreated sample and Lambda phosphatase treated sample was run on the gel, and 
a clear shift was observed for Skp1, whilst the Cep3 and Ctf13 bands were 
unchanged (Figure 30C). It should be noted, that no shift of a band does not 
necessary mean that this protein is not phosphorylated at all, but only that no 
dephosphorylation takes place. Treatment with calf intestine phosphatase (CIP) for 
example did not lead to any shifts. Previous studies identified a number of 
phosphorylation sites on Skp1 (see 1.4.1), including four phosphorylations on a 
budding yeast-specific loop between residues 37 to 64. This loop is not resolved in 
the cryoEM map, suggesting it is extended and flexible and indeed one can express 
a construct lacking this loop, as has been done for crystallisation of Skp1 (Orlicky et 
al., 2003, Tang et al., 2012, Willhoft et al., 2017). To test if the phosphorylation status 
of this loop is indeed responsible for the difference in DNA binding activity, core 
complex with Skp1 lacking the loop (coreS) was expressed, purified and tested with 
EMSA. Whilst wild-type core showed a clear dependency on Lambda phosphatase 
treatment, coreS was able to bind to DNA with and without being dephosphorylated 
(Figure 30D), confirming that the DNA binding activity of the core complex in vitro is 
regulated by the phosphorylation status of this budding yeast-specific loop. In-house 
intact mass analysis, carried out by the Proteomics STP, could correspondingly 
confirm four phosphorylations on Skp1 (Figure 31). 
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Figure 31: Mass spectroscopy analysis of Skp1 
A Intact mass analysis of CBF3 core, confirming the presence of four phosphorylations. B 
Sequence alignment of Skp1 37-64 loop. 
Note: Intact mass analysis was solely done by the Francis Crick Institute’s Proteomics STP 
5.1.2 DNA binding of full CBF3 still influenced by phosphorylation status 
Next it was tested if the full complex exhibits the same behaviour as the core in EMSA 
studies. As Ndc10 alone also binds to DNA, it was expected to see some binding 
even without Lambda phosphatase treatment. The binding after treatment should be 
stronger, however, if there is the same regulatory mechanism. As expected, EMSA 
analysis showed that the full complex can bind both with and without phosphatase 
treatment, the dephosphorylated CBF3, however, bound more strongly (Figure 32). 
 
 
Figure 32: DNA-binding of the full CBF3 
complex 
EMSA analysis of CBF3 full (CBF3) and core 
complex (core), both with and without λ-protein 
phosphatase (λ-PP) treatment. DNA alone (lane 1), 
DNA and phosphatase (lane 6) and both protein complexes alone (lane 7 and 8) were run 
as controls. 
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5.1.3 Cell cycle-dependency of Skp1 phosphorylation 
To test if the there is a cell-cycle dependent difference in the phosphorylation status 
of the 37-64 loop of Skp1, strains with tagged endogenous genes of Skp1 and Cep3 
were constructed. Cep3 was C-terminally tagged to allow for CoIP to separate Skp1 
bound within the CBF3 complex from free Skp1, as well as Skp1 included in SCF 
ligases and the RAVE complex. Skp1 was HA-tagged to allow for western blot 
detection. A strain with the Skp1 37-64 loop deleted (Skp1∆) was prepared as control 
to ensure any phosphorylation seen is indeed positioned on this loop. Both strains 
progressed through the cell cycle identically, as shown with FACS analysis (Figure 
33A). No change in phosphorylation or Skp1 protein amount could be detected in the 
Skp1 wild-type strain (Figure 33B).  
 
 
Figure 33: Cell-cycle dependency of Skp1 phosphorylation 
G1 arrested cells of HA-tagged Skp1 wild-type (WT) or 37-64 loop deleted (∆) were released 
into a synchronous cell cycle progression, which was monitored using FACS analysis of DNA 
content (A). Phosphorylation status of either Skp1 WT or ∆ was monitored using Phos-tag 
SDS-PAGE and western blotting against HA tag (B). Both the whole cell extracts as well as 
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the bound fractions of the CoIP were tested. For the CoIP a PK6-tag was fused on the C-
terminus of Cep3, to separate Skp1 bound within the CBF3 complex, from other Skp1 in the 
cell. Surprisingly two bands were seen in the whole cell extract of the Skp1∆ strain, the upper 
corresponding to wild-type Skp1 and the lower possibly to Skp1∆. Replacing endogenous 
Skp1 with tagged Skp1∆ therefore seemed to have failed, although genotyping showed a 
positive result. Reconstruction of this strain could not be repeated due to time constraints. 
However, no difference in total wild-type Skp1 phosphorylation could be detected. 
Furthermore, the CoIP of both wild-type and Skp1∆ did not yield any detectable Skp1, 
possibly due to the cell lysis method used (see 7.3). 
 
5.1.4 In vitro reconstitution of a CBF3/DNA complex 
Given the successful demonstration that both the core and full complex can bind to 
the centromeric DNA, it was attempted to reconstitute a protein/DNA complex for 
structural studies by cryoEM. This was done both with wild-type CBF3/core and 
CBF3/core containing Skp1, the DNA binding ‘active’ state. 
First, in an attempt to purify excess DNA and unbound protein from protein/DNA 
complexes, analytical size exclusion was tested. Protein was mixed with an excess 
of centromeric DNA and injected into a Superose 6 column. All tested CBF3 
complexes, however, eluted separately from the DNA, independent from buffer 
conditions, or DNA length (Figure 34A and B).  
 
 
Figure 34: Size exclusion chromatography to test protein/DNA formation 
A Profile of CBF3 S mixed with a 1:2 excess of 56bp CEN3 dsDNA. The first peak 
corresponds to CBF3 without bound DNA and the second peak to DNA alone. B Profile of 
56bp CEN3 dsDNA run on the same column and buffer alone. For both chromatographies a 
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Superose 6 10/300 column in 10mM HEPES, 300mM NaCl and 1mM DTT was used. 
Chromatographies with other constructs/DNA fragments behaved identical (data not shown). 
 
As size exclusion seemed to be too harsh to obtain a protein/DNA complex, it was 
attempted to simply add an equimolar amount of centromeric DNA to the protein 
before making negative-stain grids. However, no difference in particles could be seen 
(Figure 35A-E). It should be noted that, although DNA is not easily visible in negative 
stain EM, one would expect to see a difference at least with the full CBF3 complex. 
That is, as unbound CBF3 seems to exhibit unstructured Ndc10 forming indistinct 
density and core particles, and DNA is thought to stabilise the full complex and lead 
to a more structured Ndc10. Furthermore, grids with longer pieces of DNA, which 
can be easily seen in the micrographs, also provided no difference in protein particles 
(Figure 35C). Although DNA-binding EMSAs showed that the core can bind DNA at 
a salt concentration of 300mM, which is needed to prevent protein from aggregating, 
it was tested if lowering the salt will help formation of protein/DNA complexes. This 
was especially important, as salt concentration will rise significantly during the 1min 
incubation time of the sample on the grid due to evaporation. This increased salt 
concentration could inhibit DNA binding. As CBF3 core aggregates if kept in lower 
salt buffer, it was added to the grid in normal conditions, incubated to allow protein 
particles to adhere to the grid and subsequently it was washed twice with a low salt 
buffer (10mM HEPES, pH 7.5, 150mM NaCl, 1mM DTT) containing 3ug/ml 56bp 
CEN3 dsDNA. That way aggregation was hindered, as particles were already stuck 
to the carbon. Indeed, screening of grids showed that particles did not aggregate. 
They, however, still had no DNA bound and looked identical to unbound particles 
(Figure 35F).  
As already mentioned, negative stain is not optimal to visualise DNA, particularly if it 
is short. Therefore, cryoEM grids of coreS (DNA-binding active) with a slight excess 
of DNA were prepared and a dataset was collected to test if DNA density can be 
visualised in the cryoEM reconstruction. Besides this dataset was also recorded to 
see if this core structure, with the Skp1 37-64 loop deleted, exhibits a different 
conformation compared to the wild-type core structure described in 4.4. Such a 
difference could give insights into why this construct is DNA binding active, even if 
no DNA density can be seen. The results are described in the following section. 
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Figure 35: Negative stain analysis of CBF3 and core mixed with DNA 
Protein was prepared in 300mM salt buffer and mixed with DNA in a molar ratio of 1:1.2. 
Core was prepared with 33bp DNA (A) and without (B) and full complex was tested with 56bp 
DNA (C), without any DNA (D) or with 33bp DNA (E). F CoreS was added to the grids and 
subsequently washed with a 150mM salt buffer containing 56bp CEN3 dsDNA to test if 
lowering the salt will help DNA binding. 
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5.1.5 Structure of coreS 
A dataset was collected on the in-house Titan Krios and K2 camera of grids 
containing coreS with added DNA and processed with Relion (see Table 7 for data 
collection parameters and Figure 36 for processing workflow).  
 
Figure 36: Processing workflow of coreS dataset 
An overview of the image processing steps taken while processing the coreS dataset, 
resulting in the 3.9Å final map, as well as in some lower resolution maps showing a weak 
density for the second, flexible Gal4 domain. 
 
Although the data exposed some additional diffuse density outside the core and in 
close proximity to the second, free Gal4-domain, this could only be observed when 
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using a low threshold, and was averaged out completely upon refinement (Figure 
37A and B). 
 
 
Figure 37: CryoEM 
density maps of 
coreSΔ 
A Two of the three 
maps of the first round 
of 3D-classification 
shown at normal and 
low threshold. Class 1 
(green) shows no extra 
density when viewed 
with a low threshold. 
On the other hand, 
class 2 (blue) shows 
some diffuse extra 
density (red dashed 
line) wrapping around 
half the structure in 
close proximity of the 
second, flexible Gal4-
domain (position is 
indicated with the 
arrow). B Overlay of 
the final CBF3 core maps from the both the wild-type (grey) and SΔ (green) constructs, 
showing no difference of the two constructs, at least at the resolution obtained. On the left a 
typical side view is shown and on the right a typical top view. 
 
Multiple rounds of 3D classification, as well as focussed 3D classification, could not 
improve this extra density. Nevertheless, it was possible to achieve unrefined maps 
showing a small extra density, which must account for the second Gal4-domain in a 
number of transient positions (Figure 38). Refinement of these maps, however, still 
lead to a loss of this density, which is inferring a high flexibility of this domain and no 
discrete position.  
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Figure 38: Focussed 3D-classification of coreSΔ 
Extra density at the expected location of the second, still flexible Gal4-domain became 
apparent after focussed 3D classification in three classes (yellow, violet and blue). The whole 
core density map is shown in grey for reference. Left: typical side view. Right: typical top 
view. 
 
Further 3D classification to achieve a more distinct subset, was not possible due to 
limiting particle number. To test if this partial stabilisation of the second Gal4-domain 
is because of the 37-64 Skp1 loop deletion in this construct, we attempted the same 
procedure of focussed 3D classification to the 2nd dataset of the wild-type core. If the 
second Gal4-domain is only partially stabilised in the coreS structure (which is DNA 
binding sufficient) but not in the wild-type core structure (which cannot bind to DNA), 
then this stabilisation could rationalise the difference in activity. Especially, 
considering that the rest of the two structures are identical to each other (Figure 37B). 
Focussed 3D classification of the core data, however, showed similar densities of 
the second Gal4-domain, disproving above mentioned hypothesis. Indeed, as the 
initial particle number of the 2nd wild-type core complex dataset was about four times 
higher, more classes could be calculated, leading to a better separation of different 
orientations of the second Gal4-domain (Figure 39A). Refinement of some classes 
was therefore possible, and the best final map had an overall resolution of 3.9Å 
(Figure 39B). The local resolution of the second Gal4-domain, however, is poor, 
making the fitting of a Gal4-domain ambiguous and modelling of the atomic structure 
impossible (Figure 39C and D). Therefore, it is not possible to predict the likely path 
of DNA. Also, as both the wild-type core and coreS produced similar maps, a large 
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conformational change to accommodate DNA binding and explain the difference in 
activity can be excluded.  
 
 
Figure 39: Focussed 3D-classification of the core wild-type data 
A Four best classes showing an extra density for the 2nd Gal4-domain depicted in violet, blue, 
yellow and green. The core structure is shown in grey as a reference. The top shows a typical 
top view and the bottom a typical side view. B Best two classes could be refined without 
losing the density. C One of the two best classes coloured according to local resolution, 
showing the low local resolution at the 2nd Gal4-domain. D Final maps of the two best classes, 
showing the broken and undefined density for the 2nd Gal4-domain, making it impossible to 
build or fit a model and to predict the likely path of DNA. 
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5.2 Core complex formation 
The literature describes the assembly of CBF3 as occurring step-wise. First Skp1 
binds to Ctf13 to form an initial unstable sub-complex. This somehow gets activated 
and subsequently binds to Cep3 to form the core complex. The core is then able to 
interact with Ndc10, forming the full complex, which can bind to the centromere. 
5.2.1 In vitro assembly of the core complex 
To test this theory, an in vitro complex formation and pull-down assay was attempted. 
As it is impossible to express Ctf13 alone, both Skp1 and Ctf13 was co-expressed 
under the same conditions as the full complex, with the exception of the tag being 
located on the N-terminus of Skp1. Surprisingly, a good yield of Skp1/Ctf13 could be 
achieved and co-purified (Figure 40A), somehow speaking against the hypothesis 
that this initial complex gets readily degraded in a proteasome-associated manner. 
Cep3, was either expressed alone in budding yeast or a co-expression without Sgt1 
was used, which produces an excess of Cep3. This can easily be separated via 
heparin and further purified (Figure 40B).  
 
 
Figure 40: In vitro core assembly assay 
SDS-PAGE/Coomassie of the peak fraction from size exclusion chromatography of (A) 
Skp1/Ctf13 purification and (B) Cep3 alone. C Streptavidin-beads pull-down with purified 
tagged Cep3 and untagged Skp1/Ctf13. Three different Skp1 constructs were tested: wild-
type (Skp1 WT), residues N139 and Y140 mutated (Skp1 NY_KK) and Skp1 with the 37-64 
loop deleted (Skp1). The left side of the SDS-PAGE/Coomassie shows the input samples 
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and the right side the pull-down (Beads). The lowest band corresponds to Streptavidin, which 
dissociates from the beads after boiling. 
 
Tagged Cep3 and untagged Skp1/Ctf13 could then be used for a Streptavidin beads 
pull-down assay, to test for core complex formation in vitro without any potential 
assembly factors present. As the material was present, not only wild-type Skp1/Ctf13 
complex, but also Ctf13 in complex with Skp1 (37-64 loop deleted) and Skp1 
NY_KK (residues N139 and Y140 mutated to two lysines) were tested. As shown in 
Figure 40C, all three constructs could form the core in vitro. This formation is 
therefore independent of the Skp1 37-64 loop, as well as mutations in residues N139 
and Y140. Latter was unexpected given that the same mutations disrupt complex 
formation in vivo (see Figure 27D). Nevertheless, the assay proved that Cep3 and 
Ctf13/Skp1 form the core complex spontaneously without any additional factors 
needed. 
5.2.2 Phosphorylation status of Skp1 F-box binding domain 
As described in more detail in 4.4.3, the core structure shows a substantial difference 
in the conformation of the Skp1/Ctf13 F-box interaction site. It is also the only Skp1/F-
box structure, which was prepared from protein expressed in an eukaryotic 
expression system, rather than bacteria, opening the possibility of posttranslational 
modifications, such as glycosylations or phosphorylations. As the latter have been 
indicated of importance in complex formation, as well as the fact that there are two 
suggested phosphorylation sites in the Skp1/F-box interaction region (beginning of 
Skp1 helix α7 (S162) and α8 (T177)), it was thought that phosphorylations of one or 
both of these sites might account for the difference in the structure and be of 
importance for complex formation. The local resolution in the cryoEM map, 
unfortunately, was too low to see any evidence of phosphorylation. Hence, Skp1 
phospho-mutants (see Table 8) were co-expressed with Ctf13 and a pull-down from 
lysate was conducted, to see if there is a difference in the binding between Ctf13 and 
any of the Skp1 mutants. If phosphorylation is necessary for the interaction, then one 
would expect the alanine mutants (Skp1 SA, TA and SATA) to lose the ability to pull-
down Ctf13. However, all alanine mutants, were able to interact and pull-down Ctf13, 
ruling out that a phosphorylation on any of these two sites is essential for complex 
formation of Skp1 and Ctf13 (Figure 41). Additionally, a double phosphomimic 
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mutant of Skp1 (Skp1 SETD) also interacted with Ctf13. The only mutant which 
showed reduced binding was Skp1 TD, whereas Skp1 SE showed no difference 
(Figure 41). 
 
 
 
5.2.3 Phosphorylation status of Cep3 S575 
As described in 1.4.4 there is a phosphorylation site on Cep3 at residue S575, which 
influences DNA motility upon DNA-damage signalling (Strecker et al., 2016). Mass 
spectrometry analysis, carried out by the Proteomics STP, indeed showed evidence 
of a phosphorylation at this site. To test if this is either needed for complex formation 
or influences DNA-binding of the CBF3 complex phospho-mutants (Cep3 SA and 
SE) were tested. Co-expression of these with the other CBF3 subunits led to 
successful purification of the full complex, comparable to wild-type expressions, 
Figure 41: Skp1 S162 and T177 
phosphorylation 
Co-expression of Ctf13 with different 
phospho-mutants of Skp1 (see Table 8) 
to test if Skp1/Ctf13 heterodimer is 
disrupted. A-C SDS-PAGE/Coomassie 
of lysate (L), wash fractions (W) and 
peak fractions (peak) of StrepTactin 
affinity purification. All mutants show 
interaction with the Skp1 TD being the 
weakest. 
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ruling out a significant influence on complex formation (Figure 42A-C). EMSA was 
carried out to test a potential influence on DNA binding ability of these two constructs. 
However, both mutants bound to the centromeric DNA, and no difference was 
recorded compared to wild-type core complex (Figure 42D). 
 
 
Figure 42: Analysis of core complex containing phospho-mutants of Cep3 S575 
A SDS-PAGE/Coomassie stain of initial affinity purification of CBF3 containing Cep3 SA and 
SE phospho-mutant. B Size exclusion chromatography profiles of both core complexes as 
indicated. C SDS-PAGE/Coomassie stain of final size exclusion chromatography of the load 
and peak fractions from both core Cep3 SA and SE phospho-mutant. D EMSA DNA-binding 
assay comparing both mutants. 
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5.3 Interaction between CBF3 core and Ndc10 
Besides many insights from the core structure, the question of how is the full CBF3 
complex formed and in what way is Ndc10 interacting with the other three subunits, 
remained. As shown in 3.3, despite a stable enough interaction between Ndc10 and 
the core to withstand size exclusion chromatography, as well as a generally good 
elution profile, negative stain EM revealed non-optimal particles for structural 
elucidation. This might come from intrinsic characteristics of the Ndc10 protein, be 
resultant of purification strategy or might mean Ndc10 is lacking another interaction 
partner, to become more structured. To overcome this problem, a strategy, more 
typical of crystallography, was used, and various truncated Ndc10 constructs were 
tested, in the hope to achieve a better interaction and more suitable particles. Beside 
this, biochemical studies, as well as cross-linking mass spec were conducted to get 
a better understanding of the interaction between the largest CBF3 protein and the 
core. 
5.3.1 Ndc10 NTD and CTD interaction with the core 
The first two constructs tested were the NTD (residues 1-551), of which there is a 
crystal structure available, and the CTD (residues 551 to 956), which also stably 
expresses and purifies on its own. Both were co-expressed with the other three 
subunits in yeast, in the same way as the wild-type CBF3. In agreement with previous 
studies, which show that the N-terminal of Ndc10 is important for the interaction (Cho 
and Harrison, 2012), only co-expression of the NTD was successful, whilst the CTD 
could not be detected (Figure 43A). Even so, it was noticed that the molar ratio 
between the core and the NTD was not as expected (2x Ndc10, 2x Cep3, 1x Ctf13 
and 1x Skp1), but a significantly smaller amount of NTD was detected. This hints on 
a weak interaction, or instability of this construct. Also, Ndc10 NTD lacks the 
dimerization domain, which could be a hindrance in its interaction to the core 
complex. Further purification of this complex was carried out identical to the wild-type 
complex and size exclusion chromatography revealed a weak interaction between 
the core and Ndc10 NTD (Figure 43B). Nevertheless, negative stain EM was 
attempted, but as expected no improvement was seen. In fact, this sample seemed 
to consist of core particles as well as smaller particles which could account for the 
NTD alone, as well as aggregates (Figure 43C).  
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As it was not possible to establish if the CTD of Ndc10 was successfully expressed 
in above described co-expression and co-purification experiment, a pull-down assay 
with purified protein was done to confirm this result. Both NTD and CTD were 
expressed in E.coli, and as a control also full length Ndc10 was purified from the co-
expressed full complex via the Heparin step (see 2.5.2 for details, note that a small 
amount of core will still be present in this sample). As expected, only Ndc10 NTD 
showed an interaction with the core, whereas the CTD did not. Full length Ndc10 
also interacted with the core, however, nearly the same amount did also interact with 
the streptavidin beads in the control reaction (Figure 43D). Nevertheless, the assay 
clearly showed that Ndc10 NTD can interact with the core, whereas the CTD alone 
cannot. 
 
 
Figure 43: Interaction between core complex and Ndc10 NTD/CTD 
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A SDS-PAGE/Coomassie stain of the elution after affinity purification of co-expression of 
tagged core with untagged Ndc10 NTD (residues 1-551; middle panel) or CTD (residues 551-
956; right panel). The CTD would be ~47.3kDa and does not co-purify with the core. The 
NTD is ~64.6kDa and co-elutes with the core, however not in an equimolar ratio. B 
Suboptimal size exclusion profile of core plus Ndc10 NTD, exhibiting a shoulder and two 
joined peaks. C Negative stain EM micrograph of core plus Ndc10 NTD, made straight after 
size exclusion chromatography. The red circles highlight a typical core particle (one asterisk) 
and a smaller particle probably accounting for the NTD (two asterisks). The arrow shows 
some aggregation. D SDS-PAGE/Coomassie of a pull-down assay with tagged core and 
Ndc10 full-length (FL), NTD and CTD. As shown in A the CTD does not interact with the 
core, whereas the NTD does. Full-length Ndc10 also sticks to the beads unspecifically. 
 
5.3.2 Other Ndc10 constructs 
As the NTD of Ndc10 is essential but not sufficient for the binding to the core 
complex, limited proteolysis was conducted to find a more stable construct. Both 
Ndc10 alone and in complex with the other three CBF3 proteins, as well as the core 
complex without Ndc10 was tested. Two stable degradation bands could be detected 
for Ndc10. Band 1 was more evident in the sample including the other three subunits, 
whereas the more stable band 2 appeared in both (Figure 44A). Besides Ndc10, also 
Ctf13 is degraded very quickly and entirely, whereas Cep3 and Skp1 seem to be 
more stable, even after 15min of digest. Furthermore, there is no difference in the 
degradation pattern of Ctf13 with and without Ndc10 present. This argues against a 
tight and vast binding interface between Ctf13 and Ndc10, which would lead to some 
protection against degradation of Ctf13. 
The two Ndc10 degradation bands were tested with mass spectrometry (analysis 
done by the Proteomics STP) and it was found that both consist of a C-terminal 
truncation of Ndc10. Three constructs, ending at residues 848, 777 and 683, were 
designed accordingly and co-expression was tested. All three of these constructs co-
purified with the core (Figure 44B), however, all exhibited a similar pattern as the full 
length Ndc10: a fair amount was seen in the wash of the affinity column and the yield 
obtained was small. Their behaviour during purification was similar as well, except 
that of the smallest construct, which was unstable and nearly all was lost 
consequently (Figure 44C). Negative stain analysis again, showed no improvement 
of either of these constructs compared to the full-length protein (Figure 44D). 
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Figure 44: Various Ndc10 constructs and their interaction with the core 
A SDS-PAGE/Coomassie stain from a limited proteolysis experiment, exhibiting two stable 
Ndc10 bands (1 and 2). SDS-PAGE/Coomassie stain of the initial purification steps of three 
Ndc10 constructs: 1-683 (B), 1-848 and 1-777 (C). The first lane corresponds to the wash 
(W) fraction of the StrepTactin column, showing that all three constructs partly dissociate 
from the stably bound core; the second lane is the peak fraction of the StrepTactin elution 
(S), followed by the typical heparin elution peak. D Size exclusion profiles of the wild-type 
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(WT) core compared to two of Ndc10 constructs (1-777 and 1-848). E Negative stain 
micrographs of all three constructs, not showing any improvement of particles. 
 
5.3.3 Difference of Ndc10 interaction stability with core and coreS 
During the purification of coreS for DNA binding, as well as structural studies (see 
5.1.5), it was noticed that every purification consistently yielded more Ndc10 than 
wild-type CBF3 (Figure 45A).  
 
 
Figure 45: Difference between wild-type CBF3 and CBF3 SΔ 
A SDS-PAGE/Coomassie stain of the initial purification of both, showing an increased Ndc10 
yield for the CBF3 SΔ co-expression and purification. B Size-exclusion chromatography 
profiles showing no difference other than more CBF3 SΔ full complex. Negative stained 
micrographs of core (C) and full CBF3SΔ (D). Whereas the core particles look identical to 
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wild type, the full complex shows no improvement and one can distinguish between core 
particles (red circle) and additional diffuse density. 
 
This lead to the hypothesis that Ndc10 might bind better to coreS than core complex 
with the phosphorylated Skp1 37-64 loop. This could also mean that CBF3 S would 
produce better particles, suitable for structural studies. To test this, CBF3S was 
subjected to size-exclusion chromatography and negative stain EM. Size exclusion 
profile, however, showed no improvement compared to the wild-type CBF3, and 
consistently, negative stained particles were identical (Figure 45B-D). A hypothesis 
of how coreS binds more Ndc10 is proposed in the discussion (see 7.1).  
 
5.3.4 Cross-linking mass spectrometry 
As structural studies of the full CBF3 complex were not feasible, but structural data 
of the core and part of Ndc10 is available, cross-linking in combination with mass 
spectrometry was attempted. This method can give indications of protein/protein 
interactions, by identifying amino acid pairs which are in close proximity to each 
other. This data can then be used, to model the interaction, especially if additional 
structural, or biochemical data is available to validate the crosslinks. 
CBF3 and core protein was expressed and purified as described in 2.5.2. Straight 
after size exclusion chromatography the protein was crosslinked with disuccinimidyl 
sulfoxide (DSSO) and subjected to mass spectrometry analysis. All sample 
preparation after the crosslinking, mass spectrometry and data analysis were carried 
out by the Proteomics STP. 19 and 35 inter- and intra-molecular crosslinks were 
found in the core and CBF3 sample respectively (Figure 46A and B; Table 11). Both 
samples had many overlapping crosslinks between and within the core subunits. All 
self-links, situated within the core or Ndc10 NTD crystal structure are feasible, as the 
two crosslinked peptides are in close proximity to each other. As there is no 
sequence assigned full model available for Ctf13, crosslinks within this subunit 
cannot be genuinely validated. However, all of them are within the LRRs and many 
in close proximity of each other and therefore, too seem viable. Self-links within Cep3 
are concentrated within the Gal4-domains, as well as some between the two 
monomers, whereas none were found for Skp1. Crosslinks between the subunits of 
the core also fit very well with the cryoEM structure, as the N-terminus of Skp1, which 
lies in close proximity to the F-box distal end of the LRRs, shows corresponding 
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crosslinks. Furthermore, the Gal4-domain of Cep3 crosslinks extensively to the LRRs 
of Ctf13, which can be explained as the second, still flexible Gal4-domain is located 
in this area (see 4.4). Although there are many self-links within Ndc10, only four 
crosslinks could be recorded between Ndc10 and the core. Three of these were to 
Ctf13 and one to Cep3. Interestingly, all crosslinks to Ctf13 were from the NTD of 
Ndc10, in accordance with the biochemical data showing the NTD being essential 
for the interaction. The other crosslink was between the very C-terminus of Ndc10 
and the Gal4-domain of Cep3. These results could explain why the NTD is important 
but not sufficient for the interaction. The possible meaning of the crosslinks between 
Ndc10 and the core subunits is discussed in 7.1. 
 
 
Figure 46: Cross liking- mass spectrometry 
Data from the whole CBF3 (A) and core complex (B). Crosslinks are shown as lines and 
colour coded according to type: crosslink between subunits (green), inter- or intramolecular 
self-link (violet) or homo-multimeric self-link (red). Overall more crosslinks could be recorded 
between the core subunits when Ndc10 was not present (B), however, this might be an 
experimental artefact, as the whole complex tends to aggregate especially in the high 
concentration needed for the crosslinking reaction. 
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5.3.5 Ncd10 peptide array 
In addition to co-expression of different Ndc10 constructs, as well as pull-down 
assays and crosslinking MS, a peptide array of Ndc10 was tested against tagged 
core complex. Fourteen areas of interaction were found, whereas the control showed 
no signal (Table 12 and Figure 47A and B). Of these possible interaction sites, ten 
were in the NTD (residue 1-550), and the other four in the CTD. Of the latter, three 
were close to the NTD, between residues 574 and 620, and only one at the very C-
terminus at residues 924 to 930 (Figure 47C). These results correspond well with the 
finding that the NTD is essential for interaction, but not sufficient.  
 
 
Figure 47: Ndc10 peptide array probed against with core complex 
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A Membrane 1 (top) and membrane 2 (bottom), developed on film using a primary Anti-Strep 
and secondary Anti-mouse HRP-conjugated antibody. B Duplicate control membranes 
treated equally, except for incubation without core complex. C Protein sequence of Ndc10, 
highlighting the potential areas found in the peptide array (boxes), as well as sequence 
conservation (red letters: fully or partially conserved). The asterisks show the four crosslinks 
found between Ndc10 and the core complex. D Crystal structure of Ndc10 NTD (4ACO), 
showing solvent exposed areas found in the peptide array (yellow), as well as two of the four 
crosslinked residues (red). 
 
Furthermore, three of the four crosslinks between Ndc10 and either Ctf13 or Cep3 
correspond with an element found in the peptide array (Figure 47C). From those 
areas within the crystal structure, most are entirely or partly solvent exposed, and 
seem to be concentrated on two sides of the structure (Figure 47D). However, it 
should be noted that the crystal structure only compromises the N-terminal domain 
forming a monomer (construct used to crystallise: residues 1-551; residues resolved 
in the crystal structure: residues 44-537 with some internal loops missing), whereas 
the full-length Ndc10 is nearly double the size and forms a homodimer. Therefore, 
some or all of these areas could be inaccessible in the context of full-length protein. 
 
Table 12: Summary of peptide array data 
Conservation is indicated on a scale from not conserved at all (-) to somewhat (+), partly (++) 
and very (+++) conserved. It is specified in which domain the areas belong, and for those 
situated within the published crystal structure (4ACO) it is indicated if and to what extend 
they are on the outside of the structure (i.e. solvent exposed). 
No. Residues  Conservation Domain Solvent 
exposed 
1  1 to 26 - NTD n.a. 
2 113 to 137 + NTD yes 
3 121 to 144 + NTD yes 
4 195 to 263 ++ NTD partly yes 
5 274 to 312 +++ NTD partly yes 
6 310 to 340 ++ NTD partly yes 
7 345 to 371 ++ NTD yes 
8 386 to 412 + NTD no 
9 486 to 514 + NTD yes 
10 514 to 545 + NTD n.a. 
11 574 to 608 + CTD (centralCTD) n.a. 
12 591 to 615 +++ CTD (centralCTD) n.a. 
13 599 to 620 ++ CTD (centralCTD) n.a. 
14 924 to 949 + CTD (CTDshort) n.a. 
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5.4 Interaction between CBF3 and the Cse4-nucleosome 
Both the centromeric nucleosome and CBF3 have been shown to bind to the 
centromere in yeast. How both of these rather large complexes can simultaneously 
interact with the short centromeric sequence is a matter of some debate. 
Here, it was tested if CBF3 can recognise and bind to centromeric DNA wrapped 
around a histone octamer in vitro, as has been shown for the CCAN protein Mif2 
(Xiao et al., 2017). Therefore, nucleosomes were reconstituted both with centromeric 
DNA and Widom 601 DNA (Table 9), as well as with the canonical H3 and 
centromere-specific Cse4 full-length and a construct lacking the divergent N-terminal 
tail (Cse4 HFD). EMSAs were carried out to see if addition of CBF3 results in a shift, 
as expected if there is an interaction. First nucleosome formation was tested with a 
native agarose gel (Figure 48A). All three different histone octamers formed 
nucleosomes with Widom 601 DNA, however, only H3 containing octamer has 
formed a distinct nucleosome on centromeric DNA (147bp or 185bp). Cse4 HFD 
containing octamer seemed to have formed an inconsistent protein DNA complex, 
smearing across the gel, and Cse4 full-length did not form a nucleosome with the 
centromeric DNA at all. These results might be expected to some extent, as 
centromeric DNA is very A/T-rich and therefore suboptimal for nucleosome 
formation, and so is the Cse4 full-length protein with its relatively long N-terminal tail. 
Nevertheless, two EMSA experiments were made. The first one tested for binding of 
CBF3 with either H3 nucleosome on Widom 601 DNA or a chimeric H3 nucleosome 
on centromeric DNA (Figure 48B). If CBF3 and centromeric nucleosome simply bind 
the same stretch of DNA but have no direct interaction between them, then CBF3 
should be able to bind to the chimeric but not the Widom 601 H3 nucleosome. 
However, no binding of both nucleosomes was detected. In fact, CBF3 preferentially 
bound to the free DNA present in the nucleosome sample, independently from DNA 
sequence. The second experiment was designed to see if CBF3 interacts with any 
of the three different nucleosomes on Widom 601 DNA (Figure 48C). In this case 
centromere-specific DNA sequence is not present, however, CBF3 also non-
specifically interacts with DNA and might show a binding to the centromere-specific 
Cse4 independently to DNA sequence. If that is true, one would expect a shift of 
CBF3 mixed with Cse4 full-length and/or Cse4 HFD but not with H3. However, no 
clear shift was detected in any of the three cases, and as before CBF3 seems to 
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prefer to bind to the free DNA present in the nucleosome sample. Nevertheless, by 
careful examination, CBF3 mixed with H3 nucleosome has bound nearly all of the 
free DNA, whereas in both Cse4 nucleosomes, some free DNA is left. One should 
note that, there is approximately the same amount of free DNA present in all three 
samples. Similarly, comparing the Coomassie stain intensity between the 
nucleosomes bands alone, and mixed with CBF3 full complex, both H3 and Cse4 
HFD stay the same, but there is a reduction in intensity of the nucleosome band with 
the Cse4 full-length sample (Figure 48C). Input samples on a SDS-PAGE gel are 
shown in Figure 48D. 
 
 
Figure 48: EMSA studies of CBF3/nucleosome interaction 
A Formation of different nucleosomes: a combination of H3 octamer (H3, H4, H2A, H2B), 
HFD (Cse4 HFD, H4, H2A, H2B) or FL (Cse4 FL, H4, H2A, H2B) with either 147bp Widom 
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601, 147bp or 185bp CEN3 DNA were prepared and nucleosome formation was tested with 
a native agarose gel. Whereas all histone variants formed nucleosomes with 601 DNA, only 
H3 formed a distinct nucleosome on both centromeric DNAs. B EMSA assay to test if core 
or full CBF3 complex shows interaction with a canonical H3 nucleosomes on 601 DNA or a 
chimeric H3 nucleosome on CEN3 DNA. As controls, free DNA (lane1 and 5) and core/CBF3 
mixed with free DNA (lanes 9-12) is run. C EMSA with three types of nucleosomes, H3, 
Cse4HFD (HFD) and Cse4 full-length (FL) on 601 DNA, and core and full complex (CBF3) 
showing no interaction. As in B core and CBF3 preferably bind to the free DNA present rather 
than any nucleosome. As controls, free DNA (lane 1) and core and CBF3 mixed with DNA 
(lanes 11 and 12). D SDS-PAGE/Coomassie stain of all input samples used in A-C, as well 
as two Mif2 constructs used in Figure 47. 
 
As a control of principle, the assay was repeated with Mif2, as published before (Xiao 
et al., 2017). Two Mif2 constructs were tested, Mif2 530 and Mif2 END, which also 
included the last 19 C-terminal residues. In this case a clear shift of the nucleosome 
band can be seen when adding Mif2 530 or Mif2 END (Figure 49A and B). This shift 
becomes apparent already with the lowest concentration of Mif2, and in accordance 
with the published assays, Mif2 seems to interact better with Cse4 nucleosomes than 
the canonical H3 nucleosome. Hence, the assay is working but CBF3 shows no or 
very little binding to the nucleosome, however, further improved analysis will be 
necessary to confirm these preliminary tests and these are discussed in 7.3. 
 
Figure 49: Mif2/nucleosome interaction studies 
EMSA assays as proof of principle with the same nucleosomes used for Figure 46 and two 
different Mif2 constructs: 256-end (A) and 256-530 (B). The latter was used by Xiao et al., 
2017.
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Chapter 6. Results 4: Structural and functional 
studies of the Ndc10/Scm3 interaction 
The largest subunit of CBF3, Ndc10, has been shown to interact with the Cse4-
specific histone chaperone Scm3, which led to the hypothesis that CBF3 is involved 
in recruiting and/or loading of the Cse4-nucleosome to the centromere. Structural 
data is only available for the NTD of Ndc10, as full-length protein is too unstable for 
crystallisation. Here interaction studies between Scm3 and Ndc10, as well as the full 
CBF3 complex are described. Additionally, efforts were made to gain structural 
insights into this interaction and the previously unknown CTD of Ndc10. 
6.1 Expression and purification of Ndc10 constructs 
Previous studies (Perriches, 2014) showed that Ndc10 expressed in bacteria readily 
degrades into the NTD (1-551) and CTD (551-end). Whereas the NTD is generally 
stable and has been crystallised (Perriches and Singleton, 2012); Figure 50), the 
CTD is less stable and if expressed and purified shows various degradations, with 
one at around ~25kDa being the most prevalent (Figure 51A). As digestion of the N-
terminal sumo-tag did not lead to a different migration behaviour of this degradation 
product, it was assumed to be a N-terminal truncation. Edman sequencing, 
conducted by Alta Bioscience (Cambridge), confirmed this assumption by revealing 
the start residue to be L746. A construct from this residue to the very C-terminus has 
a size of ~25kDa, which corresponds to the mass observed on SDS-PAGE. 
Expression and purification of this construct, named CTDshort, yielded a stable and 
highly-expressed product (Figure 51B), which was deemed more suitable for 
structural studies than the unstable full CTD. It was also attempted to express the 
other half of the CTD, named centralCTD (residues 551-745). This, however, did not 
lead to an expression at any of the various conditions tested, which might not be 
surprising given that most of this region is predicted to be unfolded (Perriches, 2014). 
 
 
Figure 50: Ndc10 constructs 
Schematic of the Ndc10 protein to give an 
overview of the different constructs used in this 
thesis. 
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Figure 51: Purification of Ndc10 CTD and CTDshort 
Upper panel: SDS-PAGE/Coomassie stain of lysate (Lys), soluble fraction (sol) and peak 
fractions from the initial affinity purification of CTD (A) and CTDshort (B). **... prominent 
~25kDa degradation band, which was identified as the CTDshort construct, shown in B. 
Middle panel: typical size exclusion chromatography elution profile of CTD (A) and CTDshort 
(B). Lower panel: corresponding SDS-PAGE/Coomassie stain of the input (load) and peak 
fractions.  
 
6.2 Interaction studies of Ndc10 and Scm3  
Camahort et al., 2007 have been first to show an interaction between Scm3 and 
Ndc10 through CoIP, and Cho and Harrison, 2012 presented an in vitro pull-down 
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assay with the K.lactis homologue. To test if this in vitro interaction can be 
reproduced with budding yeast proteins, ITC studies were conducted with Ndc10 
CTD and Scm3 full-length protein. Scm3 was expressed and purified from bacteria 
cells for this purpose (Figure 52A-C).  
 
 
 
As expected, ITC showed an interaction between Ndc10 CTD and Scm3 with a KD 
of 187.9nM ± 37.7nM and a N of 0.6, suggesting a dimer of Ndc10 binding to a 
monomer of Scm3 (Figure 53A). Interestingly, if repeated with Ndc10 CTDshort, no 
interaction could be recorded, limiting the binding interface to residues 551-745 
(Figure 53B). These results confirm well with previous studies, which showed that an 
equivalent K.lactis construct binds to Scm3 (Cho and Harrison, 2012). To get a better 
understanding of which part of Scm3 is important for this binding, a series of mutant 
peptides were designed and tested with ITC. Peptides were chosen from the extreme 
N-terminus (see Table 2), taking in account existing peptide array data and sequence 
conservation of Scm3 (Perriches, 2014). Whilst wild-type, mutant 1 and 2 peptides 
showed an interaction with Ndc10 CTD, mutant 3 and 4 were impaired in their ability 
to bind Ndc10 CTD. As Mutant 4 is a combination of all other mutants, residues L23 
and L24 seem to be important for the interaction (Figure 53D-H).  
Figure 52: Scm3 purification 
A SDS-PAGE/Coomassie stain of initial 
affinity purification of Scm3. Lys.. lysate; M.. 
molecular weight marker. B Typical size 
exclusion chromatography of Scm3 and (C) 
corresponding SDS-PAGE/Coomassie stain 
of the load and peak fractions. 
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Figure 53: ITC studies of Ndc10/Scm3 interaction 
Proteins were individually expressed and the buffer was matched by gel filtration with ITC 
buffer. Peptides were synthesised by the peptide unit and dissolved in ITC buffer. 
Measurements were done on a MicroCal iTC200 (Malvern), with 20 injections per run. 
Protein/peptide concentration in the syringe was 10 times higher than the protein 
concentration in the cell. Data was analysed using the Origin software. Ndc10 CTD and Scm3 
(A) showed an interaction with a calculated KD of 187.9nM ± 37.7nM and N of 0.611, 
whereas Ndc10 CTDshort and Scm3 (B) did not interact. C shows the buffer control. D-H: 
ITC measurements with Ndc10 CTD and Scm3 peptides (see Table 2). Wild-type sequence 
peptide (D), mutant 1 (E) and mutant 2 (F) interact with Ndc10 CTD, but this interaction is 
abolished with mutant 3 (G) and mutant 4 (H). 
 
In agreement to ITC measurements, analytical size exclusion chromatography with 
a mixture of Scm3 and Ndc10 CTD or CTDshort showed a co-elution only between 
Scm3 and Ndc10 CTD, but not with the CTDshort construct (Figure 54A and B). 
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Figure 54: Analytical size exclusion chromatography with Scm3/Ndc10 
Interaction between Scm3 and Ndc10 CTD (A) and Ndc10 CTDshort (B) tested with 
analytical size exclusion chromatography. Left panel: size exclusion profiles showing that 
Scm3 co-elutes with Ndc10 CTD on a S200 10/300 (GE Healthcare) column, but not with 
CTDshort on a S75 10/300 (GE Healthcare) column; right panel: corresponding SDS-
PAGE/Coomassie stain. Proteins were mixed in an equal molar ratio and incubated for 10min 
on ice before loading. 
 
6.3 Crystallisation trials 
6.3.1 Ndc10 CTDshort 
Given the instability of the CTD, crystallisation to elucidate the structure of the 
unknown C-terminal part of Ndc10 was only attempted with the CTDshort construct. 
It was concentrated straight after size exclusion chromatography and exhaustive 
crystal trials were conducted at different incubation temperatures, as well as with 
different protein concentrations (see 2.9.1 for details). However, no crystals were 
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obtained. Furthermore, efforts to determine the oligomeric state of this construct 
remained ambiguous and both SEC-MALS and analytical ultra-centrifugation (AUC) 
indicated multiple states and aggregations. Crystallisation trials were therefore 
ended. 
6.3.2 Ndc10 CTD with NTD of Scm3 
After confirming the interaction between the CTD of Ndc10 and Scm3, as well as 
demonstration that the very N-terminus of Scm3 is important, a truncated construct 
of Scm3 was designed. This was used to test the interaction and facilitate 
crystallisation trials with both interaction partners present. The binding to Scm3 might 
help to stabilise Ndc10 CTD and enable crystallisation. 
Co-expression and purification of his-tagged Scm3 NTD and untagged CTD was 
successful and both proteins could be detected after initial affinity purification (Figure 
55A). A substantial amount of CTD degradation into CTDshort was detectable, 
speaking somewhat against a strong stabilisation of CTD when bound to Scm3. 
However, size exclusion chromatography clearly showed a co-elution of the two 
interaction partners, with a ratio of two Ndc10 CTD to one Scm3 NTD, as judged by 
band intensities (Figure 55B and C).  
 
Figure 55: Co-purification of Ndc10 CTD and Scm3 NTD 
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A SDS-PAGE/Coomassie stain of initial affinity co-purification of Ndc10 CTD and Scm3 NTD. 
Lys... lysate; M... molecular weight marker; **… prominent degradation product identified as 
CTDshort. Typical size exclusion chromatography (B) and corresponding SDS-
PAGE/Coomassie stain of the load and peak fractions (C). 
 
Co-eluted proteins were concentrated and crystallisation trials were conducted (see 
2.9.1 for details). As drops from the initial screens with 2.5 and 5mg/ml protein 
concentration, stayed mostly clear, concentration was raised to 6.8mg/ml. Further 
concentration was not possible due to aggregations becoming apparent. To further 
increase protein concentration, plates were set up with a 3:1 (protein to reservoir 
solution) ratio, as well as the more commonly used 1:1 ratio. Several initial hits were 
recorded in the 3:1 ratio drops on the PACT screen, with the best condition being 
100mM Bis-Tris Propane (pH 6.5), 200mM sodium bromide and 20% PEG 3350 
(Figure 56A). Other conditions included the same buffer and precipitant, but different 
salts, including 200mM sodium citrate, formate, acetate or K/Na tartrate (Figure 56B). 
All crystals were needles, and they appeared after ~24hrs at room temperature, but 
not at 4C. Crystals only grew for about another 24hrs, before starting to bend.  
 
 
Figure 56: Ndc10 CTD/Scm3 NTD initial crystals 
A Best initial hit, with specified condition. B Other hits, with similar conditions than A but 
different salt types including 200mM sodium citrate (top left), formate (top right), acetate 
(bottom left) and potassium/sodium tartrate (bottom right).  
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Optimisation of crystals was nonetheless attempted, by screening for optimal pH, 
salt type and concentration, as well as different PEGs and their concentrations. 
Crystals could be somewhat improved, however, diffraction was poor with spots 
being recorded only to about 15Å (Figure 57A). To test if crystals still contained both 
proteins, they were gently washed with reservoir solution and run on a SDS-PAGE, 
revealing that Ndc10 CTD was completely degraded and only Scm3 NTD and some 
slightly bigger degradation products were still present (Figure 57B). Crystal trials 
were therefore ended due to instability of Ndc10 CTD.  
 
 
6.4 Interaction studies of CBF3 and Scm3 
After verifying the interaction between Ndc10 CTD and Scm3, it was attempted to 
test if this interaction can also be seen between Scm3 and Ndc10 full length in the 
context of the CBF3 complex. Purified full length Scm3 and tagged CBF3 complex 
were used for a pull-down assay with Streptavidin beads. No clear interaction was 
Figure 57: Optimised Ndc10 CTD/Scm3 NTD 
crystals 
A Best crystals obtained with optimisation of 
crystallisation condition. To test if crystals still contain both 
proteins they were run on a SDS-PAGE, shown with 
normal contrast (B) and globally enhanced contrast (C). 
The asterisk highlights the band corresponding to Scm3 
NTD (~11kDa). Ndc10 CTD, which is 47.3kDa, has 
disappeared completely. 
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seen between the two. The same amount of Scm3 was detected in samples with full 
CBF3, CBF3 core (no Ndc10 present) as well as the negative control with Scm3 only 
(Figure 58A). To see if a complex of Scm3, Cse4 and H4 histones, is needed for 
interaction, analytical size exclusion chromatography between such a complex and 
CBF3 was conducted. This also showed no interaction, as full CBF3 complex, core 
complex, Scm3 and the histones, seem to elute separately (Figure 58B). Interestingly 
Scm3 and the histones also dissociated. Further analyses, however, are necessary 
to fully interpret these preliminary results. 
 
 
Figure 58: Interaction studies between Scm3 and CBF3 complex 
A SDS-PAGE of a pull-down assay with purified Scm3 and CBF3, as well as with core and 
Scm3 alone as controls. Input is shown on the left side of the gel, eluate in the middle and 
flow-through (FT) on the right. B Size exclusion chromatography elution profile of CBF3 
mixed with a Scm3/Cse4/H4 complex (S/C/H). Protein elutes in four major peaks, and no 
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interaction can be seen between CBF3 and Scm3, nor with Scm3/Cse4/H4 complex. The 
latter seems to dissociate during the chromatography. C Corresponding SDS-PAGE gel, 
showing the input samples on the left and the four peak fractions on the right. Due to low 
yield, peak fractions were pooled as indicated in (B) and concentrated to allow for Coomassie 
detection. Peak 1: CBF3 full complex; peak 2: core complex; peak 3: Scm3 and core (still 
present as peaks 2 and 3 are overlapping); peak 4: mostly H4 but also small amounts of 
Scm3 and Cse4. 
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Chapter 7. Discussion 
7.1 CBF3 expression strategy and complex assembly 
Expression and the role of Sgt1: The co-expression and purification strategy of the 
whole CBF3 complex described in this thesis should provide a useful tool for enabling 
further structural and functional studies not only of CBF3 on DNA, but also bigger 
budding yeast kinetochore assemblies. To my knowledge, it is the first strategy 
described with a high enough yield for structural studies. Successes have been made 
before with K.lactis CBF3 core complex, which could be expressed and purified from 
insect cells with co-expression of Sgt1 (Cho and Harrison, 2012). This and the finding 
presented here that simultaneous co-expression of Sgt1 considerably improves the 
yield, as well as the inability to express and co-purify CBF3 without Sgt1 co-
expression in insect cells, emphasise previous studies showing the involvement of 
the Sgt1-Hsp90 chaperone pathway (Kitagawa et al., 1999, Bansal et al., 2004, 
Rodrigo-Brenni, 2004, Lingelbach and Kaplan, 2004). Interestingly, co-expression 
without Sgt1 yields an excess of free Cep3, indicating either that Sgt1 is necessary 
for the formation of Skp1/Ctf13 heterodimer or for the interaction between the 
heterodimer and Cep3. A recent crystal structure of a Skp1/Sgt1 complex has shown 
that both Cep3 and Sgt1 interact with Skp1 via overlapping interfaces (Willhoft et al., 
2017). Thus, Sgt1 must dissociate before Cep3 can bind, which is further supported 
by the finding that expression of the Skp1/Ctf13 heterodimer does not co-purify with 
the simultaneously over-expressed Sgt1. Accordingly, purified Skp1/Ctf13 and Cep3 
can form the core complex without Sgt1 present, as shown with an in vitro pull-down 
assay. Hence it is more likely that the Sgt1/Hsp90 chaperones are only involved in 
the formation of the heterodimer, which then in turn is able to bind to Cep3 and 
subsequently Ndc10 on its own. Despite the assumption that the heterodimer is very 
unstable and readily degraded if not incorporated into the more stable core or full 
complex, co-expression of the heterodimer yield is surprisingly high. This could stem 
from the recombinant expression strategy used and further studies are needed to 
address this. It would also be interesting to compare Skp1/Ctf13 expression without 
Sgt1 over-expression, which should yield significantly less protein. 
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Phosphorylations on CBF3: Despite earlier studies stating phosphorylation to be 
essential for complex formation and DNA-binding (Lechner, 1991, Kaplan, 1997) no 
direct evidence was found here. However, phosphatase inhibitors in the lysis buffer 
considerably impact the yield, indicating for some role of phosphorylation, which 
could be direct or indirect. Potential phosphorylation sites have been found on all 
four subunits (Holt et al., 2009, Kao et al., 2014, Kuilman et al., 2015) and the effect 
of phospho-mutants of some of these (Cep3 S575, Skp1 S162 and T177, as well as 
the Skp1 37-64 loop) were tested here. All showed no impact in complex formation, 
a finding consistent to a later study challenging the assumption of the need for 
phosphorylations (Stemmann et al., 2002). This study, however, only showed that 
complete dephosphorylation of the Skp1/Ctf13 heterodimer did not impact further 
interaction with Cep3 and Ndc10. It cannot be excluded that the Skp1/Ctf13 
heterodimer formation itself is dependent on phosphorylation or that Ndc10 might 
need to be phosphorylated to be able to be bound by the other subunits. Cep3, which 
has been expressed in bacteria for this study and therefore cannot be 
phosphorylated can thus be excluded. Accordingly, phospho-mutants of the known 
phosphorylation site of Cep3 (S575; Holt et al., 2009, Strecker et al., 2016) had no 
influence on complex formation. An interesting potential site for Ndc10 
phosphorylation is Y706, which has been found in a global screen for potential 
targets of Cdk1 and there is also evidence of a phosphorylation on this site from 
mass spectrometry results from this thesis. In vitro pull-down assays of the Ndc10 
interaction with the core were carried out with Ndc10 which was co-purified with the 
other CBF3 subunits and subsequently separated during purification. It therefore 
could have been phosphorylated at this or other sites. The Y706 also lies within the 
CTD of Ndc10, which on its own did not show any interaction with the core complex 
in pull-down assays, whereas the NTD did. Both were expressed in bacteria and 
therefore were not phosphorylated. These are, however, mere indications and more 
thorough studies will be needed to clarify if direct phosphorylation of any of the 
subunits plays a part in complex assembly.  
All findings presented here, support the suggested model of further complex 
assembly, which is an interaction between Cep3 and Skp1/Ctf13 forming the core 
complex and subsequent interaction with Ndc10. The core complex has been shown 
to be very stably bound, whilst Ndc10 can simply dissociate and re-associate.  
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Ndc10 troubles: Although Ndc10 could be co-purified and also formed a stable full 
complex with the core subunits, the particles visualised with negative stain EM were 
unsuitable for further structural studies and Ndc10 seemed to mostly dissociate from 
the core and generally be unstructured. This could be an intrinsic characteristic of 
the Ndc10 protein or a result of the purification or sample preparation process. Ndc10 
has been described as a platform for many other inner kinetochore proteins to 
assemble, as it can interact with a number of different proteins (Cho and Harrison, 
2012). Given this and the high predicted disorder, the unstructured density might not 
be very surprising. Furthermore, it is a very unstable protein on its own, as has been 
seen during the purification process. It also incorporates a degron motif at the very 
C-terminus, which upon exposure through unfolding of the protein leads to rapid 
degradation (Furth et al., 2011, Alfassy et al., 2013). However, removal of this degron 
motif by C-terminal truncations did not improve recombinant expression, nor the 
quality of particles. The NTD alone, on the other hand, seems to be too unstably 
bound to the core, indicating a longer construct is needed for proper interaction. This 
could also be verified with both crosslinking/mass spec, as well as a peptide array. 
Both showed that most of the interaction involves the NTD, but also some 
contribution of the CTD. One should also keep in mind that the NTD on its own is 
monomeric as the dimerization domain is excluded and this could impact its binding 
stability to the core complex. Future studies should concentrate on exactly identifying 
the stable product seen with limited proteolysis to test if this construct improves 
particles for structural studies.  
The above-mentioned crosslinking/mass spectrometry results also agree well with 
previous studies concluding that Ctf13 forms the central part of the complex (Russell, 
1999), as three of the four crosslinks seen on Ndc10 are with Ctf13. None are seen 
with Skp1, which would indicate Ndc10 binds distal of Skp1. If this is the case the 
Skp1 37-64 loop would remain solvent exposed and could therefore still be 
phosphorylated or dephosphorylated to ‘regulate’ DNA binding. Indeed, initial EMSA 
studies comparing the DNA binding capability of the full CBF3 complex before and 
after lambda phosphatase treatment do show an increased binding once 
dephosphorylated. The fourth crosslink of Ndc10 is to the Gal4-domain of Cep3. As 
Cep3 is a dimer, this could either be to the already stabilised Gal4-domain bound by 
Skp1 and Ctf13, or to the remaining free, DNA-binding active Gal4-domain. If the 
latter is involved, one could assume a stabilisation of Ndc10 interaction with the core 
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upon DNA binding, as this would stabilise this Gal4-domain, strengthening the overall 
interaction of all four subunits. Indeed, if one compares a co-purification of wild-type 
and coreS∆ the latter pulls down more Ndc10 consistently. The reason for this is 
believed to be that it is DNA-binding active, rather than any direct influence of the 
Skp1 37-64 loop, as after this initial difference both wild-type and coreS∆ behave 
identically. Similarly interesting is that this crosslink links to the very C-terminus of 
Ndc10, the same stretch shown to interact with the core by peptide array and also 
the same stretch harbouring most of the degron motif. It is possible that the latter 
becomes inaccessible for the proteasome machinery upon being bound by the core 
subunits, leading to an increased stability of Ndc10 within the complex. Indeed, it 
was only possible to co-purify Ndc10 with the other subunits, whilst expression and 
purification on its own in budding yeast did not yield any protein. Whilst being an 
interesting assumption, further biochemical studies or structural data of the full CBF3 
complex are needed to clarify these points.  
Another reason for Ndc10 being unstructured could be that an interaction partner is 
needed, with the centromeric DNA being the most likely candidate. Although both 
the core and full complex were DNA-binding efficient, the binding proved to be too 
weak to successfully prepare negative stain EM grids and therefore achieve any 
structural data. One likely reason is the relatively high salt concentration needed to 
prevent the complex from aggregation, but possibly hindering DNA interaction. 
Further buffer optimisation, maybe including surfactants and screening of different 
salts, might be the key to successfully reconstitute the DNA/CBF3 complex for 
structural studies.  
The first study to describe an in vitro reconstitution of endogenous CBF3 with 
centromeric DNA also found the need for an assembly factor, as addition of either a 
small amount of yeast or E.coli lysate or purified casein was needed to successfully 
reconstitute the complex. Here, the addition of casein did not improve DNA binding 
and most likely the effect of these assembly factors seen in this study simple came 
from the prevention of aggregation of CBF3 at the low salt concentrations used in 
the assays, as also suggested by the authors themselves (Lechner, 1991). 
 
Revised model of CBF3 assembly: CBF3 assembly starts with the formation of the 
Skp1/Ctf13 heterodimer, which needs the action of the Sgt1/Hsp90 chaperones 
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interacting with both Skp1 and Ctf13. The chaperones dissociate after formation of 
the heterodimer, which becomes stable whereas Ctf13 alone is not (Figure 59A). 
 
 
Figure 59: Revised model of CBF3 complex assembly 
Assembly starts with the formation of the Skp1/Ctf13 heterodimer in a Sgt1/Hsp90 dependent 
manner (A). The Skp1/Ctf13 heterodimer can then bind to a Cep3 homodimer (B) and form 
the core complex, which can interact with either Ndc10 or DNA and ultimately lead to the 
formation of the full CBF3 complex bound to centromeric DNA (C). DNA binding of the core 
as well as the full CBF3 complex is dependent of the phosphorylation status of the 37-64 
Skp1 loop. Note: Part of this figure was adjusted from Leber et al. 2018. 
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The next step is the spontaneous binding of the heterodimer to Cep3 forming the 
CBF3 core complex (Figure 59B). This happens independently of the 
phosphorylation status of the Skp1 37-64 loop or any assembly factors and leads to 
the stabilisation and therefore inactivation of one Gal4-domains. In vitro this core 
complex is able to either bind to Ndc10 forming the full CBF3 complex or to 
centromeric DNA, whereas only the latter is dependent on dephosphorylation of the 
Skp1 37-64 loop. Therefore, the order of the last two events, the binding of Ndc10 
and to centromeric DNA, remains unclear and might even be interchangeable (Figure 
59C). The full complex without DNA, however, forms a rather loose association 
where Ndc10 can readily dissociate, which probably stems from the high disorder of 
Ndc10 without being bound to DNA or other kinetochore proteins and might also be 
influenced by the flexibility of the remaining free Gal4-domain. 
7.2 CBF3 core cryoEM structure 
The CBF3 core complex structure presented in this thesis is a great example of the 
power of cryoEM. Due to low yields and its tendency to aggregate, crystallisation of 
CBF3 core would have been very difficult and time consuming at best, and 
impossible at worst. Crystallisation needs the orderly arrangement of the 
protein/protein complex to form a crystal lattice. Proteins which tend to aggregate 
severely hinder this, as they randomly attach to each other. A limitation for the 
achieved resolution of the cryoEM reconstruction was most likely the thick ice 
needed to avoid degradation of the protein when interacting with the air-water 
interface. This is a common problem with many protein samples and it may be 
possible to improve on this in future studies by the use of surfactants or addition of 
interaction partners such as Ndc10 or the centromeric DNA.  
The tight overall interface of the core structure, explaining its stability, is the first 
structural insight into the interaction between the subunits, of the shape of Ctf13 and 
has elucidated some peculiar features, like the stabilisation of one Gal4-domain and 
a new mode of F-box binding, all of which is discussed in detail below.  
 
Ctf13 structural insights: Although the resolution obtained did not allow for building a 
full atomic model of the previously unknown Ctf13 subunit, it unambiguously 
identified as an F-box protein containing LRRs (FBXL) like Skp2. This also fits with 
the role of Sgt1 in assembly of the heterodimer as studies have shown that it 
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specifically targets proteins containing LRRs (Taipale et al., 2014, Stuttmann et al., 
2008). Ctf13 has, however, diverged from typical FBXL proteins, incorporating an 
extended helical domain after the N-terminal F-box as well as a helical insertion in 
the LRRs, which functions as a cap on the F-box distal end of the structure. This is 
atypical for proteins with LRRs, as they usually form a cap with their very C-terminal 
domain. Accordingly, the sequence of Ctf13 has diverged significantly both in the F-
box and the LRRs, in the case of the latter becoming almost unrecognisable. 
Intriguingly this has also been seen for Ndc10 NTD, which has an unexpected 
tyrosine recombinase fold unable to be predicted from the sequence alone. The 
LRRs of Ctf13 also represent another reused protein motif from unrelated cellular 
processes, such as the above-mentioned tyrosine recombinase fold of Ndc10 (DNA 
topology and transposition), the Gal4 DNA-binding domain from Cep3 (transcription), 
as well as the F-box of Ctf13 and Skp1 (ubiquitylation). Intriguingly all of these 
processes are ancient and widespread, speaking for CBF3 to be a relatively recent 
invention. This would fit with the hypothesis that point centromeres are a relatively 
young simplification of the more complex regional centromeres, emerged due to the 
lack of centromere competition in budding yeasts and actually representing a 
modification of the 2-micron plasmid partitioning system (Malik and Henikoff, 2002, 
Malik and Henikoff, 2009). 
 
A new Skp1/F-box interaction: An interesting feature of the core structure is the way 
Skp1 binds the F-box of Ctf13, as it is different to all other known Skp1/F-box 
interactions. Intriguingly all of these structures were derived from proteins expressed 
in bacteria, whilst the phosphorylation status of Skp1 has been shown to affect the 
interaction with Met30, a F-box protein containing WD40 repeats (S162; Beltrao et 
al., 2012). Mutations in the two potential phosphorylation sites of Skp1 (S162 and 
T177) within the F-box binding part did not influence formation of the Ctf13/Skp1 
heterodimer, as all phospho-mutants of Skp1 successfully co-purified Ctf13. The 
possibility that phosphorylation of these sites influences further complex formation 
like Cep3 binding, however, cannot be excluded and should be tested in the future. 
Besides the two last helices of Skp1, which in all available structures facilitate F-box 
binding, an extended loop (residues 105-112) also contacts the F-box, as well as the 
LRRs of Ctf13 in the cryoEM structure. Two aspects of this are interesting, first this 
loop has been found disordered and solvent exposed in all known Skp1/F-box protein 
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structures solved so far, and second although Ctf13 only exists in budding yeasts 
this loop of Skp1 is conserved to higher eukaryotes. This could mean that there may 
be other FBXL proteins which bind in the same manner as Ctf13. Therefore, one 
could separate between two classes of FBXL proteins binding either with or without 
involvement of this loop. Another scenario would be that Skp1 can bind to one FBXL 
protein in two different conformational states, possibly involving some 
posttranslational modifications. The latter could represent a switch between inactive 
and active state, as has been described for the Skp1/Ctf13 heterodimer (Russell, 
1999, Kaplan, 1997). Although an interesting possibility, not only for CBF3 but also 
for SCF ligases and the impact it could have on the positioning of the substrate within 
the SCF ligase, further studies are needed to test this hypothesis. For example, one 
could test if the Skp1/Ctf13 phosphor-mutants influence Cep3 binding with in vitro 
pull-down assays, or conduct in vivo interaction studies, like protein complementation 
assays with the different mutants. 
 
Gal4-domain stabilisation: The Skp1/Ctf13 heterodimer binds to one Cep3 monomer 
in a way that includes contacts with the Gal4-domain. This leads to a stabilisation 
and inactivation of this Gal4-domain, whilst the other remains free. Therefore, CBF3 
although containing a homodimer of Cep3 can only recognise one CCG triplet. A 
peculiar DNA-binding characteristic, which explains that only one CCG triplet is 
conserved in the point centromere. It also highlights the significance of structural 
biology to elucidate how proteins and protein complexes function, as one could have 
never predicted this behaviour from sequence alone.  
The remaining flexible Gal4-domain could be visualised, albeit with low resolution, 
with sophisticated focussed 3D-classification algorithm, thus stressing the 
importance of good software in extracting all information of a cryoEM dataset. It does 
not seem to exhibit, however, distinct conformations, rather a transient movement, 
which is the reason for the low local resolution obtained. Therefore, the likely path of 
the DNA could not be predicted, and here again only structural data of the complex 
bound to DNA will elucidate the exact mode of DNA binding. Biochemical evidence 
of DNA binding is discussed in the next chapter. 
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7.3 DNA-binding of CBF3 core and full complex 
Besides above-mentioned stabilisation and inactivation of one Gal4-domain by the 
binding of the Skp1/Ctf13 heterodimer, EMSA studies clearly showed that the core 
can bind centromeric DNA sequence-specifically and that the remaining free Gal4-
domain is most likely responsible for this binding. This represents the first clear 
evidence of DNA-binding capability of the core complex without Ndc10 and stands 
against the proposal that all four subunits are needed to activate CBF3 (Sorger et 
al., 1995, Stemmann and Lechner, 1996, Kaplan, 1997, Espelin, 1997, Pietrasanta, 
1999).  
Intriguingly, the core can only bind after dephosphorylation of the 37-64 Skp1 loop, 
suggesting a form of regulation of DNA-binding previously unknown. Although Skp1 
is conserved to higher eukaryotes, this loop is budding yeast-specific, as is CBF3 
itself. In vivo studies showed that one can delete this loop (Skp1∆) and cells are still 
viable (Connelly and Hieter, 1996) and mutation of the phospho-sites in this loop also 
results in viable cells (Stemmann et al., 2002). Accordingly, in this thesis it is shown 
that Skp1∆ can mimic the DNA-binding active state and does not influence core 
complex formation nor its structure. If the function of phosphorylation of this loop is 
only to inhibit DNA-binding then these results could be explained, as cells without 
the loop or phospho-sites would still be able to form the kinetochore and undergo 
mitosis. DNA-binding inhibition might, for example, only ensure that CBF3 binds to 
the centromere in a cell cycle regulated manner or hinders binding of CBF3 outside 
of the centromeric sequence. More stringent in vivo experiments are needed, 
however, to test these hypotheses and future studies should include the optimisation 
of the cell cycle regulation experiment of Skp1 phosphorylation in 5.1.3. Although the 
overall phosphorylation of Skp1 did not seem to change during the cell cycle, CBF3-
specific changes could still take place and might not have been seen due to the 
unsuccessful Co-immunoprecipitation. One possible reason for this may have been 
the method used for cell disruption, as it has been found to also affect the complex 
integrity of recombinant expressed CBF3.  
As structural data of the CBF3/DNA complex is still lacking, the details of DNA-
binding and how the phosphorylation status of the Skp1 loop effects this interaction 
is not clear. Generally, one could suggest two possible ways: First, DNA could be 
bound by the free Gal4-domain and then lie across the core structure bringing it close 
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to the Skp1 37-64 loop and the charge of the four phosphorylations inhibits DNA 
binding. Alternatively, the dephosphorylation of the Skp1 loop could lead to a 
conformational change which allows stable DNA-binding. Intriguingly, the central 
channel of the overall core structure would accommodate a double strand DNA nicely 
with only a small movement of the Skp1/Ctf13 heterodimer to open the channel. The 
DNA-binding active coreS∆, which mimics the dephosphorylated core in EMSA 
studies, however, does not seem to exhibit any movements and the central channel 
is of identical dimensions. Also, one would expect a rather strong interaction between 
the core and DNA if it would indeed lie tightly packed in the central channel and this 
does not seem to be the case in both the EMSA studies and during attempts to 
reconstitute the complex with DNA. Therefore, it seems more likely that DNA lies 
across pointing towards the Skp1 37-64 loop. It is difficult to predict the path of DNA, 
however, with the limited structural data, and future studies should concentrate on 
further optimisation of purification and/or reconstitution protocols, which should allow 
structural studies of the CBF3/DNA complex to elucidate the interaction and the 
possible effect of DNA bending and looping.  
 
DNA binding in context of the nucleosome: Preliminary EMSA studies presented 
here showed that both core and full CBF3 seem to prefer to bind to free DNA rather 
than DNA wrapped around the nucleosome. Although further optimisation of these 
assays will be needed to clarify the exact effect of Cse4 and centromeric DNA, this 
result could reflect the fact that CBF3 is supposed to be the initial factor to recognise 
centromeric DNA and then leads to the recruitment of the centromeric nucleosome 
through other proteins, like Scm3. It could also mean that CBF3 needs naked DNA 
to be able to bind to the centromere and initiate kinetochore formation or that CBF3 
DNA-binding is incompatible with a conventional left-handed nucleosome. 
Interestingly, a recent study has shown that the handedness of DNA wrapping 
depends on the supercoiling state of the DNA, and one can assemble both left and 
right-handed nucleosomes (Vlijm et al., 2017). Future studies could take advantage 
of this study and test if the binding is influenced by the handedness of the 
nucleosomes, as well as more stringently test if there is a preference to bind to naked 
DNA instead of DNA wrapped around nucleosomes.  
The question how CBF3, the Cse4-nucleosome, Mif2, Cbf1 and possibly other 
kinetochore proteins can interact simultaneously with the short centromere remains. 
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An interaction between the core and DNA with the flexible Gal4-domain, however, 
would allow the core to bind with considerable freedom of movement relatively to the 
DNA and could position it just outside the nucleosome. The majority of the Cse4-
nucleosome interaction could be facilitated through the subunit Ndc10, as has been 
previously suggested (Cho and Harrison, 2012). This would allow for a rather flexible 
arrangement, which could facilitate the Cse4-nucleosome assembly steps as well as 
could lead to unusual DNA topologies found at the centromere (Pietrasanta, 1999, 
Lawrimore et al., 2015, Diaz-Ingelmo et al., 2015). 
7.4 Interaction between Ndc10 and Scm3 
CBF3 is believed to recruit Cse4 specifically to the centromere via an interaction 
between the conserved histone chaperone Scm3 and Ndc10. Scm3 forms a trimeric 
complex with Cse4 and H4 in solution (Cho and Harrison, 2011, Zhou et al., 2011). 
This interaction does not include the N-terminus of Scm3, which is believed to be 
involved in the interaction with Ndc10. Here this finding is confirmed with interaction 
studies between the N-terminus of Scm3 and the CTD of Ndc10. The latter is the 
least characterised of Ndc10 and is involved in dimerization, DNA-binding and 
interaction to other kinetochore proteins like Scm3 and Bir1 (Cho and Harrison, 2012, 
Perriches, 2014). ITC studies could identify important Scm3 residues for the 
interaction with the Ndc10, however, it was not possible to stabilise a complex 
between the two for crystallisation studies. Hence, further optimisation will be 
necessary to find a shorter Ndc10 construct which is still Scm3 binding efficient but 
more stable for structural studies. Furthermore, mutational studies with the Scm3 
protein rather than simply peptides should be conducted to verify the impact of these 
Scm3 residues on the interaction. 
Surprisingly no interaction could be found between the full CBF3 complex and Scm3, 
although these results should be confirmed by additional experiments and 
replications. However, it would be possible that the unstructured nature of Ndc10 
seen with negative stain EM is somehow hindering Scm3 interaction. Possibly, CBF3 
needs to be bound to the centromere, before Ndc10 is able to recognise Scm3 and 
therefore helps to incorporate the Cse4-nucleosome by destabilising the 
Scm3/Cse4/H4 interaction. Both biochemical assays and structural studies should 
Chapter 7. Discussion 
 
172 
 
be conducted to test this hypothesis and elucidate the role Ndc10 is playing in 
recruiting and possibly also incorporating the Cse4-nucleosome.  
 
7.5 Recent publications  
Just before submission of this thesis an article was published presenting a modified 
core structure with and without an equivalent to the NTD of Ndc10 by Zhang et al., 
2018. The following section summarises their findings in respect to this thesis.  
The authors describe a cryoEM structure of a construct lacking the Gal4-domains of 
Cep3 (identical to the core Gal4∆ construct used here) at a similar overall resolution. 
However, the Ctf13 density is better defined enabling an atomic model of Ctf13 to be 
built. They confirm findings presented here of the unusual F-box/Skp1 interaction, as 
well as the insertion in the LRRs capping the structure on the F-box distal side. 
However, they identified eight, rather than the seven LRRs reported here. It is 
interesting that the Ctf13 subunit is better defined in this construct rather than the 
wild-type, especially as the part of Ctf13 with lower resolution in our structure is 
directly in contact with the stabilised Gal4-domain, which is completely lacking in 
their construct. The other structural details are identical to the core structure 
presented in this thesis. 
Similarly, they also co-expressed the core subunits in budding yeast itself with 
simultaneous expression of the assembly factor Sgt1. However, they report a 
difficulty in purifying the wild-type core complex with Cep3 containing the Gal4-
domains. It is possible that this difficulty may have arisen from the lack of 
phosphatase inhibitors, as in their method section these are not mentioned. As 
described in this thesis, however, they are crucial for complex integrity.  
In their case, DNA-binding can be seen without prior dephosphorylation, which again 
could stem from the lack of phosphatase inhibitor leading to dephosphorylation of 
the Skp1 loop during cell breakage. It would be interesting to test this by determining 
the phosphorylation status of their construct; however, the authors have not tried to 
assess this possibility but only state the difference. It should also be noted that whilst 
this thesis clearly shows that DNA-binding is facilitated by the Gal4-domain(s), their 
construct is lacking exactly these. Mutational studies have shown the importance of 
the conserved CCG triplet in the centromere, and it is clear that the Gal4-domain(s) 
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are responsible for this sequence-specific interaction (Ng and Carbon, 1987, 
Hegemann and Fleig, 1993, Bellizzi, 2007, Purvis and Singleton, 2008). However, 
other contacts are made with Cep3 and Ctf13 as has been shown by crosslinking 
studies (Espelin, 1997). The binding reported by Zhang et al., 2018 therefore must 
represent only these additional contacts. Furthermore, they map the DNA-binding to 
the central channel with mutational studies of Ctf13 and Cep3 residues, suggesting 
a model by which both Gal4-domains bind to DNA to the CCG and to the potential 
second TGT triplet. They argue that the core structure reported in this thesis is locked 
in an inactive state, and that the stabilised Gal4-domain needs to be freed to activate 
the complex. Indeed, the wild-type core structure presented here corresponds to the 
inactive DNA-binding state, however, unknown to the authors we excluded the 
possibility that the stabilised Gal4-domain must be set free for DNA-binding with the 
second cryoEM structure of the coreS. This construct although DNA-binding active, 
still displays the same stabilisation and therefore inactivation of the Gal4-domain in 
the vicinity to the Skp1/Ctf13 heterodimer. However, it cannot be excluded that 
dephosphorylation, rather than deletion of the 37-64 Skp1 loop is unlocking this Gal4-
domain. Equally it is possible that some part of the datasets both for wild-type and 
coreS were comprised of particles with an unlocked or rotated Gal4-domain, which 
therefore would allow DNA contacts. If those particles do not average together, for 
example because this Gal4-domain is then more flexible, they could have been 
discarded in the data processing workflow. However, at no point in any classification 
step such a subset of particles was seen and this would also not explain the peculiar 
fact that there is only one conserved CCG triplet at the centromere. Furthermore, 
mutation of the TGT triplet has no effect on DNA-binding in EMSA studies presented 
here, which would not be expected if the stabilised Gal4-domain is specifically 
binding these residues, as suggested by Zhang et al. 2018. It should be noted that 
the idea of the second TGT triplet being bound by one Gal4-domain has only ever 
being suggested as a possibility and no data directly supports this binding. The 
crosslinking study cited by Zhang et al. 2018 only shows an interaction between 
these residues (TG) and the Cep3 protein as a whole, not the Gal4-domain especially 
(Espelin, 1997). Therefore, it was surprising that the authors stated that hypothesis 
as fact in their introduction, when it would be equally possible that any other part of 
Cep3 is in contact with these two bases. However, the mutational studies shown by 
the authors is speaking clearly for the DNA to be located in the central channel. A 
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possibility which in this thesis is also not excluded, even if the stabilised Gal4-domain 
is not involved in DNA-binding itself. 
Excitingly, the authors could stabilise a complex of the core Gal4∆ and an equivalent 
of the NTD of Ndc10 for structural studies, an important achievement. Although lower 
in resolution they could dock the crystal structure of the NTD into the EM density and 
therefore describe the core binding site, as well as predict the DNA binding path. The 
interaction domain lies in the insertions of the Ctf13 F-box and the very N-terminus 
of Ndc10, supporting findings described here that the NTD is essential for the 
interaction. Interestingly, this brings the stabilised Gal4-domain in the wild-type 
structure presented here into close proximity of this binding domain. It will be 
interesting to see if the NTD interaction could be affected by the Gal4-domain by 
superposition of the two core structures upon release of the coordinates of the core 
Gal4∆ with Ndc10 NTD from the PDB/EMDB databanks. If this binding is not 
compatible, one would assume that indeed a conformational change needs to take 
place for further complex formation, possibly freeing the stabilised Gal4-domain. This 
could also explain the difficulties described here in stabilising Ndc10 on the core 
structure. 
Even more recently another CBF3 structure with centromeric DNA has been 
deposited, although not yet released nor published. It will be exciting to see how this 
new structure binds DNA, and possibly how the differences between the wild-type 
and core Gal4∆ might be explained. All these efforts together should provide a more 
accurate picture of the function of CBF3 on the point centromere and are an 
important step forward in kinetochore research. 
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